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Abstract 
Circular RNAs (circRNAs) are an endogenous class of animal RNAs. Despite their abundance, 
their function and expression in the nervous system are unknown. Therefore, a circRNA 
catalogue comprising RNA-seq samples from different brain regions, primary neurons, 
synaptoneurosomes, as well as during neuronal differentiation was created. Using these and 
other available data, thousands of neuronal human and mouse circRNAs were discovered and 
analyzed. CircRNAs were extraordinarily enriched in the mammalian brain, well conserved in 
sequence, often expressed as circRNAs in both human and mouse, and sometimes even 
detected in Drosophila brains. CircRNAs were overall upregulated during neuronal 
differentiation, highly enriched in synapses, and often differentially expressed compared to 
their corresponding mRNA isoforms. CircRNA expression correlated negatively with 
expression of the RNA-editing enzyme ADAR1. Knockdown of ADAR1 induced elevated 
circRNA expression. Together, a circRNA brain expression atlas and evidence for important 
circRNA functions is provided. 
Starting from this catalogue a circRNA, circSLC45A4 was identified. It is the main RNA isoform 
produced from its genetic locus in the developing human frontal cortex and one of the highest 
expressed circRNAs in that system. Knockdown of this conserved circular RNA in a human 
neuroblastoma cell line was sufficient to induce spontaneous neuronal differentiation, 
measurable by increased expression of neuronal marker genes and neurite outgrowth. 
Depletion of circSlc45a4 in the developing mouse cortex caused a significant reduction of the 
basal progenitor pool and increased the expression of neurogenic regulators like Notch2, 
Foxp2, and Unc5b. Furthermore, a significant depletion of cells in the cortical plate after 
knockdown of circSlc45a4 was observed. In addition, deconvolution of the bulk RNA-seq data 
with the help of single cell RNA-seq data validates the depletion of basal progenitors after 
knockdown of circSlc45a4 in the mouse cortex and reveals an increase in Cajal-Retzius cells. 
Taken together, a detailed study of a conserved circular RNA that is necessary to maintain the 
pool of neural progenitors in vitro and in vivo is presented. 
The developing mouse cortex is a good illustration for a highly spatially organized tissue and 
why knowledge of spatial information for each cell can be of great importance. However, 
obtaining transcriptome-wide and spatially resolved information from single-cells has been 
proven to be a challenging task. Current state-of-the-art experimental methods are either 
limited by the number of genes that can be detected simultaneously within a single-cell or 
require preexisting spatial information. Here, 3D-seq, a new experimental technique that allows 
unbiased, high-throughput single-cell spatial transcriptomics is introduced. 3D-seq combines 
a physical grid with combinatorial indexing to label single cells of any tissue in a unique way 
and thereby preserving the approximate spatial localization of any given cell. 3D-seq was 
applied to coronal slices of adult mouse brain, more than 70 cell types were identified and the 
3D-seq data was used to reproduce the tissue in silico with single-cell resolution. Furthermore, 
3D-seq is easy to adapt, can be applied to any tissue and can be combined with other 
technologies. 
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Zusammenfassung 
Zirkuläre RNAs sind eine Klasse endogener, tierischer RNAs. Obwohl sie hoch abundant sind, 
ist weder ihre Funktion noch ihre Expression im Nervensystem bekannt. Deshalb wurde ein 
Katalog zirkulärer RNAs erstellt, der aus RNA-Sequenzierungen von verschiedenen 
Hirnregionen, primären Neuronen, Synaptoneurosomen und neuronalen 
Differenzierungmodellen besteht. Mit Hilfe dieser und weiterer Daten konnten tausende bisher 
unbekannte zirkuläre RNAs von Mensch und Maus entdeckt und analysiert werden. Zirkuläre 
RNAs sind außerordentlich angereichert im Säugetiergehirn, ihre Sequenz ist gut konserviert, 
sie sind häufig gemeinsam in Mensch und Maus exprimiert und teilweise sogar in Drosophila 
Gehirnen. Zirkuläre RNAs waren generell höher exprimiert im Verlauf der neuronalen 
Differenzierung, sind stark angereichert an Synapsen und oft differentiell exprimiert im 
Vergleich zu der korrespondierenden mRNA Isoform. Zudem korreliert die Expression von 
zirkulären RNAs negativ mit der Expression des RNA-editierenden Enzyms ADAR1. Induzierte 
Verminderung der Expression von ADAR1 führte zu erhöhter Expression von zirkulären RNAs. 
Somit wird ein Katalog für die Expression zirkulärer RNAs vorgestellt, der Hinweise auf die 
wichtigen Funktionen zirkulärer RNAs liefert. 
Ausgehend von diesem Katalog wurde eine zirkuläre RNA, circSLC45A4, identifiziert. Diese 
zirkuläre RNA ist die Hauptisoform, die in präfrontalem, embryonalen Cortex in der 22. 
Schwangerschaftswoche von dem genomischen SLC45A4 Lokus exprimiert wird und generell 
eine der am höchsten exprimierten zirkulären RNAs in diesem System ist. Induzierte 
Verminderung der Expression von circSLC45A4 ist ausreichend, um die spontane neuronale 
Differenzierung einer humanen Neuroblastomzelllinie (SH-SY5Y) zu induzieren. Dies kann 
durch die verstärkte Expression neuronaler Markergene und das verstärkte Neuritwachstum 
belegt werden. Verminderung der Expression von circSLC45A4 im sich entwickelnden, 
embryonalen Mauscortex verursacht eine signifikante Reduktion von basalen Progenitoren 
während neurogene Regulatoren wie Notch2, Foxp2 und Unc5b verstärkt exprimiert werden. 
Außerdem wurde eine signifikante Reduktion von Zellen in der kortikalen Platte nach Depletion 
von circSLC45A4 gemessen. Weiterhin konnten die im manipulierten Mauscortex 
gesammelten RNA-Sequenzierergebnisse mit Hilfe von Daten einer Einzelzellsequenzierung 
dekonvoliert werden. Dies bestätigte die Reduktion der basalen Progenitoren und zeigte 
zusätzlich, dass vermehrt Cajal-Retzius Zellen auftraten. Somit wird eine detaillierte 
Untersuchung einer konservierten zirkulären RNA, die notwendig für den Erhalt von 
neuronalen Progenitoren ist, präsentiert. 
Der sich entwickelnde Mauscortex ist ein gutes Beispiel für ein Gewebe, das eine starke 
räumliche Organisation aufweist und verdeutlicht damit, warum die Kenntnis der räumlichen 
Lage für jede einzelne Zelle von großer Wichtigkeit sein kann. Dennoch ist es weiterhin eine 
große Herausforderung gleichzeitig Transkriptom-weite and räumlich aufgelöste 
Sequenzierdaten im selben Experiment zu sammeln. Bisher existierte keine Methode die 
beides leisten konnte. Die vielversprechendsten Methoden sind entweder begrenzt in der 
Anzahl an Transkripten, die gleichzeitig in einer Einzelzelle gemessen werden können, oder 
benötigen bereits anderweitig existierende, räumliche Informationen. Hier wird eine neue 
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experimentelle Methode vorgestellt, die Hochdurchsatz RNA-Sequenzierung von Einzelzellen 
mit räumlicher Auflösung zulässt, ohne vorherige Kenntnisse des Systems zu benötigen:  
3D-seq. 3D-seq vereint die Applikation eines physischen Gitters am Gewebe mit 
kombinatorischem Indizieren, so dass Einzelzellen individuell und räumlich markiert werden 
können. 3D-seq wurde an koronalen Schnitten von adultem Mausgehirn etabliert. Hierbei 
konnten mehr als 70 Zelltypen identifiziert werden und die so erhaltenen Daten wurden zur 
Reproduktion des Gewebes in silico genutzt. Zudem ist 3D-seq ein leicht zu adaptierendes 
Protokoll, das an jedem Gewebe angewendet werden kann und ebenfalls leicht mit anderen 
Techniken kombiniert werden kann. 
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2 Abbreviations 
AP Apical progenitor RT Reverse transcription 
ATRA All-trans retinoic acid SDS-
PAGE 
Sodium dodecyl sulfate poly-
acrylamide gel electrophoresis 
BP Basal progenitor SLC SLC45A4 
bp base pair Slc Slc45a4 
BSA bovine serum albumin SVZ Subventricular zone  
Bst brainstem TEMED Tetramethylethylenediamine 
cb Cerebellum TPM transcripts per million 
CDS coding sequence UNG uracil-N-glycosylase 
ch Cerebral hemisphere UTR Untranslated region 
circRNA circular RNA VZ Ventricular zone 
CNS central nervous system WG Gestational week 
CP Cortical plate   
ddH2O double distilled water   
dTh Dorsal thalamus   
E Embryonic day   
EB Embryoid body   
EMCV Encephalomyocarditis virus   
FAM 6-Carboxyflurescein   
HA Hyperpallium apicale   
HC hippocampus   
hnRNA heterogenous nuclear RNA   
IHA Interstitial nucleus   
IP intermediate progenitor, 
immunoprecipitation; context 
dependent 
  
IRES Internal ribosome entry site   
IT Intratelencephalic neuron   
IUE In utero electroporation   
IVT in vitro transcription   
IZ Intermediary zone   
KD knockdown   
lncRNA long non-coding RNA   
Lx Layer x   
m Medulla oblongata   
Md Dorsal mesopallium   
miRNA micro RNA   
MMLV Moloney murine leukemia virus   
MZ Marginal zone   
ncRNA Non-coding RNA   
NEC Neuroepithelial cell   
NEU Neuron   
ob Olfactory bulb   
ot Optic tectum   
PA Polyamide   
PC Polycarbonate   
PC Polycarbonate   
PDMS polydimethylsiloxane   
PFA paraformaldehyde   
pg Pituitary gland   
PLA polyamide   
PLL poly-L-lysine   
PP preplate   
qPCR Quantitative real time PCR   
RBP RNA-binding protein   
RCM reverse complementary sequence 
matches 
  
RGC radial glial cells   
RNAi RNA interference   
RNA-seq RNA sequencing   
- 2 - 
 
  
- 3 - 
 
3 Introduction 
3.1 Circular RNAs are a new class of functional RNAs 
3.1.1 Emergence and biogenesis of circular RNAs 
In 1957, Francis Crick postulated in a lecture at the University College London ‘the central 
dogma of molecular biology’ (Crick, 1970, 1958). He proposed the idea of information flow, 
meaning the transfer of information, from DNA to RNA to protein and certain variations thereof 
(Figure 1 - A). This proposal included a side note on the likely existence of RNA molecules that 
function as adapter molecules, which were indeed shortly thereafter identified as tRNAs. 
Although, this conceptualization of information flow in a cell is powerful, it is a simplified 
concept to describe the complex regulatory networks found in each cell. The view on how 
complex the regulatory networks are, was considerably broadened by discoveries that were 
made in the field of RNA biology (Morris and Mattick, 2014). The discovery of heterogeneous 
nuclear RNAs (hnRNAs) in 1969 (Warner et al., 1966) led to speculations about the existence 
of a broad RNA-based regulatory network (Britten and Davidson, 1969). The existence of a 
broad RNA-based regulatory network was further spurred by the discovery of introns in 1977 
(Berget et al., 1977; Chow et al., 1977), of ribozymes (Guerrier-Takada et al., 1983; Kruger et 
al., 1982), of the regulatory function of miRNAs (Fabian et al., 2010; Krek et al., 2005; Lagos-
Quintana et al., 2001; Lee et al., 1993; Reinhart et al., 2000), of RNA interference (Elbashir et 
al., 2001a; Fire et al., 1998), and of long noncoding RNAs (lncRNAs) (Guttman et al., 2009; 
Mercer et al., 2009). 
 
Figure 1: Central Dogma of Molecular Biology (Francis Crick, 1956) 
Unpublished note by Francis Crick depicting his postulated ‘central dogma of molecular biology’. 
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The various already mentioned RNA species have in common that all of them have a free 3’- 
and 5’-end. However, circular RNAs (circRNAs) are covalently closed RNA molecules and 
have been discovered several decades ago. They came back into focus with the broad 
description of them as a whole class of RNA molecules (Memczak et al., 2013). Already in the 
1970s, certain plant pathogens, viroids, were described to consist of single-stranded, 
covalently closed circular RNA molecules (Sanger et al., 1976). Shortly after this discovery, 
circular RNA structures were discovered in cytoplasmic RNA extracts from HeLa cells (Hsu 
and Coca-Prados, 1979). The authors speculated that these circular RNAs are indeed 
covalently closed, as not even highly denaturing conditions are able to disrupt their circular 
structure. Furthermore, they suggested that circular RNAs could be remains from a viral 
infection. But if they were produced by HeLa cells themselves, circRNAs could be serving as 
efficient translation templates. And indeed, the genome of the animal Hepatitis delta virus was 
also shown to be a covalently closed circular RNA that could hypothetically be a template for 
translation (Kos et al., 1986). It was also speculated that due to their small size and circularity, 
circRNAs had an enhanced probability of survival in error-prone, primitive self-replicating RNA 
systems and that complete replication could occur without the need for initiation or termination 
signals (Diener, 1989). Hence, it was indicated that circular RNAs could be remnants of the 
RNA world. 
However, circular RNAs are not only parts of viruses or remnants of the RNA world. Instead, 
they were shown to be produced from eukaryotic genes. The gene DCC for example produces 
at least 4 different circular RNAs that although lowly expressed were detectable by a PCR 
assay (Nigro et al., 1991). Another example is the human ETS-1 gene, which was shown to 
be non-polyadenylated, lowly expressed and not produced from genomic rearrangements or 
pseudogene transcription but instead from a splicing reaction that yields circular molecules 
(Cocquerelle et al., 1992, 1993). The authors also highlight, that the circularly spliced exons of 
ETS-1 are surrounded by unusually large introns just like the DCC circRNAs. Also, they show 
that circETS-1 is cytoplasmic and unusually stable, as it is still detectable after 48 h of 
transcriptional block with actinomycin D. They considered circular RNAs a result of missplicing 
that could potentially help shed light on splicing reactions in general. Interestingly, it became 
clear that circular RNAs are not always lowly expressed: a circular RNA originating from Sry 
was determined to be the highest expressed transcript isoform from this gene in testis (Capel 
et al., 1993). The authors reported that this circular RNA was cytoplasmic and not substantially 
bound to polysomes although it would contain a 393 amino acid long open reading frame. 
However, the mechanism of this circular RNA remained elusive. In vitro experiments in nuclear 
HeLa extracts indicated that indeed the splicing machinery is responsible for joining exons in 
an inverted order and thereby producing circular RNAs (Braun et al., 1996; Pasman et al., 
1996), a process that is also known as backsplicing (Figure 2 - A).  
Noteworthy, recent transcriptome wide studies revealed that circRNAs are an abundant 
phenomenon and not rare missplicing events. Indeed, hundreds of circRNAs were identified in 
Archaea (Danan et al., 2012), human cell lines (Jeck et al., 2013; Memczak et al., 2013; 
Salzman et al., 2012), mouse and nematodes (Memczak et al., 2013), and Drosophila (Ashwal-
Fluss et al., 2014; Westholm et al., 2014). Many of these circRNAs are highly abundant, tissue 
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and developmental-stage specific (Memczak et al., 2013). Most circRNAs are indeed produced 
from exons, however circRNAs originating from all types of genomic regions have been 
identified– introns, 5’UTRs, 3’UTRs, intergenic regions etc. (Memczak et al., 2013). 
Furthermore, exons containing circRNAs were more conserved in the third codon position, 
indicating evolutionary constraints on the nucleotide level in addition to selection at the protein 
level (Memczak et al., 2013). An important tool to identify circular RNAs is RNase R, a 3’-5’ 
exonuclease from Escherichia coli that digests linear RNA and Y-structure RNA efficiently, 
while circular RNAs and lariat RNA are left intact (Suzuki et al., 2006). To discriminate between 
circular RNAs and intron lariats a debranching assay, Sanger sequencing of the head-to-tail 
splice junction, nicking assays or a head-to-tail junction specific Northern blot can be used 
(Memczak et al., 2013).  
Converging evidence exists that circRNAs are processed co-transcriptionally. Backsplicing 
seems to be mediated by the spliceosome, as circRNAs are detected in chromatin-associated 
RNA and drugs arresting spliceosome activity significantly reduce circRNA production rates 
(Ashwal-Fluss et al., 2014; Starke et al., 2015; Zhang et al., 2014). In addition, the rate of 
circRNA production is highly affected by the presence of canonical splice sites in surrounding 
exons and correlates positively with the elongation rate of RNA Polymerase II (Zhang et al., 
2016). An RNAi screen in Drosophila melanogaster identified several pre-mRNA processing 
factors that modulate circular RNA levels. Surprisingly, circular RNA expression increased 
when core spliceosomal factors were limited (Liang et al., 2017). Backsplicing is enhanced, 
when the circRNA-surrounding introns possess highly complementary sequences. These 
highly complementary sequences are often transposable elements, like Alu elements (Ivanov 
et al., 2015; Liang and Wilusz, 2014; Zhang et al., 2014). Accordingly, circRNAs are often 
surrounded by introns that contain Alu elements (Jeck et al., 2013). Most splicing in human, 
mouse, and Drosophila occurs co-transcriptionally in the nucleus (Brugiolo et al., 2013). 
CircRNAs are pre-dominantly localized in the cytoplasm (F. Torti, personal communication, 
2013). Hence, they have to be exported from the nucleus. Their nuclear export is length 
dependent and requires the DexD-Box helicases DDX39A or DDX39B, at least in a human cell 
culture model (Huang et al., 2018). circRNAs are extremely stable, likely due to the lack of free 
3’- or 5’-ends (Enuka et al., 2016; Hansen et al., 2013; Jeck et al., 2013; Memczak et al., 2013; 
Salzman et al., 2013; Zhang et al., 2016). 
Additionally, several RNA-binding proteins were shown to modulate circRNA biogenesis, 
including the splicing factor muscleblind (MBL/MBNL1), and the RNA-binding proteins QKI, 
ADAR1 and ILF3/NF90/NF110 (Figure 2 – B) (Ashwal-Fluss et al., 2014; Conn et al., 2015; 
Ivanov et al., 2015; Li et al., 2017). MBL/MBNL1 protein binds the flanking introns of its own 
transcript and promotes circularization (Ashwal-Fluss et al., 2014). That this circularization can 
occur, has been described already in 2006 (Houseley et al., 2006), however, its function 
remained unclear. Modulation of MBL amounts strongly affects the formation of circMBL and 
of at least three other circRNAs. Since backsplicing events compete with mRNA splicing, the 
generation of circRNAs will come at the expense of its linear transcript. This suggests that 
circRNA biogenesis by itself may regulate gene expression, e.g. by preventing the production 
of the mRNA (Ashwal-Fluss et al., 2014). QKI is modulating the biogenesis of a subset of 
circRNAs during mesenchymal to epithelial transition by enhancing the pairing of circRNA 
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surrounding introns (Conn et al., 2015). The RNA editing enzyme ADAR1 was also recently 
shown to modulate the generation of circRNAs, likely by editing and disrupting inter- or intra-
intronic complementary sequences (Ivanov et al., 2015; Rybak-Wolf et al., 2015). DHX9 is a 
nuclear helicase that binds Alu elements and modulates RNA processing. Silencing DHX9 
causes an increase in host genes that encode circRNAs in addition to a general increase in 
circRNA expression (Aktaş et al., 2017). In addition, NF90/NF110 act as trans-factors that 
promote circularization in the nucleus by stabilizing the transient intronic RNA pairs and 
silencing of these genes reduced nascent circRNA production (Li et al., 2017). These proteins 
are usually exported to the cytoplasm upon activation of the immune response after viral 
infection. This reduces their ability to bind nascent transcripts in the nucleus and suppresses 
the production of a set of circRNAs.  
 
 
 
Figure 2: Circular RNAs are produced by backsplicing. 
(A) – Circular RNAs are produced by backsplicing, were the 5’ end and the 3’ end of one or several exons are joined 
in an inverted order. mRNAs on the other hand are spliced linearly. (B) – QKI, MBNL and ILF3 promote circular 
RNA production, while ADAR1 interferes with their biogenesis. 
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In general, neural tissues express wider repertoires of alternatively processed RNA isoforms 
(Wang et al., 2008; Yeo et al., 2004). Therefore it is not surprising that circRNAs are particularly 
enriched in the brain (Rybak-Wolf et al., 2015; Venø et al., 2015; You et al., 2015). 
Interestingly, many circRNAs are expressed in specific brain regions and are even enriched in 
axons and synapses. Furthermore, a subset of circRNAs are strongly modulated upon 
neuronal differentiation of in vitro cell culture systems (Rybak-Wolf et al., 2015; You et al., 
2015) as well as during specific stages of porcine brain development (Venø et al, 2015). 
Indeed, circRNAs might be involved in brain diseases, as many of them accumulate with age 
in the CNS of Drosophila melanogaster (Westholm et al., 2014). Additionally, it was recently 
reported that circRNAs with at least moderate expression in the brain are highly conserved 
between mouse and human (Rybak-Wolf et al., 2015). More specifically, in this subgroup, 60% 
of mouse circRNAs that are expressed in humans share the exact splice sites. Another 20% 
of circRNAs share at least one conserved splice site between mouse and human. Moreover 
exonic sequences giving rise to circRNA molecules display a higher occurrence of conserved 
7mers than exonic sequences giving rise to only mRNAs (Rybak-Wolf et al, 2015). 
3.1.2 Functions of circular RNAs 
A number of potential circRNA functions have been proposed (Hentze and Preiss, 2013; 
Memczak et al., 2013): as microRNA or RNA-binding protein (RBP) delivery vehicle, as RBP 
sponge or assembly factory for RBP factories, as regulators of RBP function or (m)RNA 
expression, or as template for translation itself (Figure 3 - A). 
 
Figure 3: Potential functions of circular RNAs (Hentze and Preiss, 2013). 
There is no evidence for a general function of circRNAs. However (Hentze and Preiss, 2013) propose that circRNAs 
could act as delivery vehicles, RNA-binding protein (RBP) sponges, help assembling RBP factories, regulate RBP 
function, regulate expression or even serve themselves as templates for translation. 
 
So far, few examples of the function of circular RNAs exist. The known examples for circRNA 
function are diverse and indicate that circular RNAs as a class share their topology but not 
necessarily their mode of function. circFOXO3 for example functions as protein hub and helps 
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assemble a larger protein complex. It was shown to be essential in forming a ternary complex 
with p21 and CDK2 and by this regulates cell cycle progression (Du et al., 2016).  
Translation was suggested as one likely mode of action for some of the first identified circular 
RNAs (Hsu and Coca-Prados, 1979; Kos et al., 1986). Since then it has been debated whether 
circRNA translation is a common phenomenon or whether it occurs at all. circSry, as prominent 
circRNA example, was not found at polysomes (Capel et al., 1993) and it was speculated that 
the circular form of Sry is specifically made to avoid translation. Then, in vitro experiments 
were conducted that showed how inefficiently circular templates were bound to eukaryotic 
(wheat-germ) (Kozak, 1979). While an mRNA with the same sequence was bound efficiently, 
despite its lack of a polyA-tail and a m7G-cap. Thus, it seemed that the circular structure of the 
RNA template prevented its efficient binding to the ribosome. Interestingly, circular RNA 
templates were efficiently bound to prokaryotic ribosomes, even more so than linear RNAs 
with the same sequence. This finding was reproduced for other circular and linear messages 
(Konarska et al., 1981). Both of these publications have been challenged by the discovery of 
internal ribosome entry sites (IRES). A circular RNA containing a viral IRES from 
encephalomyocarditis virus (EMCV) was translated in vitro in rabbit reticulocyte lysate, even 
though it was less efficiently translated than a linear template with the same sequence (Chen 
and Sarnow, 1995). Later on it was also demonstrated that a circular GFP containing an EMCV 
IRES can be translated in human HEK 293 FlpIn T-Rex cells (Meyer et al., 2015; Wang and 
Wang, 2015). However, these are in vitro experiments with sequences that would not occur 
naturally. Hence, it is even more exciting that examples of translated, endogenous circular 
RNAs exist: circZNF609 was identified in an expression profiling screen of in vitro muscle 
differentiation in mouse and human to be regulating myoblast proliferation. Legnini et al. found 
an open reading frame running over the head-to-tail junction, showed that circZNF609 is 
associated with the heavy polysome fraction, identified a translation product of the expected 
size with a specific antibody and showed that the translation of this circORF was splice-
dependent and cap-independent (Legnini et al., 2017). Additionally, to this example of a 
translated circRNA in mouse and human, an example of an endogenous translated RNA in 
Drosophila melanogaster exists. Here, ribosome foot printing on Drosophila melanogaster 
samples revealed ribosome-associated circular RNAs. Many of the ribosome-associated 
circRNAs had evolutionary conserved termination codons that were also matched by ribosome 
foot printing reads. Furthermore, it was shown that a circMbl-derived protein is detected by 
mass spectrometry and that circMbl and several other circRNAs are translated in vitro and in 
vivo in a cap-independent manner (Pamudurti et al., 2017). Stagsted et al. classified a subset 
of circRNAs as AUG circRNAs. Those are circRNAs that include the canonical translation start 
site that is also used in the corresponding mRNA. AUG circRNAs are conserved and are more 
abundantly expressed in comparison to other circRNAs. They are circularized in an Alu-
independent manner and are not found to act as template for translation based on RiboSeq 
analysis. Stagsted and colleagues challenge the notion that many circRNAs can be a template 
for peptides as their analysis demonstrates that most, but not all, circRNAs are not bound to 
ribosomes (Stagsted et al., 2018). In summary, translation of circRNAs seems to occur only 
under certain circumstances, maybe in stress conditions, or only in specialized cell 
compartments or at specific developmental steps. Cap-independent translation in eukaryotes 
is a specialized process as well that is mostly observed in stress, infection, and disease 
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(Merrick, 2004).Our understanding of circRNA translation will broaden as we understand the 
involvement of potential translation regulators, like the exon-junction complex (Le Hir et al., 
2016), and RNA modifications, like N6-methyladenosine (Meyer et al., 2015; Wang et al., 2015; 
Yang et al., 2017). 
CDR1as is a central part of a regulatory network of non-coding RNAs (Kleaveland et al., 2018; 
Piwecka et al., 2017). Cdr1as is massively bound by miR-7, in > 120 positions in mouse, and 
miR-671 (Hansen et al., 2013; Memczak et al., 2013). Depletion of the entire locus in a 
knockout mouse model revealed that loss of Cdr1as impairs sensorimotor gating, a phenotype 
often observed in neuropsychiatric disorders, and causes dysfunctional synaptic transmission. 
Molecularly, knockout of the Cdr1as locus specifically deregulates miR-7 and miR-671 levels 
in several brain regions by post-transcriptional effects. This in turn may cause induction of 
immediate early genes, such as Fos, a known miR-7 target. Kleaveland et al. expands the view 
on this ncRNA network by a long-noncoding RNA, Cyrano that was shown to destruct miR-7. 
miR-7 on the other hand can repress Cdr1as expression potentially by promoting the slicing of 
Cdr1as by miR-671, while Cdr1as itself stabilizes miR-7, as was shown before by Piwecka et 
al. 
Chen et al. suggest that circRNAs are used as sensors for self/non-self discrimination. 
Exogenous circRNAs are triggering an innate immune response via RIG-1, that protects cells 
against viral infection (Chen et al., 2017). It was also shown that the self/non-self discrimination 
depends on the human nature of the spliced-out intron. 
Besides these examples of circRNA function, many other modes of action could exist for this 
versatile class of RNA molecules.  
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3.2 Cortical development in Mammalia 
The brain is a highly complex organ that is composed of multiple tissues. The brain and spinal 
cord form the central nervous system. The vertebrate brain consists of an olfactory bulb, a 
cerebellum, cerebral hemispheres, a medulla oblongata, an optic tectum and a pituitary gland 
(Northcutt, 2002). All of these regions exert specialized functions (Table 1) and have changed 
their sizes and shapes over 500 million years of vertebrate evolution (Figure 4 - A). Especially 
the cerebral hemispheres have grown tremendously from lamprey to mammals. 
Table 1: Vertebrate brain regions and their function (Purves et al., 2004) 
Brain region Function 
Olfactory bulb Relaying olfactory signals from cranial nerve to higher 
centers 
Cerebellum Hindbrain structure coordinating motor functions, balance 
and posture 
Cerebral Hemispheres Processing of visual, auditory, somatosensory, and olfactory 
information. Directing conscious motor functions, speech, 
language, memory and learning. 
Medulla Oblongata Part of the brain stem, contains autonomic functions 
(cardiac, vomiting, vasomotor, and respiratory centers) 
Optic Tectum Central region to processing visual signals in many 
vertebrates (in mammals together with visual cortex) 
Pituitary Gland Hormone and neuropeptide secreting region, controlling e.g. 
blood pressure, growth, thyroid glands, and metabolism 
 
The cerebral neocortex is located within the cerebral hemispheres and a key feature of 
mammalian brain evolution (Striedter, 2005). The mammalian cerebral neocortex is six-layered 
(Figure 4 - B), and plays an important role in higher cognitive, emotional, sensory and motor 
functions. It has expanded tremendously compared to lower vertebrates (Kwan et al., 2012) 
and this expansion of the neocortex is thought to be highlighted by the gyrification of the brain 
found in certain mammals, e.g. human and other primates. However, this feature is almost 
absent from rodents, except for ferrets (Striedter, 2005). Although the six-layered structure of 
the mammalian neocortex is not found in other vertebrates, the general signal-relaying cell 
types of the pallium (layers of white and grey matter of the upper cerebrum) are found in all 
vertebrates (Briscoe and Ragsdale, 2018). It is thought that already the last common ancestor 
had neurons receiving input signals from the dorsal thalamus (dTh), relaying them first to 
intratelencephalic (IT) neurons and then to output neurons before the signal is passed on to 
the brain stem (Bst). Many different processes, e.g. neuronal migration, neuronal 
differentiation, dendro-/axo-/synaptogenesis and gliogenesis, have to be coordinated to ensure 
proper development of the mammalian neocortex during development (Komuro and Rakic, 
1998; Kriegstein and Noctor, 2004; Kwan et al., 2012; Taverna et al., 2014). 
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Figure 4: The six-layered neocortex is a unique feature of mammalian evolution. 
(A) – Vertebrates share the gross anatomical structure of their brains. While the overall function of these regions 
remained similar over 500 million years of evolution, size and shape of the brain regions changed. ob – olfactory 
bulb; cb – cerebellum; ch – cerebral hemispheres; m – medulla oblongata; ot – optic tectum; p – pituitary gland. 
Image taken from (Northcutt, 2002). (B) – The main cell types of the vertebrate pallium (layers of white and grey 
matter of the upper cerebrum) are comparable between avians, non-bird reptiles (alligator) and mammalia. The 
common ancestor is thought to have had input (green), output (red) and intratelencephalic (IT, blue) pallial neurons 
that receive information from the dorsal thalamus (dTh) and relay them to the brainstem (Bst). The cytoarchitecture 
changed during evolution, the general cell types are shared. Lx – layer x; HA – hyperpallium apicale; IHA – interstitial 
nucleus of the hyperpallium apicale; Md – dorsal mesopallium. Image taken from (Briscoe and Ragsdale, 2018).  
 
Most of our knowledge about neocortical development was obtained from studies of mouse. 
In general, cortical projection neurons are born in the dorsal germinal zones of the 
telencephalon, the ventricular and subventricular zones (VZ and SVZ) (Angevine and Sidman, 
1961). They radially migrate to their final destination in the upper layers of the developing 
cortex, either guided by the processes of radial glial cells (= locomotion) or independent of 
radial glial cells (=translocation) (Gupta et al., 2002). Early in mouse development, before 
embryonic day 10 (E10), only the ventricular zone and the marginal zone (MZ) exist (Figure 5 
- A). Until this point the neural progenitor pool is expanded. At around E10.5, the first wave of 
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cortical neurons is generated to form the preplate (PP). At E11.5 another wave of cortical 
projection neurons is leaving the VZ to form the nascent cortical plate (CP) thereby splitting 
the PP into marginal zone (MZ) and subplate (SP). As embryonic development continues, 
further waves of cortical neurons are leaving the VZ and SVZ to form the upper layers of the 
cortex (L6-L1). The cortex is formed in an inside-first, outside-later fashion. This means, that 
early born neurons are populating the lower/deeper layers of the cortex (L6), while later born 
neurons migrate past them to form the upper/superficial layers (L1). However, many different 
processes have to be spatiotemporally coordinated to allow successful generation of neurons 
from neural stem and progenitor cells (Götz and Huttner, 2005; Mora-Bermúdez et al., 2013; 
Noctor et al., 2007; Sun and Hevner, 2014). Yet, any misregulation of one of these processes 
can prevent proper development of the cortex. 
Early in vertebrate development, neural fate is induced in the ectoderm and the neural plate is 
formed. Neurulation then forms the neural tube from the neural plate. The wall of the neural 
tube is made up from neuroepithelial cells (NEC) (Figure 5 - B) (Götz and Huttner, 2005; 
Paridaen and Huttner, 2014; Taverna et al., 2014), which move their nuclei according to the 
cell cycle phase they are in: nuclei go to the ventricular surface to undergo mitosis. Then, at 
the onset of neurogenesis around E10.5 the NECs switch identity and become radial glial cells 
(RGC). RGCs give rise, directly or indirectly, to all neurons and glial cells during development. 
NECs and RGCs are often referred to as apical progenitors (AP) as they exhibit apico-basal 
polarity. These apical and basal processes expand over the entire neuroepithelium. However, 
when NECs switch their identity to RGCs they lose tight junctions but keep adherens junctions 
to connect themselves to the apical surface of the neuroepithelium. Furthermore, they induce 
astroglial marker genes like GLAST and BLBP. The pathways behind this transition are poorly 
understood. However, it was shown that transcription factors of the Hes family are involved 
(Hatakeyama et al., 2004) as well as transient expression of Fgf10 (Sahara and O’Leary, 
2009). With the switch to RGCs the cell divisions become asymmetric, each RGC giving rise 
to one daughter RGC and one differentiating cell. In the mammalian neocortex those 
differentiating cells can either form intermediate progenitors (IP) that are a type of basal 
progenitor (BP) only giving rise to neurons. Additionally, BPs (referred to as bRG in Figure 5) 
with glial characteristics that are able to self-renew can be formed from RGC division. These 
newborn neurogenic daughter cells, IPs and BPs, lose their apical endfoot that connects them 
to the apical surface in order to migrate basally. This loss is regulated by proneural genes that 
either induce downregulation of cadherins that mainly maintain this attachment through 
adherens junctions or by inducing the abscission of the apical endfoot altogether. IPs will give 
rise to two newborn neurons, BPs (=bRGs) to another BP and a neuron. Those newborn 
neurons migrate in waves to the pial surface of the brain across the intermediate zone and 
settle down in the cortical plate, where they mature and form synaptic connections between 
each other (Angevine and Sidman, 1961; Götz and Huttner, 2005; Gupta et al., 2002; Paridaen 
and Huttner, 2014; Taverna et al., 2014).  
Additionally, post-mitotic neurons in the upper cortical layers can influence the progenitor cells 
in this system (Paridaen and Huttner, 2014). It was shown that Cajal-Retzius cells, a neuron 
type born very early in the neocortex, dynamically regulates apical progenitor maintenance 
and the switch to neurogenesis and gliogenesis in the neocortex (Lakomá et al., 2011). 
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Figure 5: Development of the six-layered mouse cortex. 
(A) – Before the onset of neurogenesis neural progenitors (NP) in the ventricular zone (VZ) increase their pool by 
cell division, in which they undergo interkinetic nuclear migration (IKNM). At ~E11.5 NPs change identity to radial 
glial cells (RGC) and undergo asymmetric neurogenic divisions. The first neurons build the preplate (PP) that is 
then split by further neurons in the marginal zone (MZ) and the subplate (SP). Neurons settling in the cortical plate 
(CP) will later form the cortical layers L2-L6. Gliogenesis starts after E17. SVZ – subventricular zone, IP – 
intermediate progenitor, CR – Cajal-Retzius cell, BV – blood vessel, Ast – astrocyte, SEZ – subependymal zone, 
EL – Ependymal cell layer, DL Pyr – deep-layer pyramidal neuron, UL Pyr – upper layer pyramidal neuron, WM – 
white matter. Modified from (Kwan et al., 2012). (B) – Detailed schematic of neurogenesis in the cortex. For detailed 
description see text. Image taken from (Paridaen and Huttner, 2014). 
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All of those processes are regulated by an intricate network of highly conserved signaling 
pathways, the cell cycle, transcription factors, epigenetic modifications, and posttranscriptional 
mechanisms. Although a plethora of proteins (Taverna et al., 2014) and long noncoding RNAs 
(Aprea and Calegari, 2015) have been implicated in the regulation of corticogenesis no circular 
RNA was identified to participate in this complex process, so far. 
As previously mentioned, most of our knowledge on neocortical neurogenesis stems from 
mouse. Mice however are a lissencephalic species, meaning that they lack gyri, or folds, on 
the cerebral cortex. Humans and primates on the other hand are gyrencephalic species, which 
results in a tremendous increase of the cortex’ surface area which is often implied in higher 
cognitive functionality (Gautam et al., 2015). The reason for this gyrification could be the 
presence of two new cortical progenitor types whose pool is particularly increased in 
gyrencephalic species (Figure 6 - A). These so called outer subventricular zone (OSVZ) 
progenitors, include basal radial glial cells (bRGs) and basal radial glia-derived transit 
amplifying progenitors (Fietz et al., 2010; Hansen et al., 2010). Hence, although the insights 
gained from mice are invaluable, they cannot fully explain the more complex cortical 
development observed in humans and other primates. 
 
Figure 6: Differences in neurogenesis in mammalian neocortices depending on gyrification status. 
Progenitor type diversity increased during evolution. Neuroepithelial cells are found in lissencephalic and 
gyrencephalic species. The variety and abundance of progenitor cells increases in mid and late neurogenesis in 
gyrencephalic species (e.g. humans, primates, ferret) compared to lissencephalic species (most rodents, lower 
vertebrates). (Taverna et al., 2014)  
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3.3 Investigating single-cell gene expression with spatial resolution 
A cell is the basic biological unit of all living organisms. Often, researchers try to group them 
into cell types by their function, morphology, location, or by other criteria such as marker genes 
or molecular content. Grouping by molecular content, e.g. on RNA or protein level, is 
complicated by the measurement of the low amounts of RNA (10 - 30 pg/cell, (BioNumbers)) 
or protein per cell (42-675 pg/cell, (BioNumbers)). Hence, for a long time it was only possible 
to measure so called bulk RNA-seq samples which average over many, often different, cells 
(Figure 7 - A). Regardless of the importance of sequencing and analysis of bulk samples, 
important details might be lost due to the averaging over multiple cells and cell types. With the 
development of single-cell (q)PCR it became possible to investigate gene expression on the 
single-cell level for the first time, despite its very limited throughput (Bengtsson et al., 2008; 
Eberwine et al., 1992; Huang et al., 2014; Taniguchi et al., 2009; Warren et al., 2006). Single-
cell RNA-seq followed soon (Tang et al., 2009), but collection of single cells by micropipetting 
or laser capture microdissection was tedious (Figure 7 - B). Furthermore, since each cell had 
to be processed separately those early approaches of single-cell sequencing were cost 
intensive. 
 
Figure 7: Advancements in resolution of RNA-seq from bulk to single-cell & spatial single-cell RNA-sequencing. 
(A) – Bulk RNA-seq would average over all different cells and compartments of a human heart (human heart from 
cgtrader.com). (B) – Single-cell RNA-seq would allow the identification and investigation of single-cells from the 
same tissue. (C) – Recording spatial information before disintegration of the tissue would allow the investigation of 
single cells in their spatial context/neighborhood. 
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The development of single-cell preparation by microfluidics (e.g. Fluidigm C1) and 
microdroplets in conjunction with efficient enzyme-based tissue dissociation methods 
increased the throughput and lowered the costs of single-cell RNA sequencing tremendously. 
Since the onset of these single-cell sequencing methods a large number of papers has been 
published investigating cell populations and tissues at single-cell transcriptome resolution, 
providing insights into the cellular composition of highly complex tissues e.g. glioblastoma 
(Patel et al., 2014), mouse retina (Macosko et al., 2015) or the mouse cortex and hippocampus 
(Zeisel et al., 2015). A multitude of methods has been developed to efficiently prepare single 
cells for analysis, relying on droplets to encapsulate cells (Figure 8 - A) (Klein et al., 2015; 
Macosko et al., 2015), sorting single cells in individual wells (Figure 8 - B) (Han et al., 2018; 
Jaitin et al., 2014; Muraro et al., 2016) or labeling cells with barcode combinations to obtain 
single-cell resolution (combinatorial indexing) (Figure 8 - C) (Cao et al., 2017; Rosenberg et 
al., 2018).  
However, all of these methods require that the tissue of interest is dissociated in the initial step. 
Thereby all spatial information is lost. To overcome this loss of information, gene expression 
can be directly probed on the tissue itself by smFISH and advanced variations of it to increase 
the number of detectable transcripts, e.g. by sequential hybridization rounds or fluorophore 
combinations  
(Figure 8 - D) (Chen et al., 2015; Levesque et al., 2013; Lubeck et al., 2014) or direct in situ 
sequencing (Ke et al., 2013; Lee et al., 2014). Despite their high sensitivity, these methods are 
only able to detect a few hundred transcripts per cell that also have to be predefined in the 
used probe set. Furthermore, transcripts often cannot be assigned unambiguously to their cell 
of origin. A co-staining for a cell’s outer membranes is not compatible with the protocol and in 
highly complex tissues like a mammalian cortex even staining of a cell’s outer membrane would 
not allow to distinguish the tightly packed cells. Hence, only perinuclear or nuclear transcripts 
can be assigned to their cell of origin, limiting the quantitative power of highly multiplexed single 
molecular FISH.  
Therefore, tools were developed to complement single-cell sequencing data with spatial 
information. Using in situ experimental data to supplement single-cell RNA-sequencing data 
enabled the computational reconstruction at single-cell resolution, e.g. zebrafish embryo 
(Satija et al., 2015), the marine annelid Platynereis dumerilii (Achim et al., 2015) and the 
Drosophila embryo (Karaiskos et al., 2017). However, these methods relied on a pre-existing 
resource already holding highly reproducible spatial information for the tissue in question, a 
criterion that is often fulfilled in samples from model organisms but not in medically relevant, 
unique patient samples. 
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Figure 8: Overview of various single-cell RNA-seq and RNA-seq methods with spatial resolution. 
(A) – Drop-seq encapsulates single cells in nanodroplets together with a uniquely barcoded polyA-binding bead 
(Macosko et al., 2015). (B) – Microwell-seq traps single cells in nanowells before uniquely barcoded beads are 
added (Han et al., 2018). (C) – Combinatorial indexing relies on several rounds of barcoding. In-between these 
rounds cells are mixed and split. Each cell will hold a unique combination of barcodes in the end. (Cao et al., 2017; 
Rosenberg et al., 2018; Vitak et al., 2017). (D) – Principle of high-throughput single molecule FISH to determine 
spatial gene expression in situ (Lein et al., 2017). (E) - “Spatial transcriptomics” enables spatial gene expression 
measurements from tissue, averaging over 10-20 cells (Ståhl et al., 2016). 
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‘Spatial Transcriptomics’ (Ståhl et al., 2016) does not require additional information to produce 
a spatially resolved gene expression map. Here, the tissue is applied to a barcoded array and, 
depending on the cell density in the investigated tissue, the signal is averaged over 10-20 cells 
(Figure 8 - E). Again, using this setup single-cell resolution is lost. The combination of both, 
single-cell RNA sequencing and ‘Spatial Transcriptomics’, has been used to collect a tumor 
cell atlas from different tumor sections of a pancreatic ductal adenocarcinoma (Moncada et al., 
2018). The highly complex cellular composition of a tumor, or many diseased tissues, makes 
an unambiguous mapping of cells onto a separately obtained gene expression map difficult, 
especially when relying on distinct tissue sections even when they originate from the same 
specimen. The following table summarizes current approaches (Table 2). 
Table 2: Comparison of existing single-cell RNA-seq and spatial methods. 
Method 
Single-cell 
Resolution 
Spatial 
Resolution 
Limitations Citation 
Drop-seq ✓ X No spatial resolution (Macosko et al., 2015) 
Tomo-seq X ✓ 
Several highly 
reproducible 
specimens 
necessary 
(Junker et al., 2014) 
Spatial 
Transcriptomics 
X ✓ 
No single-cell 
resolution 
(Ståhl et al., 2016) 
FISH-based 
methods 
✓ / X ✓ 
Only (peri-)nuclear 
transcripts are 
assignable, limited 
target space, high 
turnaround time 
(Chen et al., 2015; 
Femino et al., 1998; 
Lubeck and Cai, 2012; 
Lubeck et al., 2014; Raj et 
al., 2008) 
 
Considering the advantages and drawbacks of the existing methods, there is a need for a 
method that allows to record spatial information of a single cell while still able to measure the 
transcriptome in an unbiased transcriptome-wide way. This method development is addressed 
in “7.3 - 3D-seq: a method to integrate single-cell and spatial transcriptomics”. The 3D-seq 
protocol will be the first approach that enables researchers to analyze the transcriptome of 
single cells within a complex tissue without losing the spatial information on the cell’s 
localization. 
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4 Aims of this thesis 
 
1. Collection of a circRNA expression catalogue in neural samples. 
a. Elucidation of spatiotemporal expression patterns in neural tissues and during 
neuronal differentiation. 
b. Comparison of circRNA expression to corresponding mRNA expression. 
c. Analysis of circRNA conservation in human and mouse. 
d. Evaluation of ADAR1’s influence on circRNA biogenesis in neural samples. 
 
2. Studying the function of circSLC45A4 in neuronal differentiation. 
a. Analysis of circSLC45A4’s expression pattern and conservation. 
b. Determining the localization, abundance, and expression changes in neuronal 
differentiation of circSLC45A4. 
c. Identification and analysis of the phenotype caused by circSLC45A4 
perturbation (RNAi based) in human in vitro and mouse in vivo model systems. 
d. Identification of potential interaction partners – RNA-binding proteins or RNAs 
– by establishing a pulldown approach for endogenous circSLC45A4. 
e. Investigating the potential translation of circSLC45A4. 
 
3. Development of a method that allows single-cell RNA-seq while preserving 
information on the spatial localization of single cells within a tissue. 
a. Establishing in situ reverse transcription in methanol-fixed tissue slices of adult 
mouse brain. 
b. Evaluating tissue digestion efficiency after the tissue was fixed with methanol 
and rehydrated. 
c. Optimization of a combinatorial indexing protocol on methanol-fixed tissue and 
in single cells. 
d. Design and production of a grid structure with CAD software and a 3D printer. 
e. Cell type identification and spatial reconstruction of an adult mouse brain slice 
in silico. 
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5 Material 
5.1 Chemicals, enzymes and reagents 
Chemical or reagent Composition Order # Company 
0.05 % Trypsin-EDTA -------- 25300062 Invitrogen 
0.25 % Trypsin EDTA -------- 25200072 Invitrogen 
10x CutSmart Buffer 
50 mM Potassium Acetate 
20 mM Tris-acetate 
10 mM Magnesium Acetate 
100 µg/ml BSA 
pH 7.9 @ 25°C 
B7204S NEB 
10x MOPS Running 
Buffer 
0.2 M MOPS, pH 7.0 (with NaOH) 
50 mM Sodium Acetate 
10 mM EDTA 
M1254 
S2889 
E6758 
Sigma 
Sigma 
Sigma 
10x T4 DNA Ligase 
Buffer 
50 mM Tris-HCl 
10 mM MgCl2 
1 mM ATP 
10 mM DTT 
pH 7.5 @ 25°C 
B0202S NEB 
32 % Para-
formaldehyde 
-------- 15714-S Science 
Service GmbH 
Acrylamid-
Bisacrylamid (37.5:1) 
-------- 3029.1 Roth 
Agarose NEEO Ultra -------- 2267.3 Roth 
Ammonium Persulfate -------- A3678 Sigma 
Benzonase 250 U/µl 71205-3 Millipore 
Blocking Milk Solution 3 % (w/v) skim milk powder in PBS 70166 Sigma 
Blocking Solution for 
Immunofluorescence 
1 % (w/v) BSA 
5 % (v/v) normal goat serum 
In PBS, pH 7.4 
01400.100 
ab7481 
 
Biomol 
abcam 
 
Blunt/TA Cloning Mix -------- M0367S NEB 
BSA    
CDP-Star, ready-to-use -------- 12041677001 Roche 
Collagenase, type IV 
-------- 17101015 Life 
Technologies 
DIG RNA Labeling Mix, 
10x 
10 mM ATP, CTP, GTP 
6.5 mM UTP 
3.5 mM DIG-11-UTP 
11277073910 Roche 
dNTPs 100 mM dATP/dGTP/dCTP/dTTP R0182 Fermentas 
Dropseq Lysis Buffer 
6 % (v/v) Ficoll PM-400 
0.2 % (w/v) Sarkosyl 
20 mM EDTA 
30 mM Tris-HCl, pH 7.5 
50 mM DTT 
GE17030010 
 
 
 
 
GE Healthcare 
 
 
Roth 
 
Dynabeads 
Streptavidin MyOne C1 
beads 
-------- 65002 Life 
Technologies 
EBSS --------   
ECL Western Blotting 
Reagents 
-------- RPN2109 GE Healthcare 
Ethanol -------- 5054.1 Roth 
EvaGreen 20x -------- 31000 Linaris 
FastAP 
-------- EF0651 Thermo 
Scientific 
Ficoll PM-400 -------- GE17030010 GE Healthcare 
Formaldehyde 37 % -------- 4779.1 Roth 
GlycoBlue 
coprecipitant 
15 mg/ml AM9516 Life 
Technologies 
Glyoxal Loading Dye 
(2x) 
-------- AM8551 Ambion 
Igepal CA-630 --------   
- 21 - 
 
Isopropanol -------- AE73.1 Roth 
Lipofectamine 2000 
-------- 11668019 Life 
Technologies 
Lipofectamine 
RNAiMax 
-------- 13778030 Life 
Technologies 
Maxima H Minus 
reverse transcriptase 
0.2 U/ml EP0753 ThermoFisher 
Maxima SYBR 
Green/ROX qPCR 
Master Mix 
-------- K0223 Life 
Technologies 
Methanol -------- 8388.2 Roth 
Methanol -------- 50713 Lager 
NorthernMax Pre-
/Hybridization Buffer 
-------- AM8677 Ambion 
Papain 
-------- LS003119 Worthington 
Biochemical 
Corp. 
Paraformaldehyde for 
Fixation 
4 % (w/v) paraformaldehyde 
In PBS, pH 7.4 (adjusted with HCl) 
15714-S 
 
VWR 
 
PBS 
137 mM NaCl 
2.7 mM KCl 
10 mM Na2HPO4 
1.8 mM KH2PO4 
pH 7.4, adjusted with HCl 
3957.2 
6781.1 
T877.1 
60347 
 
Roth 
Roth 
Roth 
Sigma 
 
PBST 1 % (v/v) Tween-20 in PBS 9127.2 Roth 
PEG 8000 -------- 1584 Roth 
Pierce BCA Protein 
Assay Kit 
-------- 23225 ThermoFisher 
Poly-L-lysine 
1 % (w/v) poly-L-lysine 
In ddH2O 
P2636 
 
Sigma 
 
Proteinase K, 
recombinant, PCR 
grade, 20 mg/ml 
-------- 03115879001 Sigma Aldrich 
Quick Ligation Kit -------- M2200S NEB 
Random Hexamers 0.2 μg/μl SO142 Fermentas 
Ribolock 
40 U/μl EO0384 Fisher 
Scientific 
RiboRuler high range 
RNA ladder 
-------- SM1823 Fisher 
Scientific 
RIPA Buffer 
150 mM NaCl 
1.0 % (v/v) NP-40 
0.5 % (w/v) sodium deoxycholate 
0.1 % (w/v) SDS 
50 mM Tris-HCl, pH 8.0 
Fresh: Complete mini protease 
inhibitor (EDTA-free) 
3957.2 
I3021 
D6750 
1057.1 
4855.3 
 
A32953 
Roth 
Sigma 
Sigma 
Roth 
Roth 
 
ThermoFisher 
SDS Loading Dye 5x 
(Laemmli) 
10 % (w/v) SDS 
25 % (v/v) beta-mercaptoethanol 
50 % (v/v) glycerol 
0.01 % (w/v) bromophenol blue 
0.3125 M Tris-HCl, pH 6.8 
1057.1 
8057400005 
G9012 
B5525 
4855.3 
Roth 
Merck 
Millipore 
Sigma 
Sigma 
Roth 
SDS-PAGE Running 
Buffer 
25 mM Tris 
190 mM Glycine 
0.1 % (w/v) SDS 
4855.3 
39082 
1057.1 
Roth 
Roth 
Roth 
SDS-PAGE Separation 
Buffer 
1.5 M Tris-HCl, pH 8.8 
0.4 % (w/v) SDS 
4855.3 
1057.1 
Roth 
Roth 
SDS-PAGE Stacking 
Buffer 
0.5 M Tris-HCl, pH 6.8 
0.4 % (w/v) SDS 
4855.3 
1057.1 
Roth 
Roth 
SSC Buffer 20x -------- S6639 Sigma 
Superscript II -------- 18064071 Invitrogen 
Superscript III -------- 18080085 Invitrogen 
Superscript IV -------- 18090200 Invitrogen 
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SYBR Gold Nucleic 
Acid Gel Stain 
-------- S11494 MoBiTec 
GmbH 
T4 DNA Ligase -------- M0202L NEB 
T4 PNK 
-------- EK0032 Fisher 
Scientific 
T7 RNA Polymerase -------- 10881775001 Roche 
TEMED -------- 2367.3 Roth 
Terra PCR Direct 
Polymerase mix 
-------- 639271 Clontech 
Transfer Buffer 
25 mM Tris-HCl, pH 8.5 
190 mM Glycine 
0.05 % (w/v) SDS 
20 % (v/v) Methanol 
4855.3 
39082 
1057.1 
8388.2 
Roth 
Roth 
Roth 
Roth 
Triton X-100 --------   
Triton X-100 (various 
concentrations v/v) 
-------- T8787-50ML Sigma 
TRIzol 
38 % (v/v) Phenol, pH 4.5 
800 mM Guanidiniumthiocyanat 
400 mM Ammoniumthiocyanat 
100 mM Sodium acetate, pH 5.0 
(adjust pH with acetic acid) 
5 % (v/v) Glycerin 
A980.1 
2628.4 
4477.4 
6773.2  
 
3783.2  
Roth 
Roth 
Roth 
Roth 
 
Roth 
TrypLE 
-------- 12604013 Life 
Technologies 
Vectashield Hardset 
Mounting Medium with 
DAPI 
-------- H-1500 Linaris 
 
5.2 Consumables 
Chemical or reagent Order # Company 
10 cm dish, cell culture coated 83.3902 Sarstedt 
12-well plate, cell culture coated 83.3921 Sarstedt 
15 cm dish, cell culture coated 83.3903 Sarstedt 
24-well plate, cell culture coated 662160 Greiner 
6-well plate, cell culture coated 83.3920 Sarstedt 
96-well Multiply FAST PCR plate 72.1981.202 Sarstedt 
96-well Multiply FAST PCR plate (qPCR) 721981202 Sarstedt 
BZO Seal Film, Adhesive, Optical Film 712350X Biozym 
Coverslips   
DNA LoBind tubes, 1.5 ml 5250130 VWR 
Falcon tubes, 15 ml 50199 Lager 
Falcon tubes, 50 ml 50200 Lager 
Filter pipet tips SafeSeal SurPhob, 10 µl VT0200 Biozym 
Filter pipet tips SafeSeal SurPhob, 1250 µl VT0270 Biozym 
Filter pipet tips SafeSeal SurPhob, 20 µl VT0220 Biozym 
Filter pipet tips SafeSeal SurPhob, 300 µl VT0250 Biozym 
Hybond N+ membrane RPN303B VWR 
Hybond-P PVDF membrane GE10600023 Sigma 
MAXYMUM Recovery tubes 11311984 Fisher Scientific 
Microamp 8-well caps N8010535 Thermo Scientific 
Microamp 8-well strips N8010580 Thermo Scientific 
PCR strips, 0.2 ml 72991002 Sarstedt 
PLA/PHA filament mix CF551053 Reichelt 
Superfrost Plus Adhesion Microscope Slides J1800AMNT Thermo Scientific 
Twintec LoBind PCR plates 0030129504 Neolab 
 
5.3 Commercially available kits 
Kit Order # Company 
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AMPure RNA clean beads 29168 Beckmann Coultier 
AMPure XP beads A63881 Beckmann Coultier 
BaseScope Reagent Kit 322900 ACDBio 
Bioanalyzer High sensitivity DNA Chip kit 50674626 Agilent 
Bioanalyzer RNA Nano 6000 Chip Kit 50671511 Agilent 
Bioanalyzer RNA Pico 6000 Chip Kit 5067-1513 Agilent 
ERCC RNA spike-in mix 4456740 Life Technologies 
Mix&Go Competent Cells, DH5 T3009 Zymo Research 
Nextseq 500 High Output Kit v2 (150 cycles) FC-404-2002 Illumina 
Nextseq 500/550 Mid Output Kit v2 (150 cycles) FC-404-2001 Illumina 
Qubit dsDNA HS Assay Kit Q32854 Invitrogen 
RiboMinus Eukaryote v2 A15026 Life Technologies 
Tapestation High sensitivity D5000 Ladder 50675594 Agilent 
Tapestation High sensitivity D5000 Reagents 50675593 Agilent 
Tapestation High sensitivity D5000 Screen Tape 50675592 Agilent 
Truseq RNA Sample Prep Kit v2 RS-122-2001 Illumina 
Truseq Small RNA Sample Prep Kit A RS-200-0012 Illumina 
Truseq Stranded mRNA Library Prep kit RS-122-2102 Illumina 
Zymoclean DNA Gel Recovery D4007 Zymo Research 
ZymoPURE Plasmid Midiprep Kit D4201 Zymo Research 
ZymoPURE Plasmid Miniprep Kit D4212 Zymo Research 
 
5.4 Devices 
 96-well magnetic rack, DynaMag (Life Technologies, 12027) 
 ABI StepOne Plus (ThermoFisher) 
 Bioanalyzer 2100 (Agilent, G2939BA) 
 Brand Transferpette S, 0.5-10 µl / 2-20 µl / 20-200 µl / 100-1000 µl 
 Eppendorf Centrifuge 5424R 
 eppendorf MixMate 
 Eppendorf X50s Mastercycler (Eppendorf, EPPE6311000.010) 
 EVE cell counter (VWR, 7342675) 
 GeneTouch Thermal Cycler (Biozym, 685012) 
 Keyence BZ-X700 microscope with 4x (CFI Plan Apo λ, 972030), 10x (CFI Plan 
Apo λ, 972031), 20x (CFI Plan Apo λ, 972032), 40x (CFI Plan Apo λ, 972033), 
60xOil (CFI Plan Apo λ, 972036) objectives 
 LAS4000 (Fujifilm) 
 Mini-PROTEAN Tetra Cell System (BIO-RAD) 
 Nanodrop 1000 (Thermo Scientific) 
 neoLab IntelliMixer 
 Nikon TiE Inverted microscope with 4x (Plan Fluor, MRH20041), 10x (Plan Apo 
λ, MRD00105), 20x (Plan Apo λ, MRD00205), 20xELWD (S Plan Fluor, 
MRH48230), 40xOil (CFI Plan Fluor, MRH01401), 60x Oil (Plan Apo λ, 
MRD01605) objectives and Andor iXonUltra888 EMCCD camera 
 OMEGA Pipettor Plus 
 Owl EasyCast Gel Electrophoresis System (ThermoFisher) 
 Peqstar 2x Thermocycler (Peqlab/VWR, 732-2888) 
 Projet HD 3000 
 Qubit 4 (Thermo Scientific, Q33226) 
 Roth table top centrifuge 
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 TapeStation 4200 (Agilent, G2991AA) 
 Trans-Blot SD Semi-Dry Electrophoretic Transfer Cell (BIO-RAD) 
 ultimaker 2+ 
 Vortex Genie 2 
 Zeiss AxioObserver Z1 with AxioCam MRm (Zeiss) 
 
 
5.5 Plasmids 
Name Purpose Size 
pSilencer2.1-shRNA_circSlc45a4_1 circSlc45a4 knockdown in utero 5.1 kb 
pSilencer2.1-shRNA_circSlc45a4_2 circSlc45a4 knockdown in utero 5.1 kb 
pSilencer2.1-shRNA_circSlc45a4_3 circSlc45a4 knockdown in utero 5.1 kb 
pSilencer2.1-shRNA_mRNA_Slc45a4_1 mRNA Slc45a4 knockdown in utero 5.1 kb 
pSilencer2.1-shRNA_mRNA_Slc45a4_2 mRNA Slc45a4 knockdown in utero 5.1 kb 
pSilencer2.1-shRNA_scramble Control knockdown in utero 5.1 kb 
 
5.6 Antibodies 
Antibody Dilution Order # Company 
Anti-ADAR1 1:1000 ab168809 abcam 
Anti-Digoxigenin-AP, Fab fragments 1:20000 11093274910 Roche 
Anti-DOCK7 1:1000 ab118790 abcam 
Anti-FLAG 1:2000 F3165-1mg Sigma 
Anti-FXR2 1:1000 A303-893A Biomol 
Anti-GAPDH 1:5000 G8795-200UL Sigma 
Anti-GFAP 1:1000 AB5804 Merck/Millipore 
Anti-GFP 1:400 600-1-1-215 Rockland 
Anti-Reelin 1:100 MAB5364 Merck/Millipore 
Anti-SARM1 1:1000 13022S Cell Signaling 
Technologies 
Anti-Tbr2 1:500 ab183991 abcam 
Anti-TUBB3 1:1000 801213 BioLegend 
Goat Anti-Mouse 488 1:2000 ab150113 abcam 
Goat Anti-Rabbit 647 1:2000 ab150079 abcam 
Polyclonal Goat anti-Mouse HRP 1:5000 P0447 Dako 
Polyclonal Goat anti-Rabbit HRP 1:5000 P0448 Dako 
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6 Methods 
6.1 Biochemical and Molecular Biology methods 
6.1.1 Animals 
For results chapter 7.2 - CircSLC45A4 is required to keep neuronal cells in a progenitor state 
in cell culture systems and in the mammalian brain: 
Plugged C57BL/6J females were purchased from Janvier Labs and housed in the Biomedical 
Services facility of the MPI-CBG under standard conditions. All experimental procedures were 
approved by the “Landesdirektion Sachsen” (license TVV 16-2018). 
For results chapter 7.3 - 3D-seq: a method to integrate single-cell and spatial transcriptomics: 
C57BL/6J animals were housed in the MDC animal facility under standard conditions. All 
experimental procedures were approved by “LaGeSo Berlin” (license T0325/10). 
6.1.2 BaseScope 
The BaseScope assay by ACD can be used to detect single splice junctions. The signal 
strength is increased by using a branched DNA detection system (ACDBio, 2017). In brief, 
embryonic mouse brain was fixed with 4 % PFA overnight, cryoprotected overnight with 30 % 
sucrose, and then frozen in tissue freezing medium. Then slides were cryosectioned at 10 µm 
and carried through the BaseScope standard protocol for fixed frozen tissue sections, except 
that proteinase digest was limited to 10 min at room temperature to avoid over digestion.  
Slices were mounted with one drop of Vectashield Hardset Mounting Medium with DAPI and 
imaged using a Keyence BZ 9000 microscope. 
6.1.3 Cell fractionation 
For cell fractionation a kit provided by abcam was used (ab109719). RNA was extracted from 
cytoplasmic, nuclear and mitochondrial fractions with TRIzol and analyzed by RT-qPCR. 
Sufficient fractionation of the cells was monitored by using ACTB and GAPDH as positive 
control for the cytoplasmic fraction, XIST and NEAT1 for the nuclear fraction and MT-CO2 for 
the mitochondrial fraction.  
6.1.4 Cloning, transformation and propagation of plasmids 
Cloning was performed according to standard methods. Plasmids were cut using appropriate 
restriction enzymes, dephosphorylated with FastAP and purified from an agarose gel with a 
Zymoclean Gel DNA Recovery kit. Inserts were either PCR amplified and then digested with 
the same set of restriction enzymes or for cloning of shRNAs, oligonucleotides with fitting 
overhangs were annealed and phosphorylated with T4 PNK. Insert and cut plasmid were 
ligated with T4 DNA Ligase and subsequently transformed into chemically competent bacteria 
(DH5 or Mix&Go Competent Cells, DH5). 
The ZymoPURE Plasmid Miniprep kit, or the ZymoPURE Plasmid Midiprep kit were used for 
minipreps or midipreps of bacterial DNA, respectively. 
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6.1.5 Immunofluorescence 
Immunofluorescence staining was performed according to standard protocols. In brief, cells 
were grown on poly-L-lysine (PLL) coated coverslips. Adherent cells were washed three times 
with PBS, fixed for 20 min with 4 % (w/v) paraformaldehyde (PFA) at room temperature and 
then washed again three times with cold PBS. Cells were permeabilized with PBST (15 min, 
4°), again washed twice with PBS and then blocked with blocking solution (1 h, 4°C). Then the 
primary antibody was applied, diluted in PBS with 1 % (w/v) BSA, and incubated at 4°C 
overnight. Unbound antibody was washed away by applying cold PBS 4 times. The secondary 
antibody was diluted in blocking solution and applied for 2 h at 4°C in the dark to avoid 
fluorophore bleaching. Again, unbound antibody was washed away with three PBS washing 
steps. To mount the coverslips on microscope slides for imaging, 10 μl Vectashield Mounting 
Medium with DAPI were used per coverslip. Mounting medium was dried at room temperature 
for up to 1 h and then coverslips were fixed on the microscope slide with clear nail polish. 
Slides were imaged using either a Zeiss AxioObserver Z1 with an AxioCam MRm attached or 
a Keyence Bx-700. 
6.1.6 Immunofluorescence staining of cortical slices & quantification 
For immunohistochemistry, brains were fixed overnight at 4˚C in 4% paraformaldehyde (in 
0.1M phosphate buffer), cryoprotected in 30% sucrose and cryosectioned (10 µm thick). For 
antigen-retrieval cryosections were incubated for 1 h at 70˚C (in 0.01 M Citrate Buffer, pH=6.0), 
followed by permeabilization for 20 min (in 0.5 % Triton X-100), quenching for 30 min (in 0.1 
M glycine) and blocking for 1h (10 % donkey serum 0.3 % Triton X-100) at RT. All primary 
antibodies were incubated overnight at 4˚C (in 3 % donkey serum, 0.3 % Triton X-100), 
whereas secondary antibodies for 2 h at room temperature. Nuclei were counterstained with 
DAPI. Imaging was performed using an ApoTome fluorescence microscope (Carl Zeiss) and 
pictures were assembled using Axiovision software (Carl Zeiss). For quantifications, 
composites were manually analyzed using Photoshop CS6 (Adobe) and sample averages 
compared by One-way ANOVA. p-values < 0.05 were considered significant. 
GFP antibody – Rockland 600-1-1-215; 1:400 
Secondary antibodies – Jackson Laboratory; 1:500 
6.1.7 In utero electroporation & FACS-sorting of GFP+ cells 
Plasmids for in utero electroporation (IUE) were generated by replacement of the Hygromycin 
cassette of pSilencer2.1-U6-hygro (Thermo Fisher) with a nuclear-localized GFP, followed by 
insertion of shRNAs (purchased as synthetic oligonucleotides from Eurofins). IUE was 
performed as previously described (Artegiani et al., 2012). Briefly, C57BL/6J E13.5 pregnant 
mice were anesthetized with Isoflurane (Baxter) and 2-3 µg of plasmid DNA were injected into 
the embryo ventricle, followed by the application of 6 electric pulses (30V and 50 ms each at 
1 s intervals) through platinum electrodes using a BTX-830 electroporator (Genetronics). 
Embryo brains were collected at E 15.5 for immunochemistry (whole brain) or FACS-sorting of 
electroporated cells (GFP+) (lateral cortices). After removal of meninges and ganglionic 
eminences, cortices were dissociated with papain-based Neural Tissue Dissociation kit 
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(Miltenyi Biotech) and cells were resuspended in 500 μl of ice-cold PBS. DAPI (1:1000) was 
added for dead cells discrimination and sorting of GFP+ cells was performed by BD 
FACSAriaTM III (BD Biosciences). 
6.1.8 Isolation of synaptoneurosomes from mouse brain 
Synaptoneurosomes, a fraction enriched in pinched-offed resealed presynaptic terminals still 
attached to resealed postsynaptic processes, were isolated as previously described (Gray and 
Whittaker, 1962; Huttner et al., 1983). Briefly, one adult NMRI mouse brain was dissected and 
immediately homogenized in 10 volumes of ice-cold homogenization buffer (0.32 M sucrose in 
10 mM Hepes, pH 7.4) supplemented with Complete Protease Inhibitor cocktail (Roche) and 
160 U/ml SUPERase-In RNase inhibitor (Ambion). All the following steps were performed at 
4°C: The homogenate was centrifuged (1000 x g, 10 min and 1500 x g, 10 min) to remove 
nuclei and cellular debris. The supernatant was further centrifuged at 17,500 x g for 30 min 
and the pellet (P2) was dissolved in homogenization buffer. P2 was layered on top of a 0.8/1.2 
M sucrose density gradient and centrifuged at 230,000 x g in a swinging bucket rotor for 20 
min. The synaptoneurosomes fraction was recovered from the 0.8/1.2 M interphase band, 
layered on top of 0.8 M sucrose and centrifuged as above. The pellet (P2’) was dissolved in 
homogenization buffer and used for further analysis. 
6.1.9 Northern Blotting and probe generation 
TRIzol-extracted total RNA (10-50 µg) was denatured by adding Glyoxal Loading Dye and 
incubating the samples for 30 min at 50°C. Denatured RNA was loaded on a denaturing 
agarose gel (1.2 % (w/v) agarose in MOPS buffer, 3 % (v/v) formaldehyde) and run at 80 V 
until intended separation is achieved. The gel was stained with SYBR Gold and imaged with a 
Fujifilm LAS4000 gel imaging system. The agarose gel was placed onto a wetted Amersham 
Hybond N+ nitrocellulose membrane and put between two with 1x TBE soaked Whatman 
papers. Nucleic acids were transferred onto the membrane was achieved by applying an 
electrical current in a semi-dry blotting apparatus for 1 hour at 15 V. The membrane was dried, 
and proper transfer was checked by imaging the membrane in the EtBr channel of an 
LAS4000. The membrane was washed with 50 mM Tris, pH 8.0 for 10 min at 60°C, 
prehybridized in NorthernMax Pre-/Hybridization Solution for 30 min at 68°C and hybridized 
with a specific DIG-labeled probe (0.1 nM, denatured: 2 min at 98°C) overnight at 68°C. 
Unbound or unspecifically-bound probe was washed away with 2x SSC, 0.1 % (w/v) SDS, the 
solution was changed after 30 min at 68°C for 3 times. Two additional washing steps with 0.2x 
SSC, 0.1 % SDS for 30 and 60 min at 68°C further increased the specific signal. Detection 
was achieved by following the manufacturer’s protocol of CDP Star ready-to-use detection 
solution and imaging in a Fujifilm LAS4000. 
Probes used for Northern Blotting were approximately 150 nt in length. The region to be 
targeted by the probe was amplified by PCR at which point the sequence of the T7 promoter 
was inserted (5’-TAATACGACTCACTATAGGGAG-3’). The T7 promoter was then employed 
during in vitro transcription (IVT) to amplify an RNA probe for northern blot detection. 
Detectability of the probe was achieved by incorporating digoxigenin-11-UTP into the RNA 
probe, by using DIG RNA Labeling Mix according to the manufacturer’s instruction. 
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6.1.10 Preparation of polyA+ libraries and sequencing 
PolyA+ libraries were prepared from RNA with Illumina TruSeq RNA Library Prep kit v2 (SH-
SY5Y) or Illumina TruSeq Stranded mRNA LT (mouse cortex GFP+ cells) and sequenced on 
an Illumina NextSeq 500 with 1x150 bp. 
6.1.11 Preparation of small RNA libraries and sequencing 
Small RNA libraries were prepared from total RNA with an Illumina TruSeq Small RNA Sample 
Prep Kit and sequenced on a NextSeq 500 with 1x50 bp. 
6.1.12 Preparation of total RNA libraries and sequencing 
2 µg of total RNA were used as starting material for total RNA libraries and spiked with ERCC 
RNA spike-in mix. Then, ribosomal RNA (rRNA) was depleted with the Ribominus Eukaryote 
Kit v2 or with a RNase H approach (Adiconis et al., 2013). Successful ribodepletion was 
assessed using a Bioanalyzer RNA 6000 Pico Chip. RNA was fragmented and subsequently 
prepared for sequencing using an Illumina Truseq Unstranded Total RNA Library Prep kit or 
an Illumina Truseq Stranded Total RNA Library Prep kit. Libraries were sequenced on a Hiseq 
2000 or Nextseq 500, at 1x150 nt. 
6.1.13 Protein Extraction and Western Blotting 
In general, adherent cells were harvested by scraping and centrifugation (500 x g, 5 min, 4°C), 
washed once with PBS and resuspended with twice the volume of the cell pellet in ice-cold 
lysis buffer (RIPA buffer, see 5.1). Cells were incubated on ice for 30 min, while the lysate was 
passed through a 21G needle 6 times. The lysate was cleared by centrifugation (16000 x g, 
20 min, 4°C) and the supernatant was kept for SDS-Polyacrylamide gel electrophoresis and 
western blot analysis. 
10 to 20 μg of protein, as determined by BCA assay, were denatured by addition of 5x SDS 
Loading dye and incubation at 95°C for 5 min. Proteins were then separated by size by SDS-
PAGE (Laemmli, 1970). Subsequent transfer of proteins onto a methanol activated PVDF 
membrane was achieved by semi-dry blotting in Transfer buffer. The membrane was blocked 
for 30 min at room temperature with 3 % (w/v) skim milk in PBS and incubated with protein 
specific primary antibody overnight at 4°C, slowly shaking. Unbound primary antibody was 
washed: 3 times 10 min in PBST, slowly shaking. Secondary antibody was incubated for 2 h 
at room temperature, slowly shaking, and again unbound secondary antibody was washed 
away. Detection was achieved by addition of an HRP substrate (Amersham ECL) and the 
signal was quantified with a Fujifilm LAS4000. 
6.1.14 Pulldown of circular RNA and mass spectrometric analysis 
This protocol is mainly based on RAP-MS (Engreitz et al., 2015) and (Theil et al., submitted 
2018). First, cells were grown exponentially and then interacting RNAs and protein were 
crosslinked at 254 nm (600 mJ/cm2) and harvested by scraping in 1xPBS. Cells were washed 
in 1xPBS, pelleted (500xg, 5 min) and stored at -20°. Next, 30x106 cells per sample were lysed 
by adding 900 µl Total Cell Lysis Buffer that was supplemented with Protease Inhibitor (1x 
complete Mini protease inhibitor) and RNase inhibitor (Ribolock 0.08 U/μl). Cells were lysed 
- 29 - 
 
on ice for 10 min and during that time passed 5 times through a 26G needle. Subsequently, 
the lysate was treated with RQ DNase I (2 U/ml) and RNase R (40 U/ml) for 15 min at 37°C in 
a thermomixer. The reaction was stopped by adding RQ DNase I Stop Solution (50 µl/ml). 
Then, the samples were prepared for pulldown by mixing them with the 2-fold volume of 1.5x 
Hybridization buffer and incubation on ice for 10 min. Debris was pelleted (16000xg, 4°C, 10 
min) and the supernatant was incubated with 450 pM denatured probes specific for 
circSLC45A4 the first exon of mRNA SLC45A4 or negative control probes, specific to GFP, for 
3 h at 37°C (thermomixer, shaking at 700 rpm, samples inverted every 30 min). Then 
Streptavidin MyOne C1 magnetic beads were prepared (150 µl per sample) by washing them 
4 times with 10 mM Tris-HCl, pH 7.5, 2 times with 1x Hybridization Buffer and resuspension in 
50 μl/per sample 10 mM Tris-HCl, pH 7.5. 50 µl prepared Streptavidin beads were added to 
each sample and incubate for 1 h at 37°C while mixing at 700 rpm. Then a magnetic rack was 
used to separate the beads from the flow-through and beads were washed 4 times with 500 μl 
of 1x Hybridization Buffer and 3 times with Washing Solution (Hybridization Buffer without 
detergents). The last washing step was used to split the sample 4:1 for protein and RNA 
detection. For protein detection, the beads were resuspended in 100 µl Protein Elution buffer 
with benzonase (100 U) and incubated for 3 h at 37°C, shaking at 1300 rpm. Supernatant was 
kept for protein identification by mass spectrometry. For RNA detection, beads were 
resuspended in 100 μl Proteinase K solution (1 mg/ml Proteinase K) and incubated at 50°C for 
45 min, shaking at 1300 rpm, before 1 ml TRIzol was added for subsequent RNA extraction. 
Sample preparation for proteome analysis 
Protein samples were resuspended in 50 µL of 8 M urea and 0.1 M Tris-HCl, pH 8. Proteins 
were reduced with 10 mM dithiothreitol (DTT) at room temperature for 30 min and alkylated 
with 50 mM iodoacetamide (IAA) at room temperature for 30 min in the dark. Proteins were 
first digested by lysyl endopeptidase (LysC) (Wako) at a protein-to-LysC ratio of 100:1 (w/w) 
at room temperature for 3 hr. Then, the sample solution was diluted to a final concentration of 
2 M urea with 50 mM ammonium bicarbonate (ABC). Trypsin (Promega) digestion was 
performed at a protein-to-trypsin ratio of 100:1 (w/w) under constant agitation at room 
temperature for 16 hr. Peptides were desalted with C18 Stage tips (Rappsilber et al., 2007) 
prior to LC-MS/MS analysis.  
LC-MS/MS analysis 
Reversed-phase liquid chromatography was performed by employing an EASY nLC 1200 
(Thermo Fisher) using self-made fritless C18 microcolumns (Ishihama et al., 2002) (75 μm ID 
packed with ReproSil-Pur C18-AQ 3-μm resin, Dr. Maisch GmbH) and connected on-line to 
the electrospray ion source (Proxeon) of a Q Exactive plus (Thermo Fisher). The mobile 
phases consisted of (A) 0.1% formic acid and 5% acetonitrile and (B) 0.1% formic acid and 
80% acetonitrile. Peptides were eluted from the analytical column at a flow rate of 200 nl/min 
by altering the gradient: 5-6% B in 2 min, 6-8% B in 14 min, 8-20% B in 44 min, 20-33% in 50 
min, 33-45% B in 12 min, 45-60% B in 2 min, 60-95% B in 1 min. A Q Exactive (plus) instrument 
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was operated in the data dependent mode with a full scan in the Orbitrap followed by top 10 
MS/MS scans using higher-energy collision dissociation (HCD). For standard proteome 
analyses, the full scans were performed with a resolution of 70,000, a target value of 3x106 
ions and a maximum injection time of 20 ms. The MS/MS scans were performed with a 17,500 
resolution, a 1x106 target value and a 20 ms maximum injection time. Isolation window was 
set to 2 and normalized collision energy was 26. Ions with an unassigned charge state and 
singly charged ions were rejected. Former target ions selected for MS/MS were dynamically 
excluded for 30 s. 
Processing of mass spectrometry data 
All raw data were analyzed and processed by MaxQuant (v1.5.1.2) (Cox and Mann, 2008). 
Default settings were kept except that ‘match between runs’ was turned on. Search parameters 
included two missed cleavage sites, cysteine carbamidomethyl fixed modification, and variable 
modifications including methionine oxidation, protein N-terminal acetylation, deamidation of 
glutamine and asparagine. The peptide mass tolerance was 6 ppm and the MS/MS tolerance 
was 20 ppm. Database search was performed with Andromeda (Cox and Mann 2008; Cox et 
al. 2011) against UniProt/Swiss-Prot human or mouse database (downloaded on 2014-11) with 
common serum contaminants and enzyme sequences. False discovery rate (FDR) was set to 
1% at peptide spectrum match (PSM) level and at protein level. A minimum peptide count 
required for protein quantification was set to two. A label free quantification (LFQ) method 
implemented in MaxQuant (Cox et al., 2014) was used to quantify proteins. First, we only 
selected proteins that were quantified in at least 2 out of 3 biological replicates and missing 
LFQ values were replaced by imputation with a default setting in Perseus (Tyanova et al., 
2016). Then, fold-changes and corrected p-values (two sample t-test) were computed for the 
volcano plot. 
 
6.1.15 Quantification of neurite length 
Fiji (Schindelin et al., 2012) was used to quantify neurite length on brightfield microscopy 
images taken at 20x with a Keyence BZ 9000. Therefore, the freehand line tool was used to 
trace neurites starting from the cell body to the neurite tip. The measure tool was used to 
determine the length in µm. 30 cells per condition were counted. 
6.1.16 Quantitative real time PCR (qPCR) 
All quantitative real time PCR experiments were conducted on an ABI StepOne Plus 
instrument. Depending on the sample and target gene set, cDNA was diluted 1:10 to 1:100 
with ddH2O and mixed with 2x Maxima SYBR Green/ROX qPCR Master Mix and 3.75 µl of 2.5 
μM Primer mix to obtain 15 μl of total reaction volume per well. All measurements were 
conducted at least in technical triplicates.  
For miRNA expression analysis, TaqMan assays with an attached FAM dye were quantified 
using TaqMan Universal master Mix II, no UNG-1. 
Relative quantification was performed by using the comparative ΔΔCT method (Pfaffl, 2001). 
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6.1.17 Reverse Transcription (RT) of RNA 
If not stated differently, RNA was reverse transcribed to cDNA using Maxima H Minus Reverse 
Transcriptase at 100 U per μg RNA. First, up to 1 μg of RNA was mixed with 0.5 mM dNTPs, 
0.25 μg random hexamers and filled up to 15 µl with double-distilled water (ddH2O). This 
mixture was denatured at 65°C for 5 min in a thermocycler, immediately placed on ice and 100 
U/μg RNA of Maxima RT, 4 µl 5x RT Buffer and 0.5 μl Ribolock were added. The cDNA 
synthesis was carried out with the following program in a thermocycler: 10 min at 25°C, 30 min 
at 50°C, 5 min at 85°C. 
6.1.18 Reverse Transcription of miRNAs 
The reverse transcription of miRNAs is more complex than standard total RNA reverse 
transcription due to their short size, typically around 22 nt, and the lack of a polyA-tail. 
Therefore, stem loop primers are used that only need a short overlap with the miRNAs 3’end. 
50 ng of total RNA per target miRNA or housekeeper are reverse transcribed using SuperScript 
III (100 U/reaction), 0.5 mM dNTPs, 20 U Ribolock, 1x TaqMan RT primer and 1x first-strand 
synthesis buffer were filled up to 20 μl reaction volume with ddH2O and mixed. Then the 
reaction was incubated for 30 min at 16°C, 30 min at 42°C and terminated for 5 min at 85°C.  
6.1.19 RNA extraction 
RNA was generally extracted using self-made TRIzol (see 5.1). Adherent cells were washed 
once with 1x PBS pH 7.4 and TRIzol was directly added. The samples were incubated for 5 
min at room temperature to facilitate complete dissociation. Then 200 μl of Chloroform were 
added, samples were shaken vigorously and immediately centrifuged (15 min, 12 000xg, 4°C). 
The upper aqueous phase was recovered and contained RNA was precipitated by adding the 
same volume of isopropanol. Samples were inverted and incubated for at least 10 min at -
20°C. To further aid precipitation of samples with low RNA content, 0.5 µl Glycogen 
(GlycoBlue) were added and samples were incubated for up to 16 h at -20°C before pelleting 
of the RNA and to further aid precipitation of RNA. Pelleting of the RNA was achieved by 
centrifugation (20 min, 16 000xg, 4°C). The supernatant was discarded, and the RNA pellet 
was washed twice with 80 % (v/v) ethanol. The pellet was dried (5 min, room temperature) and 
resuspended in water. 
6.1.20 RNA interference 
RNAi based knockdown of circSLC45A4 in SH-SY5Y cells was performed according to 
standard protocols with Lipofectamine RNAiMax (ThermoFisher). Briefly, 2x104 cells/cm2 were 
seeded in a 6-well plate the day before transfection. 25 pmol of siRNA were used to achieve 
knockdown of the intended target. SH-SY5Y cells were harvested 96 h post-transfection. 
6.1.21 RNase R treatment 
In order to degrade linear RNA, total RNA was treated with 3 U/μg RNase R for 15 min at 37°C 
in 1x RNase R buffer. The same amount of total RNA was used for a mock treatment without 
RNase R. After the reaction RNA from C. elegans was used as a spike-in at 10 % of the original 
RNA amount (for human samples). Then phenol/chloroform/isoamylalcohol was added to 
purify the remaining RNA. Therefore, the mixture was vigorously shaken on a Vortex Genie 2 
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and centrifuged (12000xg, 10 min, 4°C) to separate the phases. The aqueous phase 
containing the RNA was recovered and RNA was precipitated by addition of the threefold 
volume of ethanol, incubation on ice for 10 min and centrifugation (16000xg, 15 min, 4°C). The 
RNA pellet was washed with 80 % (v/v) ethanol and then the RNA was used for reverse 
transcription and analysis by qPCR. For normalization the previously added C. elegans spike-
in RNA was used. 
6.1.22 Stellaris single-molecule FISH 
Stellaris single molecule FISH was performed according to the manufacturer’s protocols 
(Biosearch Technologies). For circSLC45A4, 29 probes were used, and for mRNA SLC45A4 
as well. As a negative control, samples were carried through the protocol without addition of 
probes. 
The sequences of all Stellaris probes used can be found in 10 - Appendix: 10.1 - 
Oligonucleotides. 
6.2 Experimental methods related to 3D-seq 
6.2.1 In situ reverse transcription 
In situ reverse transcription of cells was based on (Cao et al., 2017; Rosenberg et al., 2018). 
In brief, cells were mixed with reverse transcription mix: 
Maxima H- RT Superscript IV RT 
Reagent Volume [µl] Reagent Volume [µl] 
100 µM RT primer 1.0 100 µM RT primer 1.0 
10 mM dNTPs 1.0 10 mM dNTPs 1.0 
Cell suspension @ 
1x105 cells/ml 
10.0 
Cell suspension @ 
1x105 cells/ml 
10.0 
5x Maxima RT buffer 
4.0 
5x Superscript IV 
buffer 
4.0 
Ribolock 0.5 Ribolock 0.5 
Ficoll PM-400 (20 %) 3.0 100 mM DTT 1.0 
Maxima H- RT 
enzyme 
0.5 
water 
2.0 
 
 
Superscript IV 
enzyme 
0.5 
 
Maxima H- RT and Superscript IV were incubated for 30 min at 25°C, 30 min at 37°C and 60 
min at 42°C.  
For optimizing conditions of Superscript IV RT, several additives were used as follows: 
• Proteinase K: 0.08 µg/ml final concentration of Proteinase K are incubated with cells 
for 10 min at room temperature, shaking at 700 rpm. Reaction is stopped by adding 
600 µl PBS+ 0.01 % (w/v) BSA. Cells are pelleted (3000xg, 10 min, 4°C) and washed 
with PBS. 
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• Ficoll PM-400: 5 % (v/v) Ficoll PM-400 were added to the RT reaction. 
• Pre-heating step: RT primer, dNTPs and cell solution were mixed, everything was 
incubated at 55°C for 5 min and rapidly cooled down on ice before the remaining 
reagents were added. 
 
6.2.2 Methanol fixation of tissue and cells 
Methanol fixation of cells for single-cell experiments was carried out as previously described 
(Alles et al., 2017). In brief, cells harvested by trypsinization were twice washed with PBS, 
resuspended in PBS + Ribolock (1 U/µl) to a final concentration of 5x106 cells/ml. Then, the 4-
fold volume of ice-cold methanol was added dropwise while the cells were slowly vortexed. 
Methanol-fixed cells were either used directly or stored at -80°C. For usage, cells were pelleted 
(2500xg, 10 min, 4°C), rehydrated with PBS+ 0.01 % (w/v) BSA + Ribolock (1 U/µl) and washed 
once more with PBS+BSA+Ribolock before they were passed through a 35 µm cell strainer to 
get rid of clumps. 
Methanol fixation of tissue was achieved by placing the 10 µl slices that were immobilized on 
Superfrost Plus microscope slides in cold methanol (15 min, -20°C). Next, the slices were 
rehydrated with PBS + Ribolock (1 U/µl) (3 washes). 
6.2.3 Adapter ligation 
Ligation of the adapter holding the second barcode is achieved with T4 DNA Ligase. To aid 
ligation a splint oligo is used that is first annealed to the adapter: 
Reagent Volume [µl] 
splint oligo [100 µM] 1.0 
adapter with 2nd barcode [100 µM] 1.0 
10x NEB CutSmart Buffer 0.5 
water 2.5 
 
This reaction mixture is incubated at 95°C for 5 min and then slowly cooled down to 20°C at a 
rate of 0.1°C/s. For the actual ligation reaction the following reaction setup is used: 
Reagent Volume [µl] 
Cell Solution 3.00 
10x NEB T4 DNA Ligation Buffer 1.00 
T4 DNA Ligase (400 U/µl) 0.25 
water 2.50 
 
The ligation reaction is incubated at room temperature for 1 h, slowly shaking on an eppendorf 
MixMate (500 rpm). 
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6.2.4 Tissue digestion 
For digestion of methanol-fixed and rehydrated tissue several proteases were tested for 30 
min at 37°C each: Papain at 2 g/ml EBSS, TrypLE Express 1:1 in EBSS, Collagenase Type IV 
at 5 ml/ml in PBS/EBSS (1:1), and Proteinase K at 0.02 mg/ml in EBSS. 
Finally, Papain at 2 g/ml in EBSS (37°C, 15 min and 37°C, 15 min, shaking at F9, 12 rpm on 
a neoLab Intelli-Mixer) were used in all experiments to digest coronal mouse brain slices. 
6.2.5 Estimation of AMPure XP bead purification yields 
For estimation of AMPure XP bead purification yields, 1 µg of RNA was reverse transcribed 
and split in two aliquots. One aliquot was kept (A), the other one (B) was mixed with either 40 
µl of water, 40 µl of Dropseq Lysis buffer, 40 µl of water and Triton X-100 (final concentration 
0.15 % v/v), or 40 µl of water and IGEPAL CA-630 (final concentration 0.25 % v/v) before the 
cDNA was purified with 90 µl AMPure XP beads according to the manufacturer’s instructions. 
cDNA was eluted in 30 µl water, while the other aliquot (A) was brought to the same volume 
with water. qPCR was used to calculate the recovered amount of cDNA:  
𝑟𝑒𝑐𝑜𝑣𝑒𝑟𝑒𝑑 𝑐𝐷𝑁𝐴 [%] =  2(𝐶𝑡(𝐴)−𝐶𝑡(𝐵)) ∙ 100 % 
6.2.6 Design of CAD files 
CAD files of the grid and its mounting device were created with Autodesk Fusion 360 (student 
license). 
6.2.7 Production of a grid with a 3D printer 
CAD files were loaded into Ultimaker Cura software to slice the models (.gcode file) for 3D 
printing with an ultimaker 2+. Ultimaker 2+ was set up with the manufacturer recommended 
print settings for the respective materials (extrusion speed, layer thickness minimal, extrusion 
temperature, plate heating etc.). To aid sticking of the first layer on the plate, glue from a 
conventional glue stick was applied. To ease release of the mounting device from the ultimaker 
2+ plate, a scalpel was used.  
Grids with low wall thickness (< 300 µm) were produced with a Projet HD 3000 at the 
Fraunhofer Institute for Applied Polymer Science in Potsdam Golm, with the help of Dr. Henry 
Memczak. 
 
6.3 Cell Culture Methods 
6.3.1 Culture and differentiation of SH-SY5Y 
SH-SY5Y cells were cultured and differentiated as previously described (Ross et al., 1983). In 
summary, cells were grown in DMEM/F12 (Gibco) with 10 % FBS and 1x GlutaMax (Gibco). 
For differentiation, cells were plated at a density of 1x105 cells/cm2 and induced by addition of 
differentiation medium (Neurobasal medium, 1x GlutaMax, 1x B27, 10 µM ATRA) and 
harvested 4 or 8 days later. At day 4 post-induction, 5 µM AraC were added to prevent 
overgrowth of the culture with mitotic cells. The medium was exchanged every second day. 
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6.3.2 Culture and differentiation of NTERA2 
NTERA-2 cells were cultured and differentiated as previously described (Lee and Andrews, 
1986; Pleasure and Lee, 1993; Podrygajlo et al., 2009). In brief, 1x106 cells/cm2 were plated in 
bacteriological grade dishes in DMEM/F12 (Gibco), 10 % FBS and 1x GlutaMax (Gibco). After 
2 days 10 μM ATRA was added and medium was renewed every two days until day 8. 
Embryoid bodies were then plated on a cell culture grade dish (same size as initial 
bacteriological dish) and grown as monolayer. At day 14 cells were trypsinized (5 min, room 
temperature, 0.05 % Trypsin/EDTA) and replated on a larger dish. At day 16 cells were 
trypsinized again and replated on a smaller dish while the media was additionally 
supplemented with 1 µM AraC. Finally, at day 23, cells were replated on PLL-coated dishes at 
a density of 4x105 cells/cm2 as neuronal culture. 
6.3.3 Preparation and culture of primary neurons 
Primary forebrain neurons were prepared from CD1 mouse embryos (E17.5-18.5) as 
previously described (Dotti et al., 1988; Kaech and Banker, 2006). They were maintained in 
Neurobasal-A medium with 2% B27 and 0.5 mM GlutaMAX-I (Gibco) at 37ºC and 5% CO2. 
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6.4 Computational Methods 
6.4.1 Analysis of RNA sequencing samples 
Sequencing data was converted to the fastq file format and demultiplexed using bcl2fastq and 
mapped to hg38 with STAR 2.4.1d or to mm10 with STAR 2.4.2a. Uniquely aligned reads were 
intersected with GENCODE v23 gene models (human) or GENCODE vM16 (mouse) and 
counted with HTseq (Anders et al., 2015) (human) or with GenomicRanges (Lawrence et al., 
2013) and Rsubread (Liao et al., 2013).  
6.4.2 Differential expression analysis 
Differential expression changes were determined with DESeq2 (Love et al., 2014a). DESeq2 
relies on the assumption that the majority of expressed genes is constant in between analyzed 
samples and comparatively little genes are changing in expression. Hence, for normalization 
DESeq2 finds scaling factors to normalize the gene expression distributions for different data 
sets. The principal component analysis was performed with plotPCA on regularized log 
transformed read counts. 
6.4.3 GO term analysis 
For GO term analysis, up- and downregulated genes were selected according to an expression 
cut-off (> 50 counts in scramble KD) and a significance cut-off for differential expression 
(human: adjusted p-value < 0.05; mouse: adjusted p-value < 0.001). Those selected genes 
were tested for overrepresentation of specific terms against all expressed genes (> 50 counts 
in scramble KD) with goana from the limma package (Ritchie et al., 2015). p-values are 
calculated with a Fisher’s exact test and adjusted with the Benjamini-Hochberg method 
(Benjamini and Hochberg, 1995). 
6.4.4 Identification of chimeric reads 
Please refer to (Grosswendt et al., 2014) for a detailed description on how to identify chimeric 
reads. The dataset used for chimera analysis of mouse neocortex was published by Moore 
and colleagues (Moore et al., 2015). 
6.4.5 Prediction of RCMs and calculation of H-score 
The H-score is a probabilistic score which defines how likely an exon, or a group of exons will 
form a circRNA. H takes into account the length of RCMs and the distance between them. 
Importantly, H considers the competition of circRNA flanking RCMs with all other RCMs in pre-
mRNA. RCMs are reverse complementary matches (sequences) located in circRNA flanking 
introns. RCMs form double-stranded structures across exons and promote circularization 
(Rybak-Wolf et al., 2015). Please refer to (Ivanov et al., 2015) for a detailed description. 
6.4.6 Conservation analysis 
PhyloP scores (Pollard et al., 2010) from the multiple alignment of 100 vertebrates were 
retrieved for hg19 using the UCSC table browser (Hinrichs et al., 2006). The mean was 
calculated for the following genomic regions (hg19): SLC45A4 exon 1 (circRNA exon) 
chr8:142,264,087-142,264,728; SLC45A4 exon 2 chr8:142,231,675-142,231,864; SLC45A4 
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exon 3 chr8:142,229,747-142,229,929; SLC45A4 exon 8 (CDS and 3’-UTR) 
chr8:142,220,870-142,221,800; SLC45A1 exon 1 chr1:8,377,887-8,378,248; SLC45A2 exon 
1 chr5:33,984,302-33,984,835; SLC45A3 exon 1 chr1:205,633,612-205,634,014. 
6.4.7 Reanalysis of single-cell data and marker gene determination 
Single-cell data from mouse cortex E15.5 was taken from (Yuzwa et al., 2017) and downloaded 
from GEO (GSE107122, “GSE107122_E155_Combined_All_Cells_DGE.txt”). Seurat was 
used for the re-analysis of this dataset (Butler et al., 2018). Only non-mitochondrial genes that 
were expressed in ≥ 3 cells and cells that had ≥ 200 or ≤6000 genes expressed were kept. 
Data was normalized (NormalizeData), variable genes were identified (FindVariableGenes), 
data was scaled (ScaleData) and principal components identified (RunPCA) and statistically 
significant principal components identified (PCElbowPlot, 1 to 16 were selected) with standard 
settings. Next, 14 cell clusters were identified (FindClusters, dims.use=1:16, resolution = 1.0), 
visualized with non-linear dimensional reduction (tSNE) as implemented in Seurat. Marker 
genes for these clusters were identified using the build in FindAllMarkers function and then 
individually evaluated for specific expression in the respective clusters. Based on these marker 
genes, the identity of the clusters was determined by literature research. 
6.4.8 Inference of cell type proportion changes from single-cell and RNA-seq 
data 
Marker genes for the different cell populations present in E15.5 mouse cortex were defined by 
reanalyzing single-cell data (Yuzwa et al., 2017) (GSE107122, 
“GSE107122_E155_Combined_All_Cells_DGE.txt”). Bseq-SC (Baron et al., 2016) was used 
to infer the changes in cell type proportions. An extensive tutorial for Bseq-SC can be found at 
https://github.com/shenorrLab/bseqsc. 
6.5 Computational methods related to 3D-seq 
All code for analysis of 3D-seq sequencing runs was written by Dr. Nikolaos Karaiskos, the 
latest version is accessible via https://github.com/nukappa/space-seq. 
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7 Results 
7.1 Circular RNAs in the Mammalian brain are highly abundant, 
conserved and dynamically expressed 
7.1.1 CircRNAs are abundant in the mouse and human central nervous systems 
The detailed description of circRNA expression in a wide variety of neural samples allows for 
the discovery of many insights that later on potentially help to learn about the function of 
circRNAs. Knowledge of expression patterns, localization and spatiotemporal expression 
dynamics is necessary to identify those circular RNAs that are important for neuronal 
differentiation, synaptic plasticity and neuronal activity.  
Therefore, total RNA libraries from different brain regions, primary neurons, 
synaptoneurosomes and cell lines over the course of differentiation were prepared (Rybak-
Wolf et al., 2015). Additionally, data made available by the ENCODE consortium were 
analyzed (ENCODE Project Consortium, 2012), amounting in total to 28 samples (Table 3).  
For detection of circRNAs a previously published approach (Memczak et al., 2013), that allows 
for de novo detection of circRNAs from total RNA sequencing data, was applied. CircRNAs 
are identified based on reads uniquely mapping to the head-to-tail splice junction of the 
circRNA, which is a splice junction only found in circular RNAs or in rare cases in trans-spliced 
transcripts. The head-to-tail junction spanning reads are used for quantification of a circRNA. 
To have a comparable measure for mRNAs, their quantification was limited to the splice sites 
as well. The maximum number of reads of the shared splice sites between linear and circRNA 
were counted (Figure 9 - A) to minimize effects on expression counts derived from other 
underlying sequence features, e.g. the length of surrounding introns (Rybak-Wolf et al., 2015). 
The cut-off for calling a circRNA expressed was set to two uniquely mapping, head-to-tail splice 
junction spanning reads. 
Interestingly, the fraction of spliced reads falling on circRNA splice junctions differs between 
tissues, e.g. almost 5 % of spliced reads in human cortex can be assigned to circRNAs, while 
less than 1 % of spliced reads in liver originate from circRNAs (Figure 9 - B). This generalization 
of circular RNAs being highly expressed in neural tissues was validated by qPCR for 
circRIMS2, a highly expressed and conserved circRNA that is almost exclusively found in 
neural tissues of both mouse and human (Figure 9 - C). 
Next, the number of reads falling onto the head-to-tail splice junction of a circRNA or on the 
adjacent linear splice junction of the linear RNAs was analyzed. It was revealed that linear 
RNAs are generally higher expressed than circular RNAs. However, circRNAs span a wide 
expression range and a considerable amount is expressed at more than 100 reads falling onto 
the head-to-tail junction: 565 (3.1 %) mouse circRNAs and even 5962 (8.4 %) human circRNAs 
(Figure 9 - D). 
Additionally, circRNAs were frequently found to be the higher expressed isoform from a locus. 
In mouse post-natal hindbrain and midbrain, in more than 25 % of the genetic loci that form 
circRNAs, the circRNA is the higher expressed isoform (Table 3). In human occipital lobe and 
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temporal lobe still 11.0 % or 12.4 % of circRNA-forming genetic loci express the circRNA at a 
higher level than the mRNA.  
 
Table 3: Overview of samples prepared and/or analyzed 
organism sample # circRNAs detected # circRNA > linear RNA 
mouse 
cerebellum 2407 238 9.9 % 
pre-frontal cortex 1677 166 9.9 % 
hippocampus 1212 164 13.5 % 
olfactory bulb 1771 189 10.3 % 
P19 differentiation 2735 508 18.6 % 
        undifferentiated, day 0 419 81 19.3 % 
        day 2 363 74 20.4 % 
        day 4 1128 153 13.6 % 
        day 12 1210 117 9.7 % 
post-natal forebrain (ENCODE) 6614 1182 17.9 % 
post-natal hindbrain (ENCODE) 3382 1055 31.2 % 
post-natal midbrain (ENCODE) 3758 1033 27.5 % 
primary cortical neurons 5265 646 12.3 % 
        day 1 1464 176 12.0 % 
        day 7 1949 287 14.7 % 
        day 14 2717 343 12.6 % 
        day 21 2558 369 14.4 % 
synaptoneurosomes 1773 317 17.9 % 
human 
cerebellum (ENCODE) 21071 2289 10.9 % 
diencephalon (ENCODE) 24632 2430 9.9 % 
frontal cortex (ENCODE) 38983 4089 10.5 % 
occipital lobe (ENCODE) 31085 3410 11.0 % 
parietal lobe (ENCODE) 23303 2159 9.3 % 
temporal lobe (ENCODE) 21835 2718 12.4 % 
SH-SY5Y differentiation 4264 639 15.0 % 
        undifferentiated, day 0 2166 254 11.7 % 
        day 2 1822 193 10.6 % 
        day 4 1300 174 13.4 % 
        day 8 483 83 17.2 % 
 
Next, we were interested to see from which genomic loci circular RNAs are formed 
preferentially. In contrast to mRNAs, circRNAs are spliced from a subset of genomic features 
of a genomic locus, e.g. a few exons. Therefore, we classified the circRNAs into circRNAs 
being produced from the 5’UTR, 3’UTR, coding sequence (CDS) or intronic regions of a gene 
or from ncRNAs, antisense of annotated genes or intergenic. Strikingly, most circRNAs were 
produced from the CDS of a gene, for both human (68.2 %) and mouse (55.0 %) (Figure 9 - 
E). 
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Figure 9: circRNAs are highly abundant in the mammalian brain.  
(A) - circRNAs were detected as previously described (Memczak et al., 2013), and the analysis was extended by a 
comparison of circRNA and host transcript expression in deep sequencing data. (B) – Box plots of circular spliced 
reads in 4 human sequencing libraries, the highest fraction was assigned to circular splice junctions in cortex (blue), 
compared to muscle (yellow), thyroid gland (red), and liver (green). (C) - The conserved circRims2 is highly 
expressed in mouse adult brain (left panel; EB12/14, embryonic brain day 12/14) or human cortex (right panel). 
Data represent mean ± SD, n = 3 technical replicates. (D) - circRNAs detected in mouse and human brain samples 
span a broad expression range. However, mRNA expression is generally higher. mRNA – green, circRNA – blue. 
(E) – circRNAs stem mostly from the coding sequence of a gene (CDS). 
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7.1.2 CircRNAs are differentially expressed in the brain and are enriched at 
synaptoneurosomes 
Since circRNAs were found to be predominantly expressed in neural tissue, like cortex, their 
spatial expression in the mouse brain was investigated. First, circRNA expression across 
different brain regions, e.g. cerebellum, hippocampus, olfactory bulb and prefrontal cortex, was 
compared by the number of normalized reads falling onto the head-to-tail junction. Strikingly, 
circRNA expression was found to be specific to each of these brain regions while a set of 
circRNAs exists in all brain regions (Figure 10 – A). Then, a number of circRNA candidates 
was selected and their differential spatial expression was confirmed independently by qPCR. 
Additionally, their expression was compared to their linear counterparts. In many instances the 
spatial expression of a circular RNA was independent from its linear mRNA counterpart, e.g. 
circRims2 is higher expressed in cerebellum than the mRNA, while the mRNA is more 
abundant in the striatum (Figure 10 – B). These observed expression differences for circRNAs 
in several mouse brain regions indicate a regulated way of expression for circRNAs. 
Additionally, the many examples of differential expression of circRNAs compared to their linear 
counterparts (Figure 10 – B) suggest an independent function of these circRNAs as well as 
supporting the hypothesis that circRNA expression is regulated independent of its linear 
counterpart. 
Neurons are characterized by the long extensions they extrude from their soma, known as 
neurites or more specifically as axons and dendrites. Along these neurites synapses are found, 
structures that permit the signal transduction between two cells. The signal conducting and 
receiving parts of a synapse are known as pre- and post-synaptic compartments, the 
combination of both as synaptoneurosome. It was previously shown that certain mRNAs are 
actively transported to the synapses to facilitate for example local translation at the synapses 
(Schuman, 1999). Therefore, it was analyzed whether circRNAs could be localized to the 
synapse as well, possibly serving specialized functions in these cell compartments. Thus a 
well-established protocol to extract synaptoneurosomes by centrifugation from whole mouse 
brain, was used to separate those from whole brain extract and the cytoplasmic fraction (Gray 
and Whittaker, 1962; Huttner et al., 1983). Analysis of the subcellular localization of circRNAs 
by total RNA-seq of whole mouse brain extract, cytosolic fraction and synaptoneurosomes 
revealed their predominant enrichment at the synaptic regions, compared both to their linear 
counterparts and the whole brain extract (Figure 10 – C). Here, at least 5 uniquely mapping 
reads on the head-to-tail junction were required to consider a circRNA to increase the 
confidence in the data. To make sure that this observation was not based on inherently noisy 
low expression counts of the investigated molecules, the data was split up by circRNA 
expression thresholds (Figure 10 – D). Remarkably, the enrichment of circRNAs at the 
synaptoneurosome compared to either whole brain extract or cytoplasmic fraction was robust 
over all investigated expression thresholds. Again, we confirmed the previous observations 
from RNA-seq by independent low-throughput methods, in this case by qPCR (Figure 10 – E). 
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Figure 10: circRNAs are differently expressed in brain regions and neuronal compartments. 
(A) – Clustering of mouse brain regions by normalized circRNA expression. (B) – qPCR validation of circRNA and 
mRNA expression in several mouse brain regions. (C) – circRNAs are enriched in synaptoneurosomes compared 
to whole brain extract, normalized by circular-to-linear ratio. Dashed line marks two-fold enrichment. (D) – CircRNA 
enrichment at synaptoneurosomes is robust over several circRNA expression cut-offs. (E) – Validation of circRNA 
enrichment at synaptoneurosomes by qPCR. 
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7.1.3 CircRNAs are differentially expressed during neuronal differentiation 
For a functional characterization of particular circRNAs, established cell culture models are 
needed that allow for well-understood and controlled differentiation of progenitor cells towards 
more neuronal cells. For this purpose the human neuroblastoma cell line SH-SY5Y (Ross et 
al., 1983) as well as primary mouse forebrain neurons were analyzed for their circRNA 
expression throughout differentiation (Dotti et al., 1988; Kaech and Banker, 2006). In brief, SH-
SY5Y cells were platted in conventional cell culture dishes and treated will all-trans retinoic 
acid. Primary neurons were prepared from hippocampi of embryonic mouse brains (E17.5 – 
E18.5) and grown on PLL-coated coverslips during maturation. Successful differentiation was 
validated by measuring neuronal marker genes, i.e. beta-III-tubulin, on RNA and protein level 
(data not shown).  
The expression of circRNAs and mRNAs over the course of 4 days of differentiation was 
analyzed in human SH-SY5Y and primary mouse neurons by total RNA-seq. Comparison of 
circRNA expression in undifferentiated (D1) to differentiated (D21) primary neurons revealed 
that almost 2000 circRNAs were upregulated while only 800 were downregulated (Figure 11 – 
A). Interestingly, many circRNAs were not expressed at day 1 but are only detected later on. 
This points towards a general trend of circRNAs being upregulated over the course of neuronal 
differentiation.  
The same analysis for SH-SY5Y cells showed a similar however weaker trend, with 494 
circRNAs being upregulated when comparing undifferentiated cells to day 4 of differentiation. 
At the same time 539 circRNAs are downregulated in SH-SY5Y cells. It should be kept in mind, 
that so called undifferentiated SH-SY5Y cells are already at a neuroblast stage, which is an 
already advanced step in neurogenesis that permits cells to become mature neurons 
(Kovalevich and Langford, 2013). Additionally, these numbers reflect global changes and do 
not consider slight but consistent upregulation of circRNAs overall which will be explored in the 
next section. 
Again, several candidates from both systems were selected from total RNA-seq results and 
validated by qPCR (Figure 11 – B and D). Often the same expression trend for a circRNA was 
identified in primary neurons as well as SH-SY5Y cells, e.g. CDR1as, CPSF6 and RTN4 are 
consistently upregulated, despite the fact that those differentiation systems are derived from 
different organisms. 
Analyzing the expression of all circular RNAs over the course of differentiation individually 
revealed the expression dynamics for this molecule class in both SH-SY5Y cells and primary 
neurons  
(Figure 11 – C and F). Most circular RNAs peak at a certain step of differentiation, while only 
few remain constant throughout differentiation. Many circRNAs are expressed only during 
intermediary steps of differentiation: e.g. some were only detectable at D2 for SH-SY5Y cells, 
at an early commitment point to the neuronal lineage, or at D7/D14 for primary neurons, when 
they are maturing. These intriguing expression dynamics are pointing at a tightly regulated 
expression of circular RNAs during the differentiation from progenitor cells towards neurons. 
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Figure 11: circRNAs are differentially expressed during neuronal differentiation. 
(A) – circRNA expression comparison between D1 and D21 of primary neuron maturation. (B) – qPCR validation 
of primary neurons circRNA expression changes detected previously by RNA-seq. (C) – Heatmap of primary neuron 
circRNA expression changes. Each row corresponds to a circRNA, coloring is scaled to rows. (D) - circRNA 
expression comparison between D0 and D4 of SH-SY5Y differentiation. (E) – qPCR validation of SH-SY5Y circRNA 
expression changes detected previously by RNA-seq. (F) – Heatmap of SH-SY5Y circRNA expression changes. 
Each row corresponds to a circRNA, coloring is scaled to rows. 
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7.1.4 CircRNA and mRNA changes during differentiation differ 
Considering, that circRNAs are alternative splicing events from a gene, it is of great importance 
to compare their expression changes with its linear splice isoform. mRNA expression levels 
are often measured in transcripts per kilobase million (TPM) (Wagner et al., 2012) correcting 
the expression inferred from RNA-seq count data for sequencing depth and gene length. Since 
circular RNAs are only identifiable by their unique head-to-tail junction a similar measure is not 
easily derived for circular RNAs.  
So, to investigate expression changes for circular RNAs during differentiation in respect to its 
linear counterpart, we made use of the comparison circular-to-linear ratio vs. mRNA TPM. 
Clearly, these measures are negatively correlated meaning that whenever a circular RNA is 
expressed from a genetic locus, the mRNA is not. This points to a mode were either a circular 
RNA or a linear RNA is produced from a genetic locus, indicating competition between the 
production of both possible isoforms. This observation was made in primary cortical neurons 
as well as in human SH-SY5Y cells in both undifferentiated and differentiated states (Figure 
12 – A and C). This finding also argues against the idea that circular RNAs are a mere by-
product of linear splicing, in which case no correlation between circular-to-linear ratio and 
mRNA expression would be expected. Furthermore, for SH-SY5Y cells an overall increase of 
the circular-to-linear ratio is visible, supporting the fact that circular RNA expression is in 
general higher in differentiated cells than in undifferentiated ones. 
Comparing reads mapping to the head-to-tail junction (circular RNAs) or to circRNA 
surrounding splice sites (mRNA) revealed that the overall expression of mRNAs and circRNAs 
is correlated, also during differentiation (Figure 12 – B and D). However, there are many 
exceptions found in both mouse primary neurons and human SH-SY5Y cells, in which the 
circRNA expression level is independently changed from the mRNA’s one (Figure 12 – B and 
D). 
In summary, the expression changes of a circRNA and its corresponding mRNA are often 
independent from each other (Figure 12 – B and D). Counting the number of events, revealed 
that in primary neurons 1301 circRNAs were more than two-fold upregulated at day 21 of 
differentiation compared to undifferentiated cells, while the mRNA remained stable (Figure 12 
– E). Only 625 upregulated circRNAs had linear counterparts that exhibited the same 
expression trend. A similar observation was made in human SH-SY5Y cells: 437 circRNAs 
showed increased levels in differentiated cells and that independent of their linear counterpart. 
At the same time only 57 circRNAs were upregulated together with their mRNA (Figure 12 – 
F).  
Several circRNA expression trends were validated by northern blotting. Northern blot allows 
amplification-free quantification of RNA levels (Figure 12 – G). For detection DIG-labeled RNA 
probes were used that were designed to detect circular and linear RNA at the same time. 
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Figure 12: circRNA and mRNA expression changes differ during differentiation. 
(A) - Relative quantification of circRNA expression during differentiation of primary neurons, circular to linear ratio 
vs. mRNA TPM. (B) – circRNA expression is positively correlated with mRNA expression in undifferentiated vs. 
differentiated primary neurons. (C) - Relative quantification of circRNA expression during differentiation of SH-SY5Y 
cells, circular to linear ratio vs. mRNA TPM. (D) - circRNA expression is positively correlated with mRNA expression 
in undifferentiated vs. differentiated SH-SY5Y cells. (E) – Summary of expression changes for primary neurons. (F) 
– Summary of expression changes for SH-SY5Y cells. (G) – Validation of expression changes by Northern blot for 
SH-SY5Y cells, ZNF609 and XPO1. Circle = circular RNA, arrow – linear RNA. 
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7.1.5 Circular RNAs are often conserved 
Tools to predict circRNAs became available only recently, hence little basic information about 
circRNAs is available. Thus, after having determined physiological human and mouse circRNA 
expression levels, the conservation of circRNAs between mouse and human was analyzed. 
First, using the liftOver tool (Hinrichs et al., 2006) orthologous circRNAs were identified in 
human and mouse. Then these circRNAs were assigned to different categories based on the 
conserved genomic position of utilized splice sites in these two species (Figure 13 – A). A 
splice site was only considered conserved if it did not vary by more than 2 nt in position. 
Thereby even small shifts in splice site position over 100 million years of evolution from mouse 
to human were excluded. All mouse circRNAs identified were compared to all identified human 
circRNAs, which revealed that 28.5 % of mouse circRNAs have a homolog in human (4522 
out of 15849 considered mouse circRNAs). Another 28.6 % of mouse circRNAs had at least 
one of their splice sites in a homologous position in human.  
 
Figure 13: Conservation of circRNAs  
(A) - Conservation analysis between human and mouse circRNAs using liftOver to identify homologous splice sites. 
Conservation levels are higher, if an expression cut-off (≥ 5 reads) is applied. (B) – Validation of several candidate 
circRNAs by Sanger sequencing confirming their homologous splice sites. (C) – Definition of analyzed segments 
(5’UTR, CDS – before, circRNA, after, and 3’UTR) and density of conserved 7-mers (total number of occurrences 
per total spliced length) up to chicken. Ramp underneath indicates expression levels: 2-10. 10-100, 100-500, 500-
1000 and > 1000 head-to-tail spliced reads. Error bars represent SD based on random subsamples, asterisks: *p < 
5%, **p < 1%, ***p < 0.1%, and ****p < 0.01%. 
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These numbers remained comparable when only circRNAs detected in a neuronal mouse cell 
line (P19) were examined for their conservation with human. However, the numbers increased 
dramatically when an additional expression cut-off of ≥ 5 reads on the head-to-tail junction for 
the P19 circRNAs was applied. 
A number of conserved circRNA candidates was selected and the conservation of their head-
to-tail junction was confirmed by Sanger sequencing (Figure 13 – B). Circularity was validated 
independently by RNase R treatment (data not shown), i.e. an exonuclease that specifically 
degrades linear transcripts (Suzuki et al., 2006). 
Conserved circularization indicates selective pressure that preserves conditions in which the 
splicing machinery maintains to circularize specific exons throughout evolution. This could 
potentially be caused by independent functions of circRNAs that ought to be kept or simply 
because the underlying CDS is under selective pressure to keep the protein coding sequence. 
Therefore, it was examined if those parts of a CDS that give rise to a circular RNA were more 
conserved than those parts of the same CDS that are not circularized but are coding for a 
protein (Figure 13 – C). The analysis was limited to circRNAs coming from coding sequences, 
as this is the majority of circRNAs (comp. Figure 9 – E). For this purpose, conserved 7-mers 
(human up to chicken, 300 million years of evolution) per total spliced length were counted in 
the 5’UTR, coding sequence upstream and downstream of the circRNA, the circRNA itself and 
in the 3’UTR. Strikingly, those segments being used for circularization were enriched in 
conserved 7mers compared to any other gene segment. Additionally, this effect increased with 
higher expression of a circRNA. However, interpretation of this analysis is not straightforward: 
conservation is not homogenous along the CDS. More highly expressed circRNAs are located 
closer to the transcription start of the host gene and, more highly expressed circRNAs are 
flanked by longer introns which also correlates with higher conservation levels of exons 
(compare (Rybak-Wolf et al., 2015)). 
 
7.1.6 Circular RNA expression is regulated by ADAR 
ADAR1 is an A-to-I RNA-editing enzyme that has been implicated in the regulation of circRNA 
expression (Ivanov et al., 2015; Liang and Wilusz, 2014). It was shown that ADAR1 can hyper-
edit reverse complementary sequences found in introns surrounding circRNAs. This editing 
activity would result in decreased pairing of the reverse complementary sequences, therefore 
ADAR1 negatively regulates circRNA expression. Additionally, it is known that ADAR1 is 
decreasing in expression over the course of human embryonic stem cells towards neuronal 
cells (Osenberg et al., 2010). Which would correlate with the above mentioned circRNA 
expression increase during differentiation. 
Hence, the influence of ADAR1 on circRNA expression in the investigated neural samples was 
determined. First, the H-score that is used to identify reverse complementary sequence 
matches (RCM) was computed in order to predict circularization probability (Figure 14 – A). 
This revealed that especially in the introns surrounding conserved circRNAs extensive RCMs 
can be found. Often RCMs are formed by repetitive sequence elements that rapidly evolve, 
e.g. the big class of Alu elements which is only found in primates (Schmid, 1996). 
Consequentially, the H-scores for human samples are generally higher than for mouse 
samples.  
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Figure 14: circRNA expression is regulated by ADAR 
(A) – Concept of H-score calculation. H-scores for introns surrounding circRNAs in human and mouse, split up in 
conserved and not conserved circRNAs. (B) – ADAR1 expression during SH-SY5Y differentiation. Quantification 
for p110. (C) – Efficiency of ADAR1 KD in SH-SY5Y. (D) – circRNA and mRNA expression changes as determined 
by qPCR after ADAR1 KD in SH-SY5Y cells, compared to mock KD. (E) – Editing of region close to circRTN4 by 
ADAR1 during differentiation and after ADAR1 KD. (F) – Expression changes of circRTN4 during differentiation of 
SH-SY5Y cells and after ADAR1 KD. (G) – Global changes in circRNA expression in Drosophila at different 
temperatures that regulate dAdar activity (not active at 29°C). Boxes are limited by the first quartile and the third 
quartile, median is indicated as a horizontal bar, while whiskers span 1.5 x inter-quartile range from their hinges. 
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Since circRNAs were already observed to vary throughout neuronal differentiation the 
expression of ADAR1 over the course of SH-SY5Y differentiation was examined. A decrease 
of 40 % in protein expression after 8 days of differentiation was found (Figure 14 – B, p110) 
being in good agreement with the previously observed upregulation of circRNAs during 
differentiation. Knockdown of ADAR1 in SH-SY5Y cells (Figure 14 – C) depleted the protein 
by 30-40%. This knockdown caused striking changes in gene expression: almost all tested 
circRNAs were elevated in expression and much more so than their corresponding mRNA 
(Figure 14 – D).  
Additionally, a region downstream of circRTN4 that is edited by ADAR1 on transcriptome level 
at certain points of differentiation was identified by computational analysis (Levanon et al., 
2004) 
 (Figure 14 – E). As already mentioned, editing would result in downregulation of circRNA 
expression. At day 4 of differentiation the locus was not edited, therefore circRNA expression 
was released. Indeed, qPCR revealed the expected increase in circRNA expression (Figure 
14 – F). At day 8 of differentiation the locus was edited again, which should prevent further 
elevation of expression, which was again confirmed by qPCR (Figure 14 – F). Furthermore, 
knockdown of ADAR1 would prevent editing of this site and cause the upregulation of circRTN4 
to a similar extent as on day 4 of differentiation, which was again revealed by qPCR (Figure 
14 – F).  
To investigate whether this is a global and conserved phenomenon a previously published 
Drosophila melanogaster dataset was reanalyzed. Editing by dAdar, the Drosophila 
melanogaster homolog of ADAR1, is temperature-sensitive (Rieder et al., 2015; Savva et al., 
2012) and therefore not active at higher temperatures (29°C). Comparing the relative number 
of reads on the head-to-tail splice junction to identify circRNAs or the adjacent splice junction 
to count linear RNAs revealed that only circRNA expression was increased at high 
temperatures, i.e. when dADAR is not active anymore. This is true for both investigated 
expression cut-offs, requiring circRNAs to have at least 10 reads on the head-to-tail junction 
(137 circRNAs) or 15 reads(78 circRNAs) (Figure 14 – G), and highlights the importance of 
circRNA expression regulation by ADAR as it is conserved even in Drosophila melanogaster. 
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7.2 CircSLC45A4 is required to keep neuronal cells in a progenitor 
state in cell culture systems and in the mammalian brain 
 
7.2.1 CircSLC45A4 is conserved and highly expressed in embryonic frontal 
cortex 
As mentioned above, circRNAs are abundantly expressed in neural samples, are conserved, 
are predominantly localized to the synaptoneurosomes, and are expressed in a 
spatiotemporally controlled manner (Rybak-Wolf et al., 2015). This collection of neural circular 
RNAs includes a variety of interesting molecules that are potentially important in neuronal 
differentiation. One of those being circSLC45A4, a circular RNA that is produced from an 
alternative first exon of SLC45A4 (Figure 15 - A). Interestingly, this circRNA is expressed in a 
dynamic spatial pattern in different brain regions. SLC45A4 is coding for a proton-dependent 
sugar transporter that can import glucose, fructose and sucrose, and was shown to be 
important in spermatozoa nutrition (Vitavska and Wieczorek, 2017). However, the function of 
circSLC45A4 remains elusive as it has never been studied in any biological context. 
To survey circRNA expression in development, a total RNA-seq dataset of human embryonic 
frontal cortex at gestational week (WG) 22 was analyzed (collected by the ENCODE 
consortium (ENCODE Project Consortium, 2012)). Surprisingly, this dataset revealed that 
circSLC45A4, and not its linear counterpart, is the main RNA isoform transcribed from its 
genomic locus (Figure 16 – A). And it is overall one of the highest expressed circular RNAs in 
human cortex at this developmental time point. With 460 total reads spanning the head-to-tail 
junction circSLC45A4 ranks at 295th position in terms of circRNA expression in human fetal 
cortex at WG 22 of 38983 detected circRNAs with at least 2 unique head-to-tail junction 
spanning reads (Figure 15 - B), placing it in the top 1 % of expressed circRNAs. These 460 
junction spanning reads indicate a very high expression of circSLC45A4 in this dataset. For 
comparison, amongst all circRNA-producing genes the median of all circRNA surrounding 
linear splice-junction spanning reads, or the median splice junction count for mRNAs, is 85. 
Considering both, linear splice junction spanning reads from mRNAs as well as circRNA splice 
junction spanning reads, circSLC45A4 would still be within the 99.5 percentile according to its 
expression. By the circular-to-linear ratio (refer to chapter 7.1.1) circSLC45A4 is ranked 6th of 
36408 circRNAs (top 0.02 %), when only circRNAs are taken into account whose linear 
counterpart was at least detected with 2 unique splice-junction reads as well (Figure 15 - C). 
At WG 22, neurogenesis in the cortex is almost completed, while neuronal migration and 
maturation are just beginning (Stagni et al., 2015). 
This ENCODE dataset also revealed a previously unannotated upstream exon in human that 
is necessary to facilitate the formation of circSLC45A4 by a splicing reaction. Intriguingly, not 
only is this upstream exon present in human and mouse (Figure 15 - D), but the mouse 
upstream exon is exactly duplicated in its length (420 nt instead of 210 nt in human) with the 
splice sites being conserved.  
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Figure 15: circSLC45A4 is a conserved circular RNA that is highly expressed in human embryonic frontal cortex. 
(A) – Genetic locus of circSLC45A4 in human. mRNA isoforms are shown in blue, circRNA isoforms in green. 
Coverage track shows total RNA sequencing of fetal human cortex, WG 22. Numbers on connecting lines indicate 
the number of reads supporting the splice junction. The location of circSLC45A4 (has_circ_0001829) is indicated. 
(B) – Expression rank of circSLC45A4 in fetal human cortex, ranked by total reads spanning the head-to-tail splice 
junction (295th, top 1 %). (C) – Expression rank of circSLC45A4 in fetal human cortex, ranked by circular-to-linear 
ratio (6th, top 0.02 %). (D) – Splice sites that facilitate production of circSLC45A4 in human and mouse. 
 
The phyloP score (Pollard et al., 2010) computes conservation p-values based on an alignment 
and a model of neutral evolution. Using the phyloP scores that are made available through the 
UCSC genome browser based on the alignment of 100 vertebrates, the conservation of 
circSLC45A4 was assessed. This showed that the circRNA-forming exon of SLC45A4 is 
significantly more conserved than the 8th exon of this gene, containing CDS and 3’-UTR, but 
that it is also significantly more conserved than the first exons of genes from the same gene 
family (SLC45Ax) (Figure 16 – A). This locus is exhibiting unusually strong sequence 
conservation especially in those parts of the circular RNA that are overlapping the 5’-UTR of 
SLC45A4. Overall, circSLC45A4 is conserved on nucleotide level between human and 
Xenopus tropicalis (Figure 16 – B). Only 0.94 % (6 nt out of 641 nt) of the human to X. tropicalis 
alignment in that region belong to a gap. In contrast, the 3’-UTR and intronic regions of this 
gene are much less conserved (Figure 16 – C). Already in orangutan 4.75 % of this region 
alignment result in gaps, in X. tropicalis only 43 % of this region show conservation with human. 
This may suggest that the circRNA containing part of SLC45A4 is under a stronger selection 
pressure than other regions of this gene. 
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Figure 16: The genomic region of circSLC45A4 is a more conserved than comparable regions. 
(A) – Average PhyloP scores of multiple alignments of 100 vertebra, SLC45A4 exon1 (641 nt, mean = 2.86), 2 (190 
nt, mean = 5.04), 3 (183 nt, mean = 4.52), and 8 (931 nt, mean = -0.25), SLC45A1 exon 1 (103 nt, mean = 1.13), 
SLC45A2 exon 1 (534 nt, mean = 2.64), SLC45A3 exon 1 (403 nt; mean = 1.73). T-test, p-value < 0.0001 is ****. 
(B) –Genome Browser conservation tracks visualizing the exceptional conservation of circSLC45A4 compared to 
the 3’UTR and CDS of the same gene, SLC45A4 (C). 
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7.2.2 CircSLC45A4 is localized in the cytoplasm and dynamically expressed 
during the neuronal differentiation of SH-SY5Y and NTERA2 cells 
 
To investigate the functionality of circSLC45A4 suggested by the sequence conservation 
analysis, a model system for human neuronal differentiation was employed. SH-SY5Y cells 
are a well-established and widely used human cell line to study neuronal differentiation 
(Kovalevich and Langford, 2013; Ross et al., 1983). Using two-color single molecule FISH (Raj 
and Tyagi, 2010), an average of 3.7 and 8.8 molecules of circSLC45A4 and mRNA per SH-
SY5Y cell were detected, respectively (Figure 17 – A). Fractionation experiments revealed that 
circSLC45A5 was exclusively found in the cytoplasm (93.9 % of total circRNA), while the 
mRNA was distributed throughout the cells: only half of the mRNA SLC45A4 RNA resided in 
the cytoplasm (56.4 %), while substantial amounts were localized to the nucleus (17.4 %) and 
to the mitochondria (26.2 %) (Figure 17 – B). The successful fractionation of SH-SY5Y cells 
was validated with ACTB and GAPDH as cytoplasmic markers, mitochondrial CO2 (MT-CO2) 
as mitochondrial marker, and NEAT1 as nuclear marker. 
Next, the expression of circSLC45A4 and its corresponding mRNA over the course of neuronal 
differentiation in SH-SY5Y cells was analyzed. SH-SY5Y cells can be differentiated from 
neuroblasts to neurons by induction with all-trans retinoic acid (ATRA) (Påhlman et al., 1984; 
Ross et al., 1983). Here, it was revealed that the expression of circSLC45A4 peaks at the time 
of neuronal lineage commitment or birth of young neurons (Figure 17 – C). This coincides with 
elevated expression of beta-III-tubulin, a marker gene for the generation of immature 
postmitotic neurons (Menezes and Luskin, 1994). mRNA SLC45A4 is also induced at that time 
point, but less strong (1.4-fold compared to 1.8-fold induction of circSLC45A4).  
A more complex human neuronal differentiation system is the teratocarcinoma-derived 
NTERA2 cell line that resembles in vivo differentiation of human neurons much closer (Lee 
and Andrews, 1986; Pleasure and Lee, 1993). Neuronal differentiation in these cells is induced 
via addition of all-trans retinoic acid. Upon this induction they go through an embryoid body 
(EB) stage. EBs are three--dimensional aggregates of pluripotent stem cells. From this stage 
it takes 12 days until maturing neurons are formed. circSLC45A4 was induced at a late stage 
of embryoid body formation, which coincides with the expression of PAX6, that in turn marks 
the neuroectoderm specification (Zhang et al., 2010), and the proneural protein ASCL1, which 
is an important regulator of neural fate commitment in neuronal progenitors (Guillemot et al., 
1993). The mRNA was induced less strong (3.8-fold ate D11 compared to 8.5-fold induction of 
circSLC45A4) and additionally increased in expression when neurons were formed (Figure 17 
– C). These observations indicate that circSLC45A4, despite its low copy number, may play a 
functional role in early neuronal differentiation. 
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Figure 17: Cytoplasmic circSLC45A4 is dynamically expressed during differentiation of SH-SY5Y and NTERA2 cells 
(A) – Single-molecule FISH of circSLC45A4 and mRNA SLC45A4, probe design, representative pictures and 
quantification in SH-SY5Y. Scale bar corresponds to 10 μm. Nuclei are marked with dotted lines. (B) – Fractionation 
of SH-SY5Y cells shows that circSLC45A4 is localized to the cytoplasm, while mRNA SLC45A4 is found in the 
cytoplasm, in mitochondria and in the nucleus. The successful fractionation of SH-SY5Y cells was validated with 
ACTB and GAPDH as cytoplasmic markers, mitochondrial CO2 (MT-CO2) as mitochondrial marker and NEAT1 as 
nuclear marker. (C) – circSLC45A4 expression during SH-SY5Y and NTERA2 differentiation. Expression of 
important marker genes that highlight the progression of differentiation are shown. EB – embryoid body stage, NEU 
– neurons. 
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7.2.3 Knockdown of circSLC45A4 causes spontaneous neuronal differentiation 
The dynamical expression pattern of circSLC45A4 throughout differentiation, indicate a 
possible functional role of this circRNA within differentiation. Thus, RNAi (Elbashir et al., 2001a; 
Fire et al., 1998; Meister et al., 2004) was used to specifically downregulate circSLC45A4 in 
SH-SY5Y cells. In order to specifically target the circRNA and not the linear transcript, the 
siRNAs were designed to target the circRNA-specific head-to-tail junction (Figure 18 – A). To 
increase the reliability of the results, three independent but slightly shifted siRNAs were used. 
Only consistent changes across these three replicate experiment setups were considered. 
Additionally, to control for effects the transfection of the cells might have, control samples were 
transfected with a scrambled siRNA that does not have any targets in the known human 
transcriptome but has a comparable nucleotide composition as the siRNAs targeting 
circSLC45A4. To monitor the reaction of SH-SY5Y cells to the knockdown of circSLC45A4, 
the levels of beta-III-tubulin (TUBB3) as important marker for neuronal differentiation were 
measured by qPCR. Strikingly, TUBB3, proneural factor ASCL1, key regulator of neurogenesis 
NOTCH1 and mature neuron-characterizing GABBR1 and VGLUT1 were consistently 
upregulated following the depletion of circSLC45A4 (Figure 18 – B). This indicates that the 
depletion of circSLC45A4 spontaneously induces neuronal differentiation. While the pre-
mRNA levels of SLC45A4 were slightly increased, the levels of mRNA were unaffected after 
knockdown of circSLC45A4. 
This initial result was further supported by immunofluorescence studies of TUBB3 in SH-SY5Y 
cells after knockdown of circSLC45A4. Again, a consistent upregulation of this marker for the 
generation of immature postmitotic neurons was observed, while a marker for progenitor cells 
(GFAP) was constant (Figure 18 – C). One hallmark of neurons is their intricate morphology, 
exhibiting long protrusions from the cell body, known as neurites or more specifically as axons 
and dendrites. Hence, after knockdown of circSLC45A4 microscopic pictures were used to 
trace the present neurites and thereby measure their length. Remarkably, the neurite length 
was almost twice as long in cells in which circSLC45A4 levels were reduced. The average 
neurite length was increased to 19.9 µm, compared to 12.0 µm after scrambled knockdown. If 
SH-SY5Y cells are differentiated by addition of ATRA the neurites grew to an average of 26.7 
µm (Figure 18 – E). Thus, downregulation of circSLC45A4 seems to induce neurite growth 
almost as strong as the standard differentiation protocol.   
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Figure 18: Knockdown of circSLC45A4 in SH-SY5Y cells causes spontaneous differentiation. 
(A) – siRNA design strategy for circSLC45A4-specific knockdown. (B) – qPCR measurements after knockdown of 
circSLC45A4 in SH-SY5Y cells, each dot indicating a separate biological replicate, averages are marked. Fold 
Changes are compared to scramble KD, the baseline is marked as horizontal line at fold change 1. n.d. – not 
determined (C) – Immunofluorescence of SH-SY5Y cells 96 h after knockdown of circSLC45A4, staining for GFAP 
and TUBB3. (D+E) – Results of neurite length measurements after circSLC45A4 knockdown, scramble knockdown 
and differentiation with ATRA. All neurites of 30 cells per condition measured. **** - t-test p-value < 0.0001 
Having established that the knockdown of circSLC45A4 induces spontaneous differentiation 
of SH-SY5Y cells towards a more neuronal phenotype, RNA-seq was used to understand the 
transcriptomic changes caused by this perturbation. For this purpose, 6 biological replicates of 
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circSLC45A4 knockdown were collected, two for each of the three individual siRNAs. For the 
scramble KD, 2 biological replicates were collected. PolyA selected libraries were prepared for 
all samples and subsequently sequenced. Sequencing data was demultiplexed using 
bcl2fastq, mapped to the human genome version hg38 using STAR (Dobin et al., 2013) and 
counted using the R package GenomicAlignments (Lawrence et al., 2013).  
Differential expression analysis was performed using DESeq2 (Love et al., 2014b). 1019 
significantly upregulated (= 3 %) and 1101 significantly downregulated (= 3.2 %) genes were 
identified (Figure 19 – A). In addition to the previously detected expression changes of 
neurogenesis regulators like ASCL1 and NOTCH1, genes connected to axonogenesis were 
significantly upregulated, e.g. plexins. To validate these findings by qPCR several significantly 
deregulated genes were selected and measured on independent samples (Figure 19 – B). The 
strongest upregulated gene was TIMM17B. TIMM17B codes for a protein that is part of the 
mitochondrial translocase complex TIM23 (Sokol et al., 2014). Furthermore, PRKCA, protein 
kinase C alpha, was approximately 2-fold induced after knockdown of circSLC45A4. PRKCA 
is a well-known protein kinase that participates in many signaling pathways, i.e. 
phosphorylating GAP43 and thereby regulating axonogenesis (Coggins and Zwiers, 1991).  
 
Figure 19: RNA-seq shows that knockdown of circSLC45A4 induces neuron development. 
(A) MA plot showing gene expression changes after knockdown of circSLC45A4. Based on 6 biological replicates, 
two for each siRNA used. Fold changes are considered significant and highlighted in red, if adjusted p-value < 0.05. 
(B) – qPCR validation of selected gene expression changes. Each dot represents one biological replicate. Fold 
changes are compared to scramble KD, the baseline at Fold Change = 1 is marked as solid horizontal line. 
 
The observation that circSLC45A4 induces spontaneous differentiation was further confirmed 
by a comprehensive Gene Ontology analysis, using TopGO (Alexa and Rahnenfuhrer, 2016). 
Genes for GO enrichment analysis were carefully selected, first based on their expression: i.e. 
only genes that had more than 50 counts in the scrambled knockdown were used. Second, 
only significantly deregulated genes (p-adj < 0.05) were selected and then compared to all 
genes above the same expression cut-off. GO analysis reveals if amongst the deregulated 
genes specific GO terms are significantly overrepresented (Fisher’s exact test). However, 
when testing multiple hypothesis, just by chance a significant result may be found. Hence, it is 
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necessary to adjust the p-value for multiple hypothesis testing, e.g. with the Benjamini-
Hochberg method (Benjamini and Hochberg, 1995). This analysis indicated the upregulation 
of genes connected to homophilic cell-cell adhesion, cell morphogenesis involved in 
differentiation, neuron projection morphogenesis/guidance as well as axonogenesis (Table 4). 
Most terms amongst the downregulated genes are evidently not connected to neuronal 
differentiation, e.g. muscle related terms like smooth muscle contraction (Table 5). However, 
the GO analysis of downregulated genes is dominated by a few significantly deregulated genes 
and after Benjamini-Hochberg adjustment of the p-value were no longer significant (p-
adj > 0.05). 
Table 4: Results of GO term analysis of significantly upregulated genes after circSLC45A4 KD in SH-SY5Y 
 Term Enrichment1 p-value2 p-adjusted3 Example genes 
GO:0007156 
homophilic cell adhesion 
via plasma membrane 
adhesion molecules 
14/65 6.22E-10 1.24E-05 
DCHS1, CELSR3, CELSR2, 
TRO, CADM4 
GO:0098742 
cell-cell adhesion via 
plasma-membrane 
adhesion molecules 
15/98 2.17E-08 2.05E-04 
DCHS1, CELSR3, CELSR2, 
TRO, CADM4 
GO:0007399 
nervous system 
development 
72/1573 2.76E-07 1.26E-03 
SEMA6C, GATA2, PRKCA 
GO:0045652 
regulation of 
megakaryocyte 
differentiation 
9/40 5.14E-07 1.35E-03 
SETD1A, KMT2A/B/C, TNRC6B 
GO:0050808 synapse organization 18/185 1.03E-06 1.35E-03 SHANK1, L1CAM, NLGN2, BSN 
GO:0034968 
histone lysine 
methylation 
12/88 2.03E-06 2.35E-03 
DOT1L, KMT2A/B/C/D 
GO:0016571 histone methylation 13/107 2.88E-06 2.35E-03 DOT1L, KMT2A/B/C/D 
GO:0030219 
megakaryocyte 
differentiation 
9/51 4.48E-06 2.92E-03 
SETD1A, KMT2A/B/C, TNRC6B 
GO:0048667 
cell morphogenesis 
involved in neuron 
differentiation 
27/412 5.89E-06 2.98E-03 
DAG1, ULK1, SEMA6C, SZT2 
GO:0018022 
peptidyl-lysine 
methylation 
12/98 6.39E-06 2.98E-03 
SETD1A, KMT2A/B/C, TNRC6B 
GO:0048812 
neuron projection 
morphogenesis 
28/453 1.18E-05 3.01E-03 
DAG1, ULK1, SEMA6C, SZT2 
GO:0031175 
neuron projection 
development 
36/675 1.78E-05 3.25E-03 
DAG1, SEMA6C, NCAM1, LRP1 
GO:0120039 
plasma membrane 
bounded cell projection 
morphogenesis 
28/465 1.91E-05 3.93E-03 
DAG1, SEMA6C, NCAM1, LRP1 
GO:0048858 
cell projection 
morphogenesis 
28/468 2.14E-05 3.94E-03 
DAG1, SEMA6C, NCAM1, 
NEO1 
GO:0048666 neuron development 38/744 2.69E-05 4.28E-03 
DAG1, SEMA6C, NCAM1, 
NEO1 
GO:0097485 
neuron projection 
guidance 
15/171 2.86E-05 4.54E-03 
DAG1, SEMA6C, NCAM1, 
PLXNA2 
GO:0007409 axonogenesis 22/328 3.09E-05 4.54E-03 DAG1, SEMA6C, NCAM1 
GO:0045814 
negative regulation of 
gene expression, 
epigenetic 
10/80 3.16E-05 5.28E-03 
PHF1, DOT1L, HIST2H2AA3/4 
GO:0061564 axon development 23/353 3.22E-05 5.43E-03 
DAG1, SEMA6C, NCAM1, 
PLXNA2 
1 enrichment = number of deregulated genes/number of all genes in that term; 2 p-value determined by 
Fisher’s exact test; 3 adjusted with Benjamini-Hochberg method 
Table 5: Results of GO term analysis of significantly downregulated genes after circSLC45A4 KD in SH-SY5Y 
 Term Enrichment1 p-value2 p-adjusted3 Example genes 
GO:0060087 
relaxation of vascular 
smooth muscle 
4/6 5.97E-06 
0.078 GUCY1A3, PRKG1, ADORA1, 
RGS2 
GO:0045932 
negative regulation of 
muscle contraction 
5/14 1.73E-05 
0.109 GUCY1A3, PRKG1, ADORA1, 
PDE5A 
GO:0044557 
relaxation of smooth 
muscle 
4/8 2.68E-05 
0.109 GUCY1A3, PRKG1, ADORA1, 
RGS2 
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GO:0045986 
negative regulation of 
smooth muscle 
contraction 
4/9 4.72E-05 
0.161 GUCY1A3, PRKG1, ADORA1, 
RGS2 
GO:0006041 
glucosamine metabolic 
process 
3/4 6.44E-05 
0.188 GNPDA2, GNPNAT1, PGM3 
1 enrichment = number of deregulated genes/number of all genes in that term; 2 Fisher’s exact test; 3 
adjusted with Benjamini-Hochberg method 
7.2.4 Pulldown of circSLC45A4 identifies direct interaction partners 
In order to understand the role of circSLC45A4 in more detail, its direct interaction partners 
need to be identified. This can be achieved by crosslinking the RNA to proteins or RNAs in 
close proximity by UV light (254 nm) and subsequent pulldown (Engreitz et al., 2015). The 
pulldown is achieved by using multiple biotinylated DNA probes that are antisense to the target. 
These biotinylated probes can be efficiently enriched with a streptavidin matrix. Interacting 
proteins can be identified by mass spectrometry analysis, interacting RNAs by next-generation 
RNA sequencing.  
To achieve enrichment of circular RNAs with antisense probes is not trivial. As shown above 
more than 50 % of human and mouse circRNAs overlap with 5’UTR, 3’UTR or coding 
sequence of annotated genes (cf. Figure 9 – E). Therefore, probes designed antisense to a 
circRNA will also enrich the corresponding linear transcript. To make sure that the linear 
transcript was specifically depleted, samples were treated with RNase R, an efficient 
exonuclease that leaves circular RNAs intact but degrades linear RNAs (Figure 20 – A).  
100x106 SH-SY5Y cells were UV-crosslinked at 254 nm, lysed, RNase R treated and incubated 
with biotinylated antisense probes to enrich for circSLC45A4 and its interaction partners. First, 
the enrichment of circSLC45A4 was determined by qPCR and compared to either an unspecific 
RNA, actin beta (ACTB), or the linear transcript mRNA SLC45A4. While almost all circular RNA 
SLC45A4 present in the input was recovered in the eluate, only 1 % of actin beta and 84 % of 
mRNA SLC45A4 were precipitated. In the negative control, using probes against GFP, which 
is not expressed in these samples, around 1 % of the initial amount of all three measured 
RNAs was left in the eluate. Furthermore, the expression level of circSLC45A4 is far lower in 
the input than that of actin beta and mRNA SLC45A4. Therefore, the relative abundance of 
circSLC45A4, actin beta and mRNA SLC45A4 was calculated compared to a spike-in. This 
revealed that after pulldown of circSLC45A4 was 100 times more abundant in the eluate than 
actin beta or mRNA SLC45A4. In the control pulldown the relative abundances of the 
measured RNAs to each other were similar to the input (Figure 20 – B). In total, 6 biological 
replicates were analyzed by mass spectrometry, identifying 961 enriched proteins and 
potential interaction partners (Figure 20 – C).  
Several interesting putative interaction partners were then validated using reverse pulldown 
experiments. SKP1, an essential component of the SCF complex that is regulating the 
degradation of cyclin E and NOTCH1 (Nakayama and Nakayama, 2006), was overexpressed 
in HEK293 cells with a 3xFLAG-tag. The pulldown of SKP1-3xFLAG from HEK293 cells worked 
efficiently as SKP1 was enriched in the eluate, while the negative control GAPDH was not 
detected in the eluate  
(Figure 20 – D). However, the enrichment of circSLC45A4 was marginal and did not change 
between the samples with and without crosslink at 254 nm. Compared to the IgG negative 
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control the enrichment is only two-fold and hence the interaction between circSLC45A4 and 
SKP1 does not seem to be very prevalent. As only 1 % of all circSLC45A4 molecules present 
in HEK293 lysate were bound to SKP1-3xFLAG. In SH-SY5Y approximately 4 copies of 
circSLC45A4 are expressed per cell  
(cf. Figure 17 – A) and expression levels determined by qPCR suggests a similar expression 
level of circSLC45A4 in HEK293 cells (data not shown). Hence, an interaction of SKP1-
3xFLAG and circSLC45A4 would only occur in 1 out of 100 cells. For the other candidate 
interaction partners, antibodies suitable for immunoprecipitation of the endogenous proteins 
were available. Therefore, endogenous reverse pulldown experiments for DOCK7, FXR2 and 
SARM1 were conducted with crosslink at 254 nm from SH-SY5Y cell lysate and monitored by 
Western blotting (Figure 20 – E, F and G). While the reverse pulldown for DOCK7 and FXR2 
worked efficiently, SARM1 could not be pulled down, although pulldown conditions were 
optimized (several input amounts and several antibody amounts tested, Protein A and Protein 
G beads tested; data not shown). GAPDH, which was only detected in the input samples, as 
well as unspecific IgG raised in rabbits served as controls for specific binding of the used 
antibodies. 
DOCK7 is a guanidine nucleotide exchange factor that is involved in neuronal polarity and 
axon generation through interaction with Rac1 GTPase and myosin VI and was shown to 
regulate neurite formation (Sobczak et al., 2016). Although circSLC45A4 is 6-fold enriched in 
the DOCK7 pulldown compared to the IgG negative control, ACTB and mRNA SLC45A4 are 
120-fold and 33-fold enriched respectively. Thus, while circSLC45A4 is bound by DOCK7, this 
interaction is neither exclusive nor prevalent. Given that only an average of 4 molecules (cf. 
Figure 17 – A) of circSLC45A4 are expressed in SH-SY5Y cells, pulling down only 2.3 % 
(Figure 20 – E) of circSLC45A4 that existed in the input sample would mean that this interaction 
exists in only 1 out of 44 cells. Hence, despite interaction of circSLC45A4 with DOCK7, it is 
unlikely that circSLC45A4 is functioning through the interaction with DOCK7.  
FXR2 is an RNA-binding protein that was shown to regulate adult hippocampal neurogenesis, 
for example through destabilizing Noggin mRNA and hence decreasing BMP signaling (Guo 
et al., 2011), but also by other non-discovered mechanisms. circSLC45A4 is 14-fold enriched 
in the FXR2 pulldown, compared to the IgG negative control. But still, only 5.3 % (Figure 20 – 
F) of circSLC45A4 present in the input sample were pulled down with FXR2. This would 
translate to one complex of circSLC45A4-FXR2 per 19 cells, given the low expression level of 
circSLC45A4. In addition, other RNA molecules, mRNA ACTB and mRNA SLC45A4, are again 
enriched stronger– 155-fold and 116-fold respectively. Thus, an interaction between FXR2 and 
circSLC45A4 is neither exclusive nor abundant. This renders it unlikely that circSLC45A4 
functions through the interaction with FXR2, despite the fact that the interaction was validated 
by reverse pulldown. 
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Figure 20: Pulldown of circSLC45A4 identifies direct interaction partners. 
(A) – Workflow for a circRNA pulldown experiment. (B) – Pulldown efficiency for circSLC45A4, mRNA SLC45A4 
and unrelated mRNA ACTB. 6 biological replicates for specific circSLC45A4 pulldown probes and unspecific control 
probes against GFP. (C) – Many potential protein interaction partners were identified by mass spectrometric 
analysis after circSLC45A4 pulldown compared to the control pulldown, 961 enriched proteins. (D) – Reverse 
pulldown of SKP1 +/- Xlink and compared to IgG neg. control. (E) – Reverse pulldown of DOCK7, FXR2 (F) and 
SAMR1 (G) + Xlink and compared to IgG neg. control. * - contamination with non-reduced/reduced antibody chains 
overlays signal. 
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7.2.5 CircSLC45A4 interaction with miRNAs 
Many examples exist in which circular RNAs regulate miRNAs levels and thereby regulate 
cellular processes. Best characterized is the interaction of Cdr1as with miR-7 (Hansen et al., 
2013; Memczak et al., 2013; Piwecka et al., 2017): Knockout of Cdr1as caused downregulation 
of miR-7 in mouse brain and thereby probably derepressed miR-7 targets, e.g. the immediate 
early genes c-Fos (Zhao et al., 2015) and Klf4 (Okuda et al., 2013).  
Hence, a method that is able to unambiguously identify miRNA:RNA target interactions 
(Grosswendt et al., 2014) was used to identify whether circSlc45a4 interacts with miRNAs from 
an AGO HITS-CLIP experiment in mouse brain (Moore et al., 2015). This analysis predicted 
several miRNAs to interact with circSlc45a4: miR-9-5p, miR-30c/e-5p, miR-135a/b-5p and 
miR-181a-5p. Strikingly, the interactions were not distributed along the entire circRNA but were 
predicted to occur in almost the same site on the circRNA (Figure 21 – A). Since comparable 
human brain datasets are not available, miRNAs that possibly bind to human circSLC45A4 
were predicted in silico using miRanda (Enright et al., 2003). Again, many miRNA interaction 
partners of human circSLC45A4 were predicted. However, of the previously identified chimeric 
miRNA:circRNA interactions only miR-135a-5p was predicted as well (Figure 21 – B). 
Subsequently, miRNA levels were measured using qPCR and small RNA-seq after knockdown 
of circSLC45A4 in SH-SY5Y cells (Figure 21 – C and D). Surprisingly, of the predicted 
interacting miRNAs, only miR-135 was downregulated after knockdown of circSLC45A4.  
Small RNA sequencing was used additionally to monitor the levels of both miRNA isoforms, 
3p (arises from the 3’-arm of the hairpin) and 5p (arises from the 5’-arm of the hairpin). For 
miR-135 only the levels of the 5p strand were lower, while the 3p strand was stably expressed 
after circSLC45A4 KD (Figure 21 - D). This suggests that circSLC45A4 either regulates miR-
135 levels post-transcriptionally or that miR-135 levels are changed as a secondary effect due 
to the spontaneous differentiation that is induced in SH-SY5Y cells after knockdown of 
circSLC45A4. Hence, we looked at potential tailing and trimming of the miRNA as this would 
be a possible mode of action for circSLC45A4 to regulate miR-135 levels. For tailing and 
trimming to occur the miRNA and the target RNA have to be highly complementarity beyond a 
common 8-mer seed interaction (Ameres et al., 2010; Rüegger and Großhans, 2012). Hence, 
we used RNAhybrid to predict the interaction structure of miR-135a/b with circSLC45A4 
(Krüger and Rehmsmeier, 2006). The pairing between miR-135 and circSLC45A4 (or miR-
135b/circSlc45a4) is extending beyond the 8-mer seed interaction. Either the pairing is 
continued until miRNA base 13 (circSLC45A4 and miR-135a, circSlc45a4 and miR-135b) or 
additional bulges are introduced at miRNA base 9 (circSLC45A4 and miR-135b – 9 bases, 
circSlc45a4 and miR-135a – 4 bases) (Figure 21 – E). In any case, the pairing continues at 
the 3’most part, miRNA bases 19-23 are always paired to the circRNA. However, this base 
pairing pattern is not sufficient to apply a more general rule for the consequences of this 
pairing. Degradation is described for extensive base pairing or for partial pairing with restrictive 
rules (de la Mata et al., 2015) that are not fulfilled in the pairing of circSLC45A4 and miR-135. 
Yet, small RNA sequencing data was used to investigate potential tailing or trimming of miR-
135a-5p after circSLC45A4 knockdown. But no extensive tailing or trimming of miR-135a-5p 
after circSLC45A4 knockdown was found (Figure 21 – F). The above findings would suggest 
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that circSLC45A4 either stabilizes this miRNA, catalyzes its biogenesis, or that miR-135 levels 
are deregulated after circSLC45A4 knockdown due to a secondary effect. 
To establish the interaction of circSLC45A4 and miR-135 beyond computational predictions 
and correlations, the previously described circSLC45A4 pulldown approach was used to 
measure the enrichment of miRNAs. After pulldown of circSLC45A4 miR-135a was slightly but 
not significantly enriched (Figure 21 – G). Furthermore, no enriched miRNAs were detected, 
possibly because of the limitation of the method, e.g. low crosslinking frequency that potentially 
misses many of the 8 nt long miRNA seed interactions. 
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Figure 21: circSLC45A4 interacts with miRNAs. 
(A) – miRNA:circSlc45a4 interactions as identified by chimeric reads. (B) – miRanda predicts multiple 
miRNA:circSLC45A4 interactions. (C) – Fold changes of miR-135a, miR-181a and miR-9 in SH-SY5Y cells after 
knockdown of circSLC45A4. Determined by qPCR with TaqMan probes. Average of 7 biological replicates. (D) – 
Analysis of small RNA sequencing confirming the depletion of miR-135a-5p after knockdown of circSLC45A4 in 
SH-SY5Y cells. Based on 6 biological replicates. (E) – Base pairing of circSLC45A4 and miR-135a/b-5p, predicted 
with RNAhybrid. (F) – No extensive tailing or trimming of miR-135a-5p is detected after knockdown of circSLC45A4. 
(G) – Pulldown of circSLC45A4 enriches for certain miRNAs, e.g. miR-135a-5p, but not significantly.  
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7.2.6 Knockdown of circSlc45a4 in vivo significantly disturbs neurogenesis in 
the developing cortex of mice by depleting the basal progenitor pool 
In vitro cell culture models, like SH-SY5Y cells, have the advantage that a complex process 
like neurogenesis can be analyzed in a simplified system. However, this is also one of their 
main limitations, as these in vitro models lack multiple features that are important in complex 
tissues or developing organisms, e.g. three-dimensional cell-cell interactions, tissue polarity 
and complex temporal and spatial regulation of differentiation processes.  
To characterize the effect of circSlc45a4 in a more physiologically relevant system, the 
expression of circSlc45a4 during mouse brain development was investigated (Figure 22 – A). 
qPCR analyses of samples from different developmental time points of mouse brain 
development revealed that circSlc45a4 is highest expressed in adult mouse brain. Additionally, 
it was revealed that circSlc45a4 expression peaks during development at embryonic day (E) 
16.5 and at postnatal day 3. The first peak of circSlc45a4 expression is coinciding with peaks 
of neurogenesis in the nucleus accumbens, tufted cells, isle of Calleja as well as the formation 
of the corpus callosum and the neurogenesis in cortical layer IV (Finlay and Darlington, 1995). 
To further assess the distribution of circSlc45a4 within the tissue, E15.5 mouse cortices were 
stained for circSlc45a4 and mRNA Slc45a4 using BaseScope, an in situ hybridization method 
that allows the specific detection of splice sites (Figure 22 – B). Interestingly, the expression 
of circSlc45a4 and mRNA Slc45a4 was not restricted to a specific layer of the cortex which 
suggests a rather general role of these molecules in the developing cortex.  
This observation and the upregulation of circSlc45a4 in differentiating progenitors and neurons 
compared to proliferating progenitors at E14.5 (M. Dori, F. Calegari personal communication, 
and (Aprea et al., 2013)) suggests a functional role of circSlc45a4 throughout mouse cortical 
development. Thus, the levels of both circular and mRNA Slc45a4 in the developing neocortex 
were perturbed by in utero electroporation. In utero electroporations can be used to introduce 
DNA constructs or siRNAs to brain regions adjacent to the liquid-filled ventricle at several 
points during mouse brain development (Fukuchi-Shimogori and Grove, 2001; Saito and 
Nakatsuji, 2001; Tabata and Nakajima, 2001). Pregnant mice were anesthetized, and embryos 
were made accessible so that nanoliters of liquid containing the constructs could be injected. 
The constructs were then electroporated into the cells of the ventricular zone (VZ) of the 
developing lateral cortex. In utero electroporation experiments were conducted at E13.5 to 
target both proliferating and differentiating progenitors. shRNA constructs were used to 
knockdown circSlc45a4 (3 constructs as mix), mRNA Slc45a4 (2 constructs as mix) and as a 
control a scrambled shRNA was used. All used constructs also included a nuclear GFP marker 
for microscopic identification of manipulated cells by green fluorescence. Mice were 
electroporated at E13.5, sacrificed and analyzed at E15.5. First, GFP positive cells were 
collected by FACS and the efficiency of the knockdowns was assessed by qPCR (Figure 22 – 
D). circSlc45a4 was efficiently depleted by specific shRNA-mediated KD to approximately 20 
% compared to scramble KD, the mRNA level was reduced to 75 %. mRNA Slc45a4 was only 
depleted to 50 % compared to scramble KD with its specific shRNA and circRNA levels were 
unaffected.  
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Next, the distribution of manipulated cells within the different cortical layers was quantified 
(Figure 22 – E and F). Therefore, coronal sections from the manipulated brains were produced, 
the existing cortical layers at that developmental time point were identified and the number of 
manipulated cells in each layer was counted. This number was then normalized to the total 
number of cells in the quantified area and the distribution across the different layers was 
calculated. Both, the knockdown of mRNA Slc45a4 and circSlc45a4 disturbed the cortical 
development. Quantification of GFP+ cells (= electroporated) revealed a significant depletion 
of cells from the cortical plate (CP), for both circRNA and mRNA KD (Figure 22 - F). Intriguingly, 
only after knockdown of the circular RNA a significant depletion of cells from the subventricular 
zone (SVZ) was observed (Figure 22 - F). This raised the question, whether the distorted 
distribution could be caused by a distortion of progenitor pools. Therefore, the proportions of 
apical progenitors (AP), basal progenitors (BP), and neurons (NEU), defined by cellular 
localization in the cortex and expression of Tbr2, the main marker of BP (Englund et al., 2005), 
were quantified. Apical and basal progenitors were distinguished by basal progenitor-specific 
staining with Tbr2 (data not shown) and subsequently quantified. This analysis revealed a 
significant depletion of BPs (Tbr2+ in VZ and SVZ), as well as a significant increase of APs 
(Tbr2- in VZ) after knockdown of circSlc45a4 compared to scramble knockdown (Figure 22 - 
G). Apical progenitors are located in the ventricular zone and are undergoing mitosis in this 
region, while basal progenitors are produced from asymmetric divisions of apical progenitors 
and are mainly located in the subventricular zone and divide there. Basal progenitors are 
thought to give rise to neurons only, while apical progenitors can give rise to both neurons and 
glia (Salomoni and Calegari, 2010). Interestingly, the population of BPs was significantly 
affected only in the VZ and not in the SVZ (Figure 22 - H), indicating that circSLC45a4 KD 
specifically impaired the cell-fate switch from AP to BP. This could be caused by a migration 
defect of the cells, premature differentiation or faster differentiation that limits the time spent 
as basal progenitor during neurogenesis.  
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Figure 22: Knockdown of circSlc45a4 disturbs neurogenesis in the developing cortex. 
(A) – Expression levels of circSlc45a4 in developing whole mouse brain as determined by qPCR. (B) – Splice-site 
specific in situ hybridization of circSlc45a4 and mRNA Slc45a4. Probe against bacterial DapB as negative control. 
MZ – marginal zone, CP – cortical plate, IZ – intermediate zone, SVZ – subventricular zone, VZ – ventricular zone. 
Scale bar is 50 µm. (C) – Representation of an in utero electroporation. Subpanel modified from (dal Maschio et al., 
2012). (D) – Knockdown efficiency of in utero electroporation. Determined by qPCR, 3 biological replicates. Error 
bars as standard errors of the mean. (E) – Manipulated cells (white – GFP+) in developing cortex at E15.5 for 
scrambled control KD, mRNA Slc45a4 and circSlc45a4 knockdown. Nuclei are DAPI stained (blue). Scale bar is 50 
µm. (F) – Cell distribution per cortical zone, 4 biological replicates. (G) – Percentage of electroporated cells that are 
classified as apical (AP) and basal progenitors (BP) as well as neurons (NEU) by Tbr2+ staining and localization. 
(H) – Percentage of basal progenitors in ventricular (VZ) and subventricular zone (SVZ) after scramble, circRNA or 
mRNA knockdown. 
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7.2.7 Knockdown of circSlc45a4 induces significant transcriptomic changes in 
the developing cortex 
The plasmids used for in vivo knockdown of circSlc45a4, mRNA Slc45a4 and scrambled 
control also carried a GFP marker to track the manipulated cells in vivo. Furthermore, this 
enabled the purification of the manipulated cells from embryonic mouse cortices by FACS. 
RNA was extracted from the cells and used to prepare polyA+ RNA-sequencing libraries. 
Analysis of the gene expression changes induced after circSlc45a4 knockdown vs. scramble 
knockdown revealed strong expression changes of up to 16-fold induction or 8-fold 
downregulation of many genes (Figure 23 – A). shRNAs are prone to induce off-target effects, 
either by downregulation of unintended targets, unintendedly functioning as miRNAs or simply 
by overloading Dicer and thereby impairing its function, or by lowering the effective AGO2 
concentration available for endogenous miRNAs. To minimize the chance of hitting unintended 
targets, the shRNA sequences were scored using siSPOTR (Boudreau et al., 2013) which 
revealed that the potential miRNA seed sequences in the used shRNAs against circSlc45a4 
are targeting few (shRNA 1: 4 out of the top-50 downregulated genes, shRNA 2: 1, shRNA 3: 
1) of the top-downregulated genes with a maximum of 1 7mer-1A site per target. This renders 
it very unlikely to induce a downregulation up to 8-fold (Bartel, 2018). Nucleotide BLAST 
(Altschul et al., 1990) of the 18mer from position 2-19 of the shRNA did not yield any targets 
with more than 14 nt overlap to the shRNA and hence will not cause a downregulation of these 
targets either (Elbashir et al., 2001b). 
As a scrambled shRNA only serves as control for the overexpression of a short-hairpin RNA 
in a cell, the knockdown of an expressed target, in this case mRNA Slc45a4, is especially 
important to ensure that the measured changes are not caused by overloading Dicer or 
lowering the effective concentration of AGO2. In such an instance, one would expect to find 
similar changes for both circRNA and mRNA knockdown. To investigate this, principal 
component analysis (PCA) was applied to the gene expression data that was collected by 
RNA-seq. PCA linearly transforms the original data while preserving the variation. Principal 
components (PCs) are directions in the data along which the variation is maximal (Ringnér, 
2008). Hence, PCA can be used to visualize the variation in highly dimensional data. Here, 
PCA showed that circSlc45a4 and mRNA Slc45a4 knockdown in the developing mouse cortex 
are varying from each other and the scramble knockdown (Figure 23 – B). Furthermore, 
comparison of circSlc45a4 KD vs. scramble KD with circSlc45a4 KD vs. mRNA Slc45a4 KD 
revealed that the changes induced by circSlc45a4 knockdown are stable and that these two 
comparisons are well correlated with R2=0.6975 (Figure 23 – C). The grey dashed lines mark 
a log2-fold change between comparisons. Genes that were found to be changed significantly 
in circSlc45a4 vs. scramble KD (total 3864 genes) are highlighted in red and 96.8 % (= 3740 
genes) of those are in the first and third quadrant and below the grey dashed lines. This is a 
good indication that the measured transcriptomic changes are induced specifically by depleting 
circSlc45a4. As the up- or downregulation of genes in response to the depletion of circSlc45a4 
does not seem to depend on the control the sample is compared to.  
The 3864 significantly deregulated genes included interesting candidates involved in 
neurogenesis. Unc5b, a netrin receptor, is the strongest upregulated gene after knockdown of 
circSlc45a4, with a 16-fold induction. It is important for the migration of cortical interneurons 
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from the medial ganglionic eminence (MGE) into the cortex. Unc5b itself is regulated by the 
transcription factor Sip1, deletion of Sip1 leads to overexpression of Unc5b which in turn 
strongly inhibits the migration of interneurons from the MGE into the cortex (van den Berghe 
et al., 2013). Cortical interneurons are a very diverse group of neurons, with at least 23 known 
subtypes in adult primary visual cortex (Poulin et al., 2016) whose subtypes are already 
emerging in the developing mouse brain (Mi et al., 2018). One of those subtypes are VIP 
Parm1+ interneurons. Hence, the observed upregulation of Parm1 after knockdown of 
circSlc45a4 is especially intriguing. Cortical interneurons originate from the ventral 
telencephalon and migrate into the cortex (Molyneaux et al., 2007; Wonders and Anderson, 
2006), yet the here manipulated cells are derived from the neocortical germinal zone.  
It has previously been shown, that the correct migration and positioning of interneurons in the 
cortex also depends on the interaction with radial glia cells in the neocortical germinal zone 
(Polleux et al., 2002; Yokota et al., 2007). Genes that are known to regulate the development 
of the cortex through the production of neurons from progenitor cells in the ventricular and 
subventricular zones were also deregulated. Most prominently the transcription factor Foxp2, 
which impairs radial migration of neurons if overexpressed (Clovis et al., 2012). Foxp2 was 
induced 5-fold after circSlc45a4 knockdown. This upregulation of Foxp2 might explain why the 
cortical plate is not populated. However, overexpression of Foxp2 does not explain the 
observed decrease in basal progenitors, as it has been shown that overexpression of Foxp2 
at E13.5 does not cause any distortions in the apical or basal progenitor pools (Clovis et al., 
2012). Another important upregulated factor is Notch2 (3.8-fold induction), which together with 
Notch1-4 and their interactors is part of a highly conserved signaling pathway that has an active 
role in many developmental and homeostatic processes (Bray, 2016). In particular it was 
shown for the cortex, that overexpression of a constitutively active form of Notch at E13.5 kept 
progenitors as proliferating radial glia cells and by this prevented the generation of neurons.  
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Figure 23: Knockdown of circSlc45a4 and mRNA Slc45a4 are distinct from each other. 
(A) – MA plot of circSlc45a4 knockdown in mouse cortex versus scrambled knockdown. 2151 genes are significantly 
(p < 0.01) upregulated and 1713 are significantly downregulated, both highlighted in red. (B) – Principal component 
analysis (PCA) separates the three measured conditions. (C) – Comparison of circSlc45a4 knockdown vs. scramble 
KD with circSlc45a4 KD vs. mRNA Slc45a4 KD shows a good correlation (R2=0.6975, Pearson, red line). Genes 
that were found significantly changed in circSlc45a4 vs. scramble KD (comp. A) are highlighted in red. Dashed grey 
lines mark area where log2FC in both comparisons are below 1.  
 
The most strongly downregulated gene is Nptx2 (-4.23 fold), a neuronal pentraxin that is 
involved in excitatory synapse formation (O’Brien et al., 1999; Tsui et al., 1996; Xu et al., 2003). 
However, since the cortical plate is not populated after circSlc45a4 knockdown, this is probably 
a secondary effect. Furthermore, Gcg, the preproprotein of glucagon, is strongly 
downregulated (-4.0-fold). However, the role of glucagon in the brain, besides its effects on 
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feeding behavior (Abraham and Lam, 2016), is not understood. Scrt1, a member of the Snail 
superfamily of transcription factors, is required for the detachment of cells from the ventricular 
surface and the onset of radial migration (Itoh et al., 2013) and was found to be 2.89-fold 
downregulated. Reduced levels of this gene could explain the increased number of progenitors 
in the ventricular zone and the depletion of cells in the cortical plate. Taken together, 
circSlc45a4 KD induces significant expression changes in developing mouse cortex. However, 
it remains unclear how circSlc45a4 depletion induces these changes. 
Expression changes measured by RNA-seq were further validated by qPCR (Figure 24 - A) 
and compared to TPM (transcripts per million) values retrieved from RNA-seq experiments 
(Figure 24 - B). Both of these measures are in good agreement and again suggest that 
consequences of circRNA and mRNA KD are different and independent from each other. 
 
 
Figure 24: Validation of expression changes in developing cortex with qPCR. 
(A) – qPCR validation of induced expression changes after knockdown of circSlc45a4, mRNA Slc45a4 and 
scramble KD in embryonic mouse cortex. Average of 3 biol. replicates. Standard deviation as error bar. (B) – TPM 
(transcripts per million) values for various genes, illustrating that most changes are specific to circSlc45a4 
knockdown. 
 
Instead of looking at deregulated genes individually, it can be useful to search for groups of 
genes that are associated with certain functions, e.g. with a gene ontology analysis (Table 6). 
Genes were selected by expression level (at least 50 counts in scramble KD) and significance 
of the fold change (padj < 0.01). Amongst the upregulated genes those connected to 
development, cell adhesion and localization as well as signaling are significantly 
overrepresented. Whilst the downregulated genes are connected to metabolic processes, cell 
fate commitment and nervous system processes. However, after adjustment of the p-value by 
the Benjamini-Hochberg method (Benjamini and Hochberg, 1995) none of the GO terms of the 
downregulated genes remained significant (padj < 0.05), while the GO terms for upregulated 
genes remained significant. 
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Table 6: Results of GO term analysis of significantly upregulated genes after circSlc45a4 KD in mouse cortex 
Upregulated genes  
Term Enrichment1 p-value2 p-adj3 Example genes 
GO:0009653 
anatomical structure 
morphogenesis 
305/1578 5.00E-19 8.61E-14 
Unc5b, Notch2, Pag1, Gnaq, Rbpj 
GO:0023052 signaling 513/3060 5.11E-19 8.61E-14 Unc5b, Notch2, Pag1, Gnaq, Rbpj  
GO:0007165 signal transduction 466/2761 1.90E-17 3.91E-13 Unc5b, Notch2, Gas7, Foxp2, Fat3 
GO:0007154 cell communication 511/3097 2.10E-17 7.12E-13 Unc5b, Notch2, Ldha,Pag1, Plcb1 
GO:0023051 regulation of signaling 335/1880 2.41E-15 6.67E-12 
Unc5b, Notch2, Plcb1, Gnaq, 
Igfbp5 
GO:0010646 
regulation of cell 
communication 
331/1862 5.43E-15 1.38E-11 
Unc5b, Notch2, Plcb1, Nell2, 
Timp2 
GO:0048856 
anatomical structure 
development 
517/3236 1.01E-14 1.12E-10 
Unc5b, Notch2, Gas7, Foxp2, Fat3 
GO:0009966 
regulation of signal 
transduction 
299/1652 1.68E-14 1.12E-10 
Unc5b, Notch2, Plcb1, Sfrp2, Rbpj 
GO:0007155 cell adhesion 143/635 3.53E-14 1.99E-10 
Fat3, Pag1, Plcb1, Ccdc80, 
Cyfip2, Vcam1 
GO:0035295 tube development 140/617 3.59E-14 1.99E-10 
Unc5b, Notch2, Foxp2, Sfrp2, 
Ptges3, Gna13 
GO:0022610 biological adhesion 143/637 4.61E-14 1.12E-09 
Fat3, Pag1, Plcb1, Ccdc80, 
Cyfip2, Vcam1 
GO:0032502 developmental process 546/3486 5.57E-14 1.50E-09 
Unc5b, Notch2, Gas7, Foxp2, 
Fat3, Plcb1 
GO:0051240 
positive regulation of 
multicellular organismal 
process 
190/937 8.67E-14 1.75E-09 
Notch2, Foxp2, Plcb1, Sfrp2, 
Timp2, Rbpj 
GO:0051094 
positive regulation of 
developmental process 
174/838 1.27E-13 8.04E-09 
Notch2, Foxp2, Plcb1, Sfrp2, 
Timp2, Rbpj 
GO:0035239 tube morphogenesis 117/491 1.60E-13 9.53E-09 
Unc5b, Notch2, Sfrp2, Hs2st1, 
Gna13 
GO:0048731 system development 433/2659 3.06E-13 9.53E-09 
Unc5b, Notch2, Gas7, Foxp2, 
Fat3, Plcb1 
GO:0032879 regulation of localization 293/1654 5.56E-13 1.07E-08 
Plcb1, Gnaq, Igfbp5, Sfrp2, Nell2, 
Gna13 
GO:0051239 
regulation of 
multicellular organismal 
process 
289/1626 5.58E-13 1.67E-08 
Notch2, Foxp2, Fat3, Plcb1, 
Igfbp5, Sfrp2 
GO:0007166 
cell surface receptor 
signaling pathway 
246/1332 7.36E-13 1.89E-08 
Unc5b, Notch2, Usp46, Pag1, 
Plcb1, Gnaq 
Downregulated genes 
GO:0008088 axo-dendritic transport 16/55 9.06E-06 0.094 
Tmem108, Nef1, Spg7, Snapin, 
Ap3m2, Trak1/2  
GO:0006221 
pyrimidine nucleotide 
biosynthetic process 
9/20 1.69E-05 0.094 
Dut, Umps, Cad, Tyms, Dctd, 
Nme6, Tbpl1 
GO:1901607 
alpha-amino acid 
biosynthetic process 
14/46 1.85E-05 0.094 
Park7, Shmt2, Asns, Atp2b4, Cad, 
Adi1, Asl 
GO:0006220 
pyrimidine nucleotide 
metabolic process 
10/25 2.02E-05 0.094 
Dut, Umps, Cad, Tyms, Nt5c, 
Dctd, Nme6, Tbpl1 
GO:0008652 
cellular amino acid 
biosynthetic process 
14/47 2.43E-05 0.094 
Park7, Shmt2, Asns, Atp2b4, Cad, 
Adi1, Asl 
GO:0044281 
small molecule 
metabolic process 
131/1105 5.19E-05 0.157 
Eno1b, Pgm2l1, Pfkb, Abcg2, 
Wdtc1, Atp5o 
GO:0072527 
pyrimidine-containing 
compound metabolic 
process 
12/39 6.49E-05 0.157 
Thtpa, Dut, Umps, Cad, Tyms, 
Nt5c, Dctd, Nme6 
GO:0019752 
carboxylic acid 
metabolic process 
72/534 6.53E-05 0.157 Dut, Tyms, Dctd, Dnph1, Shmt1 
GO:0072528 
pyrimidine-containing 
compound biosynthetic 
process 
9/24 9.62E-05 0.201 Dut, Umps, Tyms, Dctd, Shmt1 
GO:0006082 
organic acid metabolic 
process 
74/561 1.06E-04 0.201 
Eno1b, Pfkb, Abcg2, Wdtc1, 
Cbfa2t3 
GO:0006520 
cellular amino acid 
metabolic process 
32/187 1.15E-04 0.201 
Park7, Arg2, Shmt2, Sars2, Asns, 
Gclc, Azin1 
GO:0043436 
oxoacid metabolic 
process 
73/557 1.44E-04 0.201 
Eno1b, Pfkp, Abcg2, Wdtc1, 
Cbfa2t3, Park7 
GO:0009162 
deoxyribonucleoside 
monophosphate 
metabolic process 
5/8 2.06E-04 0.231 Dut, Tyms, Dctd, Dnph1, Shmt1 
GO:0009130 
pyrimidine nucleoside 
monophosphate 
biosynthetic process 
5/8 2.06E-04 0.253 Dut, Umps. Tyms, Dctd, Shmt1 
GO:0022616 DNA strand elongation 8/21 2.09E-04 0.253 
Parp1/2, Dna2, Rad50, Rnaseh2a, 
Nbn, Pcna 
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GO:0009219 
pyrimidine 
deoxyribonucleotide 
metabolic process 
6/12 2.29E-04 0.253 
Dut, Tyms, Nt5c, Dctd, Tbpl1, 
Shmt1 
GO:0009157 
deoxyribonucleoside 
monophosphate 
biosynthetic process 
4/5 2.50E-04 0.253 Dut, Tyms, Dctd, Shmt1 
GO:0009177 
pyrimidine 
deoxyribonucleoside 
monophosphate 
biosynthetic process 
4/5 2.50E-04 0.253 Dut, Tyms, Dctd, Shmt1 
GO:0036265 
RNA (guanine-N7)-
methylation 
4/5 2.50E-04 0.253 Trmt112, Mettl1, Bud23, Wdr4 
 
1 number of identified genes in the entire GO term; 2 Fisher’s exact test; 3 adjusted with Benjamini-Hochberg method 
7.2.8 Single-cell sequencing reveals that circSlc45a4 KD results in depletion of 
basal progenitors and increase in Cajal-Retzius cells 
A few of the observed up- and downregulated genes might be false positives as the initial 
composition of cell types considered in this analysis was different: i.e. in the scramble KD cells 
from all layers are present, in circSlc45a4 KD the cortical plate and the SVZ are less populated. 
For example, the downregulation of Cux2 could be explained by the absence of cells from the 
cortical plate in mRNA and circRNA KD compared to the scramble KD. 
Hence, Bseq-SC (Baron et al., 2016), a bioinformatics pipeline that takes single-cell RNA-seq 
data to inform bulk RNA-seq, was used to assess changes on cell type levels. Bseq-SC can 
estimate cell type proportions in bulk RNA-seq data based on gene expression sets that have 
been identified in a corresponding single-cell RNA-seq data set. Hence, the effects on the 
measured gene expression caused by changes in cell type proportions and by the knockdown 
of the circRNA or mRNA itself could be deconvolved (Figure 25 - A). Pre-existing single-cell 
data was taken from (Yuzwa et al., 2017), who assessed different time points of cortical 
development in embryonic mice, and reanalyzed using Seurat (Butler et al., 2018). To visualize 
the high-dimensional single-cell RNAseq data, a nonlinear dimensionality reduction method, 
the t-distributed stochastic neighbor embedding (tSNE) (Amir et al., 2013; van der Maaten and 
Hinton, 2008), was used. The tSNE plot for embryonic day E15.5 illustrates the 14 identified 
cell types (Figure 25 - B). Specific marker genes for these 14 cell types were identified and 
assessed for being exclusively expressed in a single cell type and only marginally in any other 
cell type (Figure 25 - C). The cluster identity was determined with literature research for 
described functions of the selected markers. The unique gene expression sets determined for 
the different cell types present in the cortex at that developmental time point are then used to 
estimate cell type proportions in the bulk RNA-seq data (Figure 26). 
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Figure 25: Analysis of single-cell data identifies 14 cell types in mouse embryonic cortex at E15.5. 
(A) – general workflow of Bseq-SC. Single-cell RNA-seq data is used to decouple changes introduced by the 
knockdown from variation in cell populations. (B) – tSNE plot of embryonic mouse cortex at E15.5, data from (Yuzwa 
et al., 2017), reanalyzed. (C) – Subset of identified marker genes that were used for cell population analysis. All y-
scales are set from 0 to 4. 
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These marker genes were used to define cell types in Bseq-SC to assess cell type variations 
after circSlc45a4 knockdown or mRNA Slc45a4 knockdown compared to scramble KD. 
Consistent with immunofluorescence and cell counting, the basal progenitor population is 
depleted after knockdown of circSlc45a4, but not after mRNA Slc45a4 knockdown (Figure 26 
– A). Furthermore, Cajal-Retzius cell numbers were significantly increased after circSlc45a4 
knockdown, but unaltered after mRNA Slc45a4 knockdown. Cajal-Retzius cells were described 
over 100 years ago by Ramón y Cajal (Cajal, 1890) and Gustaf Retzius (Retzius, 1893) and 
are a neuronal cell type found in the uppermost layer of the developing neocortex. They 
produce the extracellular matrix protein reelin (Kirischuk et al., 2014). Reelin is one of the key 
proteins in regulating radial migration of neurons in the cortex (Gupta et al., 2002). After mRNA 
Slc45a4 knockdown subcortical projection neurons were more frequent than in the scramble 
KD control, as well as neural stem/progenitor cells (Figure 26 - B). 
 
Figure 26: Bseq-SC determines downregulation of basal progenitors and upregulation of Cajal-Retzius cells after 
circSlc45a4 knockdown. 
(A) – Shifts in cell population between scramble KD and circSlc45a4 KD. Cluster 4 (basal progenitors) and Cluster 
10 (Cajal-Retzius cells) are significantly altered. t-test: * = p < 0.05. (B) – Shifts in cell population between scramble 
KD and mRNA Slc45a4 KD. Cluster 1 (subcortical projection neurons) and cluster 5 (neural stem/progenitor cells) 
are significantly altered. t-test: * = p < 0.05. 
- 77 - 
 
 
The predicted increase of Cajal-Retzius cells is intriguing, as this could cause the depletion of 
the basal progenitor pool. Hence, reelin immunofluorescence was used to qualitatively assess 
the number of Cajal-Retzius cells (Figure 27). Reelin levels were strongly increased after 
knockdown of circSlc45a4 in embryonic mouse cortices at E15.5. Knockdown of mRNA 
Slc45a4 did not change the reelin levels compared to the scramble knockdown control. 
 
Figure 27: circSlc45a4 knockdown causes an increase in Reelin. 
Electroporated mouse cortices at E15.5. Electroporated cells are GFP+, nuclei are stained with DAPI. Reelin levels 
are increased after knockdown of circSlc45a4 but not after knockdown of mRNA Slc45a4 or in the control 
knockdown. Scale bar 50 µm. 
  
7.2.9 Investigating the potential translation of circSLC45A4 
Although the impact on neuronal differentiation by knockdown of circSLC45A4/circSlc45a4 in 
different systems, human SH-SY5Y cells and developing mouse cortex, is evident, its mode of 
action remains elusive. RNA molecules can either act directly on targets, e.g. interactions 
partners, or they can hold information for protein translation. Importantly, circRNAs have been 
shown to act as both: directly (e.g. (Memczak et al., 2013; Piwecka et al., 2017) and as 
translation template (Legnini et al., 2017; Pamudurti et al., 2017). 
circSLC45A4 contains the canonical start codon of its corresponding mRNA and a potential 
open-reading frame (ORF) would extend beyond the head-to-tail junction and terminate with 4 
stop codons in the 5’UTR of human SLC45A4 (Figure 20 - A). Next, the conservation of the 
potential protein sequence after the head to tail junction was analyzed (Figure 20 – B). The 
protein sequence after the head-to-tail junction shows lower conservation than the part of 
circSLC45A4 that overlaps with the CDS of the mRNA. However, this part is still exceptionally 
conserved for a 5’UTR that is not annotated to be translated. Furthermore, the STOP codons 
found in human are still found in dog and all mammals investigated have at least 2 STOP 
codons in the very same position. Chicken and frog (Xenopus tropicalis) would already 
- 78 - 
 
terminate the potential ORF one amino acid after the head-to-tail junction. Still, a translation of 
circSLC45A4 is conceivable based on its sequence properties.  
Therefore, an in vivo model was employed to investigate translation in the adult mouse brain. 
So called Ribotag mice (Sanz et al., 2009) express an HA-tagged version of the ribosomal 
protein Rpl22. With help of the Cre-LoxP system (Tsien, 2016) this Rpl22-HA is only expressed 
in certain cell types. In this case all Neurod6-expressing neurons, which are mostly cortical 
neurons (Figure 20 - C), heterozygously express Rpl22-HA. Brains from these and wildtype 
(WT) mice are lysed to generate homogenate that is than subjected to an HA-specific pulldown. 
The retrieved eluate from the WT brains should only contain background binders, while the 
eluate from the Neurod6-Cre:Ribotag+/- mice should contain RNAs that are bound to ribosomes 
in Neurod6-positive neurons. To verify the specificity of the pulldown, certain housekeeper, 
neuronal and non-neuronal marker genes were quantified using qPCR (Figure 20 – C). A fold 
change compared to the WT eluate larger than 1 would indicate an enrichment of a specific 
RNA at ribosomes from Neurod6-positive neurons. This was indeed the case for the 
housekeepers Eef1a and Actb, as well as the neuronal marker genes Neurod6 and Rbfox3 
and the ribosomal RNA 18S. As expected, non-neuronal marker genes like Gfap, Aldh1l1 and 
Olig1 were depleted, or at least not more abundant than in the control pulldown. Having verified 
the validity of this pulldown experiment, the enrichment of circSlc45a4 and mRNA Slc45a4 
was measured. However, none of these two RNAs was enriched at ribosomes from Neurod6-
positive neurons (Figure 20 – C). 
Yet, this method was developed with non-circular RNAs as main target. If there are circRNA-
specific translation mechanisms, like specialized ribosomes, one would not expect to capture 
a circRNA with the before mentioned Ribotag-pulldown. Hence, the identification of peptides 
that would be specific for translated circSLC45A4 from SH-SY5Y cell lysates by mass 
spectrometry was attempted. Therefore, an in silico trypsin digest was performed with the 
ExPASY tool PeptideMass (Wilkins et al., 1997, 1999) and based on this, peptides with at least 
5 amino acids length that are specific for the circRNA were selected and ordered as heavy-
spike tide synthetic peptides (Figure 20 – B). Since some of the peptides are overlapping with 
a hydrophobic transmembrane domain also found in the linear mRNA protein product and as 
further hydrophobic amino acids (V, I, L, F, W, C, L and R) occur after the head to tail junction, 
SDS extraction was used to prepare lysates from human SH-SY5Y cells and mouse Neuro2a 
cells. A mass spectrometry setup was used that is able to identify proteins in an amol 
expression range. However, a circSLC45A4-specific peptide was not found. This could either 
mean that circSLC45A4 is not translated or that its translation product is lower abundant than 
in the amol-range. 
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Figure 28: Analyzing the putative translation of circSLC45A4. 
(A) – Overview of circSLC45A4, its potential open-reading frame and how it overlaps with the canonical Start codon 
and part of mRNA SLC45A4. (B) – Conservation of the peptide sequence encoded within circSLC45A4 up to frog 
(Xenopus leavis). Annotated is a transmembrane domain (dark red) that also exists in the protein encoded by the 
mRNA, the head to tail junction (blue) and the peptides that have been used in mass spectrometry to identify the 
peptide encoded by the circRNA. (C) – qPCR results for a Ribotag pulldown from Neurod6+ cells from adult mouse 
brain. 
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7.3 3D-seq: a method to integrate single-cell and spatial 
transcriptomics 
7.3.1 Developing a tool to integrate single-cell and spatial transcriptomics 
The already beforehand discussed mammalian cortex is a good example for a tissue whose 
spatial organization is of utter importance. The cortex is built up in layers originating from 
waves of migrating neuronal cells. Most current single-cell methods, although delivering a very 
detailed picture of the transcriptional landscape, do not allow for the recording of the original 
spatial position of a cell in the tissue. To overcome this problem, two approaches seem 
feasible: a) leaving the tissue intact and using highly multiplexed single-molecule FISH with 
pre-defined probe-sets or b) compartmentalizing the tissue and labeling cells in situ in any 
given compartment before breaking the tissue up into single cells. smFISH has a number of 
limitations, e.g. the used probe set has to be predefined and therefore unbiased investigation 
of the tissue is impossible, the labeled transcripts can only be assigned to a cell if they are 
nuclear or at least perinuclear, the turnaround time for each experiment is high (approx.. 14 
days for a 5x5 mm piece of mouse cortex with 600 probes, Sten Linnarsson personal 
communication) and the amount of data collected is large (terabytes per experiment, Sten 
Linnarsson (Karolinska Institute, Stockholm, Sweden), personal communication) at an overall 
high cost per experiment (cf. 3.3 - Investigating single-cell gene expression with spatial 
resolution).  
Hence, a tool to preserve spatial information of any given cell while still obtaining transcriptome 
data with single-cell resolution was developed. For this purpose, a tissue is first 
compartmentalized to obtain groups of 500-5000 cells depending on the cell density in the 
tissue (Figure 29 - A): this tissue is fresh frozen in embedding medium as it is usually done for 
in situ hybridization experiments and similar techniques (Fischer et al., 2008). The tissue is 
then cryosectioned in sections with the thickness of approximately one cell layer, for mouse 
brain that would correspond to roughly 10 µm. Then, the tissue is fixed and permeabilized 
using methanol and a 3D-printed grid is applied to the section with the help of a mounting 
device. The mounting device presses the grid onto the tissue to avoid any leakiness in-between 
the compartments. At the same time only the tissue under the grid walls gets pressed and 
subsequently destroyed. Yet, the overall integrity of the tissue section is preserved which would 
allow several consecutive rounds of in situ barcoding to increase the resolution of the method. 
The in situ barcoding can either be achieved by reverse transcribing the RNA and including 
compartment specific barcodes in the primer sequences or by ligation of short 
oligonucleotides. After the in situ barcoding step a single-cell solution has to be obtained, either 
enzymatically, or in case this is not feasible, at least the nuclei can be released with a tissue-
appropriate method. Next, the cells undergo an optimized combinatorial indexing protocol (Cao 
et al., 2017; Rosenberg et al., 2018) to obtain transcriptome information with single-cell 
resolution (Figure 29 - B). The transcriptome information as well as the barcodes attached to 
the molecules during the protocol are read by next-generation sequencing. This data is then 
used to create an in silico tissue map that traces the cells back to their original tissue position 
while having information on their transcriptome.  
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To date, this would be the only existing method that allows the investigation of single-cell 
transcriptomes while preserving each cell’s spatial position in the very same tissue section. 
 
Figure 29: General workflow of 3D-seq. 
(A) – [1] Tissue (e.g. a mouse brain) is cryosectioned, fixed, and permeabilized in methanol. [2] The grid is applied 
to the tissue, the grid walls section the tissue in compartments. [3] Cells in each compartment are barcoded in situ 
with a reverse transcription reaction and an individual barcode per compartment. [4] The tissue is enzymatically 
digested (in case enzymatic digestion is not feasible, nuclei can be released) to obtain a single-cell solution. Each 
single cell contains cDNA with a compartment specific barcode. [5] – Combinatorial indexing is used to obtain 
single-cell resolution. [6] The transcriptome and the attached barcodes are read by next generation sequencing. 
[7] – A tissue map is created in silico by placing the cells back in their original tissue position. (B) – Molecular 
workflow for 3D-seq. UMI – unique molecular identifies; bc 1 – barcode 1; bc 2 – barcode 2; i5 and i7 – Illumina 
multiplex indices. 
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7.3.2 Establishing in situ reverse transcription in fixed tissue for 3D-seq 
barcoding 
The RT reaction is the first step in this multi-step protocol (Figure 29 – B) with the purpose to 
create a sequencing library that contains information on single-cell transcriptomes and spatial 
information for each of these cells. Thus, a crucial step of this protocol is the in situ barcoding 
of cells in each grid compartment to record their spatial position within the tissue. Hence, it 
needs to be determined to which extend an in situ barcoding by reverse transcription (RT) is 
feasible. The barcode would be part of the RT primer (cf. Figure 29 – B “within grid”). 
Template-switching, also known as SMART (Zhu et al., 2001), has wide applications in single-
cell RNA-sequencing where amplification of low input material amounts is especially important. 
A chimeric RNA/DNA oligo (template switch oligo, TSO) that has 3 Gs on its 5’end can be used 
to cause a so-called template-switch, where the RT enzyme will continue the replication 
beginning at the 5’end of the TSO. This way a known sequence is incorporated at the 3’end of 
the first-strand cDNA that can later be used for additional full-length amplification of the cDNA, 
e.g. by PCR. The two RT enzymes under investigation are Maxima H- Reverse Transcriptase 
and Superscript IV. The main difference between these two Moloney murine leukemia virus 
(MMLV)-based RT enzymes is there template switching capability. Upon reaching the 5’end of 
an RNA most MMLV RTs will use their terminal transferase activity to add a few nucleotides, 
mostly C, to the 3’end of the newly synthesized cDNA strand preparing the RT product for 
template switching. Maxima H- Reverse transcriptase possess this template switching 
capability (ThermoScientific, 2017), while Superscript IV was engineered to mostly lose this 
capability (Xu et al., 2017). While the ability to amplify full-length cDNA can be advantageous 
in any single-cell RNA-seq protocol, processivity and efficiency, understood as ability to 
reverse transcribe RNAs from a broad expression range, should be considered as well. For 
this purpose primers were designed to either measure the amount of a reverse transcribed 
molecule with the entire RT primer attached (Figure 30 – A, Set 1) or to measure the amount 
of reverse transcribed molecule, e.g. due to self-priming, RT hopping etc. which could cause 
additional amplification with Set 2 compared to Set 1, (Figure 30 – A, Set 2). These primers 
were used in a qPCR reaction on cDNA generated in situ from different amounts of 
permeabilized P19 mouse cells (Figure 30 – B). 3D-seq will mostly operate in a range were 
100-5000 cells are localized within one compartment. In this range, Superscript IV was 
significantly more efficient in reverse transcribing the two tested genes Actb (5.3-fold in 1000 
cells and 11.1-fold in 100 cells) and Tubb3 (16.6-fold in 1000 cells and 100-fold in 100 cells). 
Thus, Superscript IV would capture up to 11.1-fold more transcripts from the same number of 
cells. An advantage that outweighs the option to amplify the material by PCR after template 
switching with Maxima H-. Hence, Superscript IV was used in all following experiments.  
Next, it was analyzed whether permeabilization time and reaction time of the RT influence its 
efficiency (Figure 30 – C). Therefore, a 10 µm mouse brain slice was permeabilized with 
methanol and the RNA was reverse transcribed in situ. The longer the cells were permeabilized 
and the longer the RT reaction time was, the higher was the yield for the genes tested in a 
subsequent qPCR. In total, the yield increased 1.5- to 2.5-fold. Notably, the efficiency was 
even higher compared to an identical approach, where TRIzol extraction, which is otherwise 
routinely used for RNA extraction, was applied. A 10 µm mouse brain slice contains little RNA 
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and TRIzol extraction, especially the precipitation step, is inefficient when used on small RNA 
amounts. This finding does not allow any conclusions about the efficiency of in situ vs. in vitro 
reverse transcription. It rather implies, that more material is recovered after in situ RT than by 
TRIzol extraction from low input samples. 
Furthermore, in situ RNA is highly structured and bound by proteins. Hence, certain RT pre-
treatments and additives were evaluated in a standard reaction volume of 20 µl and a 3D-seq 
adjusted volume of 5 µl (Figure 30 – D). The effects of protein digestion with a mild Proteinase 
K treatment, increasing the viscosity of the mixture with Ficoll or resolving the RNA’s secondary 
structures by pre-heating were analyzed. For this purpose, qPCR was used to quantify 4 genes 
from methanol-permeabilized HEK293 cells: ACTB, TUBB, VCL and TOP1. While these 
changes to the protocol rather decreased the yield in the larger reaction setup (20 µl), the 
effects in the smaller reaction volume were either neglectable or limited to 2 out of 4 tested 
genes. Therefore, none of these adjustments were included in the 3D-seq protocol.  
The RT reaction is the first step in a multi-step protocol (Figure 29 – B) with the purpose to 
create a sequencing library that contains information on single-cell transcriptomes and spatial 
information for each of these cells. Therefore, it is important to analyze metrics like the number 
of recovered cells, the median number of genes per cell, the median number of UMIs (unique 
molecular identifier, (Islam et al., 2014; Kivioja et al., 2011)) per cell, and the PCR bias (= 
number of reads/UMI) to evaluate this protocol and the impact of its steps by next-generation 
sequencing (Figure 30 – E). Using Superscript IV and hence not including a template-switch 
step (HEK293) was compared to using Maxima H- with a template-switch test (HEK293), a 
standard Drop-seq run with template switch (HEK293) and a SPLIT-seq run with template 
switch (mouse brain). The median number of genes or UMIs/cell are largely dependent on the 
number of reads that are spent per cell. So, while the number of genes/UMIs per cell are larger 
for the Drop-seq and SPLIT-seq runs than for the 3D-seq runs, the numbers become very 
comparable when considering the number of reads per cell. The PCR bias shows that the 3D-
seq protocol variant w/o TSO (= Superscript IV, 10.1 reads/UMI) is comparable to SPLIT-seq, 
while both protocols need to spend approximately twice the number of reads per cell to obtain 
a similar number of genes or UMIs/cell as Drop-seq. However, it is evident, that the protocol 
variant using Superscript IV (10.1 reads/UMI) is significantly more efficient than using Maxima 
H- (44.9 reads/UMI) in the initial RT step. Taken together, these RT optimization experiments 
increased the yield of the protocol’s first step significantly by 8.8-fold. The choice of the right 
RT enzyme alone increased the yield 4.4-fold (Figure 30 - E, PCR bias), adjusting the 
permeabilization and reaction time increased the yield by another 2-fold (Figure 30 – C). 
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Figure 30: Reverse transcription in situ is efficient. 
(A) – Primer design scheme for experiment shown in (B). (B) – Ratio of RT efficiencies between two different 
enzymes – Maxima H- and Superscript IV. Values > 1 indicate that Maxima H- works more efficient in that condition, 
values < 1 indicate that Superscript IV is more efficient. 20 ng of naked RNA (roughly ~1000 cells) were used as 
proxy for RT efficiency. (C) – RT efficiency depending on time of methanol permeabilization (10 or 30 min) and RT 
reaction time (15 or 30 min) on adult mouse brain slices. One slice was harvested in TRIzol and RNA was extracted 
for RT, no permeabilization step. Water served as negative control. (D) – Evaluation of (pre)-treatment steps for 
RT. STD – standard conditions without pre-treatment, + Prot. K – mild Proteinase K digest before RT, + Ficoll – 
Ficoll addition to RT reaction, +pre-heating – heating of permeabilized cells to 55°C, 5 min, before addition of RT 
enzyme. (E) – Evaluation of sequencing results for a 3D-seq run on HEK293 cells. w/o TSO – Superscript IV RT, 
w/ TSO – Maxima H- RT with addition of a template-switch oligo step after ligation of the second barcode, Drop-
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seq – standard Drop-seq run from HEK293 cells, SPLIT-seq – SPLIT-seq run on mouse brain from (Rosenberg et 
al., 2018). For w/o TSO and w/ TSO only cells with at least 100 UMIs were considered. 
 
7.3.3 Methanol fixed mouse brain can be digested into a single cell solution 
using papain 
Methanol is routinely used to fix and permeabilize cells, for example in Drop-seq experiments 
(Alles et al., 2017). SPLIT-seq uses PBS/Triton X-100 for permeabilization and para-
formaldehyde for fixation. In order to compare the efficiency of both approaches, the recovered 
median number of genes/cell and UMIs/cell was analyzed. Although the number of reads spent 
per cell was comparable (not shown), methanol fixation was significantly more efficient in terms 
of recovering genes and UMIs/cell (Figure 31 – A and B). 
 
Figure 31: Methanol fixation allows more efficient recovery of genes and UMIs/cell than PBS/Triton X-100 
permeabilization and para-formaldehyde fixation. 
(A) – Median # of genes and UMIs/cell from methanol-fixed and -permeabilized HEK293 cells carried through the 
3D-seq protocol. (B) - Median # of genes and UMIs/cell from PFA-fixed and PBS/Triton X-100-permeabilized 
HEK293 cells carried through the 3D-seq protocol. 
 
Previously published combinatorial indexing protocols intent to increase the throughput of 
single cells per experiment (Cao et al., 2017; Rosenberg et al., 2018). 3D-seq however uses 
combinatorial indexing for its versatility and is aiming to record the spatial information of each 
cell. This entails, that the tissue is first fixed and permeabilized, then the RT reaction is run in 
situ and afterwards the tissue is digested to obtain a single cell solution. In all other protocols 
the tissue is first digested and once a single cell solution is obtained, the cells are fixed and 
permeabilized which results in the loss of all spatial information.  
Hence, it is crucial to evaluate whether methanol-fixed tissue, here adult mouse brain slices 
on standard microscope slides, can still be digested into a single cell solution after methanol 
fixation. As starting point the suggestions from the Worthington Tissue Dissociation Guide on 
digesting adult mouse brain were consulted (Worthington Biochemicals). Then, it was 
qualitatively evaluated whether papain, collagenase, TrypLE or Proteinase K were able to 
disintegrate methanol-fixed tissue (Figure 32 - A). Two fixation times, 10 and 30 min, were 
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tested. Optical inspection of the glass slide after 30 min at 37°C with the different enzymes 
showed, that Papain was most efficient in digesting the tissue, while Collagenase and 
Proteinase K only partly detached the tissue. TrypLE left the tissue almost completely intact. 
Still, PBS was used to collect the detached cells and tissue pieces into a tube to be able to 
evaluate the digestion further in a microscope. Papain showed by far the most complete 
digestion of the tissue into a single cell solution. This was improved by shaking the tissue 
during the Papain digest (Figure 32 - B). The measured cell sizes ranged from 6.14 µm to 
17.92 µm, which is within the expected range of neural brain cells (Hamberger et al., 1971). 
This and additional TrypanBlue staining indicate that the visible round structures are indeed 
single cells or single nuclei. 
 
Figure 32: Methanol fixed mouse brain slices can be digested into single cells with Papain. 
(A) – 10 min and 30 min methanol-fixed mouse brain slices were rehydrated and digested with papain, collagenase, 
TrypLE or Proteinase K (cf. 6.2.4 - Tissue digestion). Scale bar – 50 µm. (B) – Additional shaking during Papain 
digestion improves the retrieval of single cells further. Cell sizes were measured with AxioVision 4.8. 
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7.3.4 Optimization of material recovery throughout ligation, bead purification 
and cell pelleting 
All single-cell sequencing protocols have to be designed to tackle very low input amounts. 
Hence, material loss throughout the individual steps of these procedures are a challenge that 
needs to be addressed. During 3D-seq, material loss can occur, next to the already mentioned 
reverse transcription step, also during ligation, during the cell pelleting steps and during bead 
purification (cf. Figure 29 – B).  
During the ligation step a second barcode is added to the reverse transcribed molecules. At 
this step, the cells are still intact. First, it was analyzed whether changing certain parameters 
of the ligation step could increase its yield: adapter concentration (2 or 5 µM), reaction volume 
and thereby changing the enzyme concentration (10, 20 or 50 µl), different ligation enzymes 
(Figure 33 – A) by qPCR. The primer combination named “Ligation amount” (Figure 33) was 
used in these reactions. It was revealed that increasing the adapter concentration while 
keeping the reaction volume minimal increased the ligation yield 2-3-fold for T4 DNA Ligase. 
The Quick Ligation mix worked best for 2 µM adapter in a 10 µl reaction, the Blunt/TA ligation 
mix with 5 µM adapter in a 50 µl reaction. Considering the cost per reaction (per 96-well plate: 
20,89 € (T4 DNA Ligase), 253,44 € (Quick Ligation mix), 152,06 € (Blunt/TA cloning) it was 
decided to further on use T4 DNA Ligase with 5 µM adapter in a 10 µl reaction for the 3D-seq 
protocol. Next, it was checked whether certain additives (PEG8000, 20 U/µl T4 DNA Ligase 
instead of 10 U/µl and 10 µM adapter instead of 5 µM) can increase the ligation efficiency 
further (Figure 33 – B). For this, qPCR was used with two sets of primers: one that measures 
all reverse transcribed cDNA (“RT amount”) and one that measures all reverse transcribed and 
ligated cDNA (“Ligation amount”) (Figure 33). Since the two products differ by up to 50 bp, 
their amplification efficiency was determined by qPCR on a dilution series (data not shown) 
and included in the calculation of ligated RT product. Under standard conditions (5 µM adapter, 
10 U/µl T4 DNA Ligase, 10 µl reaction) approximately 50 % of the reverse transcribed cDNA 
were also ligated with a second barcode. Addition of 4.2 % PEG8000 doubled the ligation 
efficiency for certain genes, while even higher concentrations of T4 DNA Ligase or of the 
adapter did not significantly enhance the ligation efficiency. Next, the influence of PEG8000 
addition was investigated on transcriptome-wide level by next-generation sequencing to rule 
out any undesired effects. Two runs of 3D-seq were conducted with and without PEG8000 
addition, one with tissue and one with a cell suspension. Surprisingly, many incomplete 
barcode combinations were found after addition of PEG8000, meaning that the second 
barcode was ligated unspecifically to not correctly reverse transcribed cDNA (Figure 33 – C). 
Thus, PEG8000 was not added in subsequent experiments as it increased the number of 
unspecific ligations. 
In order to trace back as many cells of the intact tissue as possible within the 3D-seq grid in 
silico, as little cells as possible should be lost throughout any steps of the 3D-seq protocol. 
Most prone for cell loss are the cell mixing, washing and pelleting steps after reverse 
transcription and ligation. Hence, a number of pelleting conditions were analyzed by counting 
the cells before and after centrifugation at 4°C: increasing speed, increasing centrifugation 
time, using special coated tubes (Figure 33 – D). MAXYMUM recovery tubes used at 2500xg 
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for 10 min turned out to be most efficient in pelleting fixed cells as this setup recovered 59-
63 % of cells.  
AMPure XP bead purification is used in this protocol after cell lysis (cf. Figure 29 – B). To 
efficiently lyse the cells, different lysis buffers were tested, each of them use high detergent 
concentrations (0.2 % Sarkosyl, 0.15 % Triton X-100 or 0.25 % IGEPAL). The presence of 
detergents can disrupt the binding of DNA to the carboxylated beads even in the presence of 
PEG and salts. qPCR showed that 80.1 % of cDNA without the addition of any detergents can 
be recovered with AMPure XP beads, while only 51 % can be recovered in the presence of 
detergents (Drop-seq buffer with 0.2 % Sarkosyl), 68.9 % (0.15 %Triton X-100) or 59.1 % (0.25 
% IGEPAL). To account for this effect in subsequent 3D-seq runs, solutions containing high 
detergent concentrations were diluted 4x with water before proceeding with AMPure XP bead 
purification. 
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Figure 33: Minimizing material loss in ligation, cell pelleting and bead purification 
(A) – Comparison of several ligation conditions, changed adapter concentration, changed reaction volume, several 
ligation enzyme mixes. (B) – qPCR quantification of influence from certain ligation reaction additives. (C) – Ratio of 
incomplete/complete barcodes quantified from sequencing for a 3D-seq run on tissue and on cell suspension with 
and without addition of PEG8000 to the ligation reaction. (D) – Optimization of cell recovery after pelleting. (E) – 
Percentage of recovered cDNA after AMPure XP bead purification of cDNA without detergents present, cDNA in 
Drop-seq buffer (0.2 % Sarkosyl), Triton X-100 lysis buffer (0.15 % Triton X-100) and IGEPAL lysis buffer (0.25 % 
IGEPAL). 
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7.3.5 Designing and producing a grid with CAD software and a 3D printer 
A central part of the 3D-seq approach is to compartmentalize the tissue with a grid. Using a 
grid has several advantages, e.g. it is simple to use, several grids with different geometries 
can be applied consecutively to increase the final resolution and the compartmentalization with 
a grid will leave the tissue intact. A CAD software, Autodesk Fusion 360, was used to design 
a grid (Figure 34 – A) and a fitting mounting device (Figure 34 – B). The mounting device has 
recesses that hold the grid in place, when it is put onto a tissue on a microscope slide. 
Furthermore, the mounting device has drill holes for 3.5 screws that are then used to fasten 
the grid onto the tissue and minimize leakiness (Figure 34 – C). This grid design was then used 
to be printed on an ultimaker 2+ with polyamide (PLA) or polycarbonate (PC) as printing 
material. PLA is a more flexible and easier to print material that allows to build finer structures, 
while PC is a tougher material that bends less and has higher heat resistance. The PLA 
available for the ultimaker 2+ can only withstand temperatures up to 40°C (= glass transition 
temperature, engineering term referring to the temperature at which a hard material becomes 
brittle and then viscous/rubbery). Hence, it started bending and melting during standard 
reverse transcription conditions and was therefore incompatible with the 3D-seq protocol (data 
not shown). Despite PC is solid up to 147°C (= glass transition temperature) it was not suitable 
for the 3D-seq setup either, as it was impossible to print fine grid walls of the necessary 
thickness (100 – 300 µm) using the ultimaker 2+ (data not shown). Thus, a Projet HD 3000 
was used with a proprietary PA-mixture (VisiJet SR200) that was able to print grids that both 
were sufficiently heat stable (glass transition temperature 46°C, (Vargas et al., 2014)) and 
contained finer walls (100 – 300 µm) (Figure 34 – D). An important parameter for the leakiness 
of the grid is the wall thickness, the thicker the wall the less likely are leaks caused by imperfect 
walls. However, increasing the thickness also increases the amount of tissue lost for analysis 
as it is crushed underneath the grid walls. Thus, grids of several wall thicknesses were printed 
and microscopically analyzed (Figure 34 – D). While the 100 µm walls exhibited a number of 
imperfections, the 300 µm walls were more even, just like the 150 and 200 µm grids (data not 
shown). Therefore, the 150 µm grid was the preferred choice to minimize material loss. When 
the grid is applied to an unstained mouse brain section (Figure 34 – F), anatomical structures 
of the brain like the cortex, the hippocampus, the corpus callosum, and so on, are still visible 
and help the orientation in later analysis. Next, the leakiness of the grid was investigated by 
plating cell lines from mouse (P19) and human (SH-SY5Y) in a predefined pattern onto a PLL-
coated microscope slide with the help of an ibidi cell chamber (Figure 34 – E). Then, the cells 
were fixed in methanol, the 300 µm grid was applied, and the 3D-seq protocol was performed. 
The position of the plated cell lines under the grid was known and used to compare the 
obtained next-generation sequencing data to the expected cell identities (Figure 34 – E). Of 
the sequenced cells only 151 had more than 4 UMIs identified and were considered in this 
analysis. The identity of the cell was determined by the number of UMIs mapping 
unambiguously to a certain species – mouse or human. If a cell contained more than 20 % 
UMIs from both species, it was called a “mixed” cell. Such mixed cells can either occur due to 
leakiness of the grid, as the barcode combinations would not be sufficient anymore to identify 
single cells, or due to mixing of cell content later during the protocol. It was shown in previous 
combinatorial indexing experiments that the mixing during later protocol steps is minimal 
(Rosenberg et al., 2018), hence the mixing rate estimated here should be due to the leakiness 
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of the grid. 145 out of 151 considered cells have 100 % species purity (< 20 % UMIs from the 
other species), while 6 out of 151 cells were mixed (≥ 20 % UMIs from the other species). 6 
mixed cells out of 151 total cells would correspond to 3.97 % mixed cells. 
 
Figure 34: Designing, producing and evaluating the grid. 
(A) – Image of grid from Autodesk Fusion 360. (B) – Image of mounting device, left: bottom part; right: top part. (C) 
– mounting device with grid inside. (D) – Grids produced with Projet HD 3000. (E) – Estimation of leakiness. Cells 
are seeded on a microscope slide in a known pattern, fixed with methanol and then the grid is applied. A 3D-seq 
run is conducted and the leakiness is estimated in silico by comparing the expected organism identity to the in silico 
identified one. (F) – Grid when applied to a coronal mouse brain section. CX – cortex, CC – Corpus callosum, HPF 
– Hippocampal formation. 
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7.3.6 3D-seq allows the identification of cell types from adult mouse brain slices 
3D-seq is supposed to be applied to tissue sections that are placed on standard microscope 
glass slides. This has several advantages, first 3D-seq is compatible with already existing 
tissue cuts e.g. from precious medical samples, second standard sectioning protocols exist for 
almost all tissues, third no specialized equipment is needed for the initial preparation step of 
the tissue and fourth a microscopic inspection of the tissue with high resolution is possible and 
enables the collection of additional information about the tissue. To develop the method, we 
are applying it to coronal sections from adult mouse brain (Figure 35 - A). Since anatomical 
structures are visible within the tissue even without additional staining, they can manually be 
annotated with the help of the Allen Brain Atlas (Allen Institute for Brain Science, 2011) and 
later on be used as additional information.  
The shown mouse brain section was then carried through the 3D-seq protocol, sequenced and 
yielded 80 UMIs/cell (median) or 158.8 UMIs/cell (mean) and 16 genes/cell (median) and 27.2 
genes/cell (mean) when considering all cells with more than 50 UMIs expressed and counting 
only genes with at least 2 UMI counts. The data obtained here, as for any single-cell RNA-
sequencing experiment, is of high dimensionality. Hence, a nonlinear dimensionality reduction 
method, the t-distributed stochastic neighbor embedding (tSNE), that was previously 
suggested for dimensionality reduction (Amir et al., 2013; van der Maaten and Hinton, 2008), 
was used. First, a principal component analysis was conducted to determine the statistically 
significant principal components (PCs), 100 PCs were then reduced to two dimensions using 
tSNE (Figure 35 - C). 71 clusters were identified with 50 (cluster 70) to 584 cells (cluster 0) per 
cluster (Figure 35 – D). The number of UMIs/cell is equally distributed across the clusters, 
indicating that the cluster identity is not build on noise in the data but on actual biological 
meaning. However, it should be noted that with deeper data, e.g. recovering more UMIs or 
genes/cell some clusters will collapse and be united with others as the sparse data can let cells 
seem different on the transcriptome level. Hence, marker genes for each cluster were 
determined and biological identities assigned with the help of mousebrain.org (Linnarson lab) 
(Table 7). 
Table 7: Marker genes identified for clusters from coronal mouse brain section 
clus
ter 
# of 
cells 
gene p-value1 Ave. 
logFC2 
Positive in 
cluster3 
Positive 
in all4 
Adj. p-
value5 
cell type 
mousebrain.org 
brain region 
4 146 Zdhhc14 0 4.65 0.44 0.00 0 Excitatory 
neurons, mostly 
cerebral cortex 
& HC 
Cortex, HC 
& minor in 
other 
regions 
4 146 Myo16 0 4.40 0.31 0.00 0 Excitatory 
neurons, mostly 
cerebral cortex 
& HC 
Cortex, HC 
& minor in 
other 
regions 
4 146 Osbpl8 8.65E-247 4.26 0.31 0.01 1.29E-242 Excitatory 
neurons, mostly 
cerebral cortex 
& HC 
Cortex, HC 
& minor in 
other 
regions 
5 133 Gad2 0 4.18 0.29 0.00 0 Trilaminar cells, 
hippocampus 
Cortex/HC 
thalamus 
6 124 Snap25 3.62E-287 3.51 0.59 0.02 5.38E-283 Excitatory 
neurons, 
cerebral cortex 
Cortex/HC 
7 122 Ubr5 0 4.23 0.40 0.01 0 R-LM border 
Cck 
interneurons, 
cortex/hippocam
pus 
Cortex/HC 
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7 122 Ahi1 0 3.94 0.40 0.00 0 R-LM border 
Cck 
interneurons, 
cortex/hippocam
pus 
Cortex/HC 
7 122 Adarb2 4.21E-119 3.59 0.28 0.01 6.25E-115 R-LM border 
Cck 
interneurons, 
cortex/hippocam
pus 
Cortex/HC 
8 114 Cadps2 0 4.37 0.40 0.00 0 all kinds of 
neurons 
everywhere 
8 114 Ankrd17 0 4.01 0.44 0.01 0 all kinds of 
neurons 
everywhere 
9 107 Sparcl1 0 4.04 0.73 0.02 0 inhibitory and 
excitatory 
neurons 
  
9 107 Abca3 3.27E-269 3.49 0.30 0.00 4.87E-265 inhibitory and 
excitatory 
neurons 
  
10 104 Dst 0 4.36 0.81 0.02 0 Excitatory 
neurons, 
cerebral cortex 
Cortex/HC 
11 102 Herc1 0 4.33 0.53 0.01 0 all kinds of 
neurons 
everywhere 
12 101 Kif5c 0 3.98 0.90 0.02 0 all kinds of 
neurons 
everywhere 
13 101 Gls 0 4.98 0.54 0.00 0 Cholinergic 
neurons, septal 
nucleus, 
Meissnert and 
diagonal band 
Hypothalam
us 
13 101 Rimbp2 0 4.95 0.50 0.00 0 Cholinergic 
neurons, septal 
nucleus, 
Meissnert and 
diagonal band 
Hypothalam
us 
14 100 Cdh13 0 4.76 0.69 0.01 0 Excitatory 
neurons, 
cerebral cortex 
or midbrain 
cortex, 
midbrain 
14 100 Pex5l 1.25E-251 4.49 0.34 0.01 1.86E-247 Excitatory 
neurons, 
cerebral cortex 
or midbrain 
cortex, 
midbrain 
15 100 Tulp4 0 4.76 0.59 0.00 0 Non-border Cck 
interneurons, 
cortex/hippocam
pus 
Cortex/HC 
15 100 Ralgapa
2 
0 4.01 0.36 0.00 0 Non-border Cck 
interneurons, 
cortex/hippocam
pus 
Cortex/HC 
16 99 Cdk17 0 4.85 0.52 0.00 0 Excitatory 
neurons, 
cerebral cortex 
Cortex/HC 
16 99 Gm1580
0 
0 4.68 0.51 0.00 0 Excitatory 
neurons, 
cerebral cortex 
Cortex/HC 
17 95 Cplx2 0 4.37 0.84 0.01 0 all kinds of 
neurons 
everywhere 
18 94 Susd4 0 4.79 0.44 0.00 0 Excitatory 
neurons 
Cortex, HC, 
thalamus, 
hypothalamu
s 
18 94 Nin 0 4.63 0.59 0.00 0 Excitatory 
neurons 
Cortex, HC, 
thalamus, 
hypothalamu
s 
19 93 Map1b 0 3.56 1.00 0.04 0 Afferent nuclei 
of cranial nerves 
VI-XII 
Medulla 
20 93 Grin2b 0 3.39 1.00 0.05 0 Excitatory 
neurons, 
cerebral cortex 
Cortex/HC 
21 92 Rgs7 0 4.39 0.77 0.01 0 Excitatory 
neurons, 
cerebral cortex 
Cortex/HC 
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21 92 Cltc 7.91E-159 3.26 0.26 0.01 1.18E-154 Excitatory 
neurons, 
cerebral cortex 
Cortex/HC 
22 89 Ptprg 0 5.15 0.87 0.01 0 Excitatory 
neurons, 
cerebral cortex 
  
23 89 Kif5a 0 3.34 1.00 0.05 0 Excitatory 
neurons, 
cerebral cortex 
  
24 89 Fam19a
2 
0 5.27 1.00 0.01 0 Excitatory 
neurons, 
cerebral cortex 
  
25 88 Cacna2
d3 
1.09E-261 3.01 0.94 0.05 1.62E-257 Non-border Cck 
interneurons, 
cortex/hippocam
pus 
Cortex/HC 
26 87 Cadps 0 4.38 1.00 0.02 0 Excitatory 
neurons, 
cerebral cortex 
Cortex/HC 
27 86 Sntg1 0 4.38 1.00 0.02 0 Excitatory 
neurons, 
cerebral cortex 
Cortex/HC 
28 85 Kif5b 0 5.56 1.00 0.00 0 Excitatory 
neurons, 
cerebral cortex 
Cortex/HC 
29 85 Tcf4 0 4.18 1.00 0.02 0 Excitatory 
neurons, 
cerebral cortex 
and 
oligodendrocyte
s 
Cortex/HC, 
thalamus 
30 85 Gpr158 0 4.45 1.00 0.02 0 Excitatory 
neurons, 
cerebral cortex 
Cortex/HC, 
thalamus 
31 83 Mbp 0 3.59 1.00 0.04 0 oligodendrocyte
s 
everywhere 
32 81 Calm1 0 3.66 1.00 0.03 0 Excitatory 
neurons 
Cortex/HC, 
thalamus 
33 79 Syne1 0 3.91 1.00 0.03 0 Excitatory 
neurons, 
cerebral cortex 
Cortex/HC 
34 78 Cacna1c 0 4.31 1.00 0.02 0 Excitatory 
neurons 
Cortex, HC, 
thalamus, 
hypothalamu
s 
35 78 Wwox 0 5.22 1.00 0.00 0 Excitatory 
neurons, 
cerebral cortex 
Cortex/HC 
36 78 Limch1 0 5.46 1.00 0.00 0 Excitatory 
neurons 
Cortex, HC, 
thalamus, 
hypothalamu
s 
37 77 Dclk1 0 4.79 1.00 0.01 0 Excitatory 
neurons, 
cerebral cortex 
Cortex/HC 
38 77 Mbnl2 4.05E-263 4.47 0.47 0.01 6.03E-259 Afferent nuclei 
of cranial nerves 
III-V 
hypothalamu
s 
38 77 Frmd4b 2.10E-175 3.97 0.33 0.01 3.13E-171 Afferent nuclei 
of cranial nerves 
III-V 
hypothalamu
s 
38 77 Lmtk2 1.48E-139 3.11 0.26 0.01 2.20E-135 Afferent nuclei 
of cranial nerves 
III-V 
hypothalamu
s 
39 76 Ppp2r2c 0 5.17 1.00 0.01 0 Excitatory 
neurons 
everywhere 
40 76 Cacna1
d 
0 5.33 1.00 0.01 0 Excitatory 
neurons, 
midbrain 
Cortex, 
Thalamus 
41 76 Alcam 0 5.09 1.00 0.01 0 broadly 
expressed 
everywhere 
42 76 Cmip 0 5.70 1.00 0.00 0 Excitatory 
neurons 
everywhere 
43 75 Kcnq3 0 4.36 1.00 0.02 0 Excitatory 
neurons 
everywhere 
44 75 Cdc42b
pa 
0 4.81 1.00 0.01 0 Excitatory 
neurons 
everywhere 
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45 73 Ptms 0 5.45 1.00 0.00 0 broadly 
expressed, 
highest in 
enteric glia 
everywhere 
46 71 Camk2n
1 
0 4.19 1.00 0.03 0 Excitatory 
neurons, 
cerebral cortex 
Cortex 
47 70 Elmo1 0 5.34 1.00 0.01 0 Non-border Cck 
interneurons 
Cortex/HC 
48 69 Unc79 0 5.41 1.00 0.00 0 Excitatory 
neurons, 
cerebral cortex 
Cortex/HC 
49 69 Ttc3 0 3.86 1.00 0.03 0 Excitatory 
neurons 
everywhere 
50 68 Dnm1 0 5.32 1.00 0.01 0 Excitatory 
neurons, 
cerebral cortex 
Cortex/HC 
51 68 Kif1b 0 3.50 1.00 0.03 0 Excitatory 
neurons, 
cerebral cortex 
Cortex/HC 
52 68 Slc8a1 0 5.03 1.00 0.01 0 broadly 
expressed 
everywhere 
53 67 Frrs1l 0 5.18 1.00 0.01 0 Excitatory 
neurons 
everywhere 
54 67 AI31418
0 
0 5.65 1.00 0.00 0     
55 67 Nell1 0 5.44 1.00 0.00 0 broadly 
expressed, 
highest in 
inhibitory 
interneurons of 
HC 
everywhere 
56 63 Atp2a2 0 5.45 1.00 0.00 0 Afferent nuclei 
of cranial nerves 
VI-XII 
medulla, 
hypothalamu
s 
57 63 Nfix 0 5.56 1.00 0.00 0 broadly 
expressed, 
highest in 
granule 
neuroblasts 
dentate 
gyrus, cortex 
58 63 Rbfox2 0 5.13 1.00 0.01 0 Excitatory 
neurons 
everywhere 
59 63 Rnf150 0 4.73 1.00 0.01 0 Excitatory 
neurons 
everywhere 
60 62 Npas3 0 5.29 1.00 0.01 0 (Non-border 
Cck) 
interneurons 
Cortex/HC 
61 62 Ptprj 0 5.62 1.00 0.00 0 Excitatory 
neurons 
Cortex/HC 
62 62 Peg3 0 5.34 1.00 0.00 0 serotonergic 
neurons 
hypothalamu
s 
63 62 Sh3rf3 0 5.63 1.00 0.00 0 Non-border Cck 
interneurons 
Cortex/HC 
64 61 Calm3 0 5.57 1.00 0.00 0 broadly 
expressed, 
neurons 
everywhere 
65 60 Kcnh1 0 5.35 1.00 0.00 0 R-LM border 
Cck 
interneurons 
Cortex/HC 
66 60 Snrnp70 0 5.09 1.00 0.00 0 broadly 
expressed, all 
cell types 
everywhere 
67 58 Ptprn2 0 4.00 1.00 0.02 0 broadly 
expressed, 
neurons 
everywhere 
68 55 Diaph2 0 5.36 1.00 0.01 0 broadly 
expressed, 
neurons 
everywhere 
69 55 Plxna4 0 5.16 1.00 0.01 0 excitatory 
neurons 
everywhere 
70 50 Kcnip1 0 5.39 1.00 0.00 0 broadly 
expressed, 
neurons 
Cortex/HC, 
thalamus 
1calculated with Wilcoxon rank sum test; 2average logFC in cluster vs. all cells; 3 positive cells 
in cluster [%/100]; 4positive cells of all cells [%/100]; 5p-value adjusted with Bonferroni method  
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Figure 35: 3D-seq run on coronal mouse brain section allows identification of cell types. 
(A) – Stitched microscopic images of a coronal mouse brain section. Positions of grid compartments (1x1 mm) are 
annotated, as well as major mouse brain regions according to the Allen Mouse Brain Reference Atlas. CX – Cortex, 
CC – Corpus Callosum, HPF – Hippocampal Formation, STR – Striatum, DG – Dentate Gyrus, TH – Thalamus, HY 
– Hypothalamus, PAL – Pallidum. (B) – Violin plots for UMIs/cell (only cells with > 50 UMIs were kept for this 
analysis) and genes/cell. Each dot is a cell. Horizontal line = median, dashed horizontal line = mean. (C) – tSNE 
plot for 6732 cells from a coronal mouse brain section carried through the 3D-seq protocol with more than 50 UMIs 
yield 71 clusters, based on 100 PCs, resolution = 3, perplexity = 30. (D) – Number of cells per cluster and number 
of UMIs/cell in each cluster. 
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7.3.7 Spatial reconstruction of mouse brain in silico  
The main aim of 3D-seq is the unbiased spatial reconstruction of tissue in silico. During the RT 
barcoding step all cells are labeled with a specific RT barcode depending on their localization 
within the grid. This barcode can then be used for tracing the cells back to their approximate 
original position within the tissue. The resolution is limited to the size of each grid compartment. 
Here, this would mean that each cell is placed back within 1 mm2 of its original position.  
First, the distribution of UMIs/cell and genes/cell across the tissue was analyzed to rule out 
grid induced artifacts, e.g. that certain grid compartments contribute cells with high UMIs while 
others contribute only cells with low UMIs (Figure 36). Notably, two compartments are almost 
devoid of cells. The upper left corner compartment did contain only a small tissue part (cf. 
Figure 35 – A) which could explain that there was only one cell detected. However, the 4th 
compartment in the 4th column is also empty although it contained large parts of the thalamus 
(cf. Figure 35 – A). This is probably due to a hydrophobic effect: the grid is made from 
hydrophobic material while the reverse transcription mixture is water-based. Hence, if the drop 
of RT mixture is not placed right on the tissue the mixture will be held above the tissue. 
Nevertheless, all other compartments hold 1 - 787 cells with varying numbers of UMIs and 
genes. Hence, the number of UMIs/cell or genes/cell does not dependent on the position of 
the cells in the grid.  
 
Figure 36: Distribution of UMIs/cell and genes/cell in each compartment of the grid. 
(A) – UMIs/cell in each compartment. Cells (dots) are colored by number of UMIs detected. (B) – Genes/cell in each 
compartment. Cells (dots) are colored by number of genes detected. 
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Figure 37: 3D-seq allows in silico reproduction of a spatial gene expression map. 
(A) – Image from mousebrain.org showing the expression of Zdhhc14, Myo16 and Osbpl8 (marker genes for cluster 
4) as well as Malat1 and Meg3 (for comparison). (B, C, D, E, and F) – Spatial gene expression maps based on 3D-
seq data. Each dot is a single cell, grey – no UMIs for gene detected, red – cells with UMIs for respective gene 
detected and colored according to expression level. (B) – Zdhhc14. (C) – Myo16. (D) – Osbpl8. (E) – Malat1. (F) – 
Meg3. (G) – Spatial mapping of all cells belonging to cluster 4 based on 3D-seq data. Grey – cells of other cell 
clusters, red – cells belonging to clusters. 
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The mouse brain is a very well analyzed tissue in terms of spatial gene localization, resources 
like mousebrain.org (Linnarson lab) and the Allen Brain Atlas (Allen Institute for Brain Science, 
2011) offer large single-cell RNA-seq datasets that are prepared from specific brain regions or 
in situ hybridizations of a wide variety of genes, respectively. Mousebrain.org additionally offers 
a quantitative measure for gene expression per cell type in certain brain regions (Figure 37 - 
A). In our data set Zdhhc14, Myo16 and Osbpl8 were identified as marker genes for cluster 4. 
Analyzing the individual gene expression patterns for these genes reveals that they are usually 
expressed in more than one cell type. Zdhhc14 is expressed in a number of neurons of the 
central nervous system (CNS), mostly in cortical and hippocampal neurons, and can also be 
found in non-neuronal cells, e.g. in oligodendrocytes. Evaluating the spatial gene expression 
of Zdhhc14, obtained by 3D-seq, confirms this. Most Zdhhc14 positive cells are found in the 
cortex, but also other regions such as the hypothalamus and striatum hold Zdhhc14-positive 
cells. A similar pattern is expected and found for Myo16. Osbpl8 on the other hand is higher 
and more broadly expressed than Zdhhc14 and Myo16, according to mousebrain.org. Hence, 
for Osbpl8 there are also cells found in the hippocampal area and in the thalamus (Figure 37 
– B, C, and D). However, the data analyzed is sparse (cf. Figure 35 – B and D). Therefore, it 
will contain false negatives. According to the 3D-seq dataset 70 cells express Zdhhc14 (1.04 
% of all cells), 53 cells express Myo16 (0.78 %), and 80 cells express Osbpl8 (1.19 %). For 
comparison, the spatial patterns of two highly expressed genes, Malat1 which is expressed in 
almost all cells, and, Meg3 which is expressed in all neuronal cells (Linnarson lab). In the 3D-
seq dataset Malat1 is expressed in 2411 (35.81 %) cells and Meg3 in 1168 cells (17.35 %). 
So, even generally highly and widely expressed genes are only detected in one-fifth to one-
third of the cells (Figure 37 – E and F). Therefore, the spatial expression trends recovered here 
are limited and some trends might not be detectable at this point. An alternative to displaying 
spatial expression on the gene level is the in silico assignment of cells belonging to a certain 
cluster to their original place within the tissue. The three marker genes for cell cluster 4, 
Zdhhc14, Myo16 and Osbpl8 are widely expressed, all three of them are moderately expressed 
in excitatory neurons of the cerebral cortex and hippocampus according to mousebrain.org. 
Hence cluster 4 was assigned the identity ‘excitatory neurons, mostly cerebral cortex and 
hippocampus’. Indeed, roughly half of the 146 cells belonging to cluster 4 are localized in grid 
compartments holding parts of the cortex (75 cells, 51.37 %). Further cells of cluster 4 are 
found in the hypothalamus, striatum and thalamus according to 3D-seq data. Mousebrain.org 
confirms this: at least 2 of the 3 markers are also expressed in cell types of the striatum (MSN 
in Figure 37 - A) or the di- and mesencephalon, which comprises the thalamus and 
hypothalamus. 
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8 Discussion 
8.1 Circular RNAs in the Mammalian brain are highly abundant, 
conserved and dynamically expressed 
In order to obtain a broad overview of circRNA expression in neural systems, a circRNA 
catalogue was created. To do so, 29 different types or stages of neural cell culture models and 
tissues were investigated by total RNA-seq. circRNA expression was found to be stage-
specific and in many cases tissue specific. circRims2 for example is most highly expressed in 
the cerebellum, while the expression of the corresponding mRNA is highest in the striatum. 
This suggests a regulated, region-specific expression of circRNAs. Furthermore, circRNAs are 
strongly enriched in synaptoneurosomes compared to their linear counterparts. One 
explanation could be that circular RNAs diffuse to these distal cell parts and persist longer 
because of their exceptional stability. Another explanation for the enrichment of circRNAs at 
the synapse could be their active transport to this cell part. How mRNAs, RBPs or miRNAs are 
transported to the synapses it not fully understood (Dahm and Kiebler, 2005; Doyle and 
Kiebler, 2011; Holt and Bullock, 2009). However, all of these molecules are exerting 
specialized functions at the synapse that require their specific transport to this localization. 
Although there are no insights into the function of circRNAs at the synapse yet, this finding is 
quite intriguing and worth following up onto. Since circRNAs can be sliced open by microRNAs 
(Hansen et al., 2013), they could function as cargo-carrying adaptor molecules. Furthermore, 
when considering the long half-life of circRNAs compared to their linear counterparts (Zhang 
et al., 2016) their predominant localization at the synapse seems reasonable from an energetic 
point of view. Transporting an mRNA or a circRNA to the tip of an axon will cost a similar 
amount of ATP. Considering the longer half-lives of most circRNAs compared to the 
corresponding mRNA the transport needs to happen less frequently to maintain the same 
molecule concentration at the synapse. Synaptic density in human is approximately 4 times 
higher than in mouse brain (Herculano-Houzel, 2009), which could explain the generally higher 
number of circRNAs in human brain compared to mouse brain. Another difference between 
mouse and human is the expanded repertoire of inverted Alu repeats in primate introns (Daniel 
et al., 2014), that were already shown to be important in circRNA biogenesis (Ivanov et al., 
2015). 
circRNA expression was overall upregulated during neuronal differentiation. In both, cell lines 
(SH-SY5Y and P19) and primary neuron culture, in many cases but not always, the 
upregulation of the circRNA was coupled to the upregulation of the mRNA. This would argue 
that it is not the overall transcriptional output from a genetic locus that drives circRNA 
expression, but that production of mRNA or circRNA from a genetic locus can be specifically 
regulated. But how could the expression of the circRNA be specifically regulated? So far, the 
insights into the biogenesis of circRNAs are limited. However, splice regulators such 
muscleblind (MBL/MBNL) have been implicated in circRNA biogenesis (Ashwal-Fluss et al., 
2014), as well as RBPs like QKI (Conn et al., 2015), ILF3 (Li et al., 2017), and the RNA-editing 
enzyme ADAR1 which antagonizes circRNA production (Ivanov et al., 2015). In human cell 
culture systems ADAR1 was also found to negatively regulate the expression of circRNAs, as 
its knockdown caused the upregulation of many circRNAs but not their linear counterparts. 
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Furthermore, an editing site in an intron of circRTN4 was identified that correlated well with the 
observed expression changes of circRTN4 during neuronal differentiation. The overall 
regulation of circRNA expression by ADAR activity was also uncovered in Drosophila 
melanogaster. Interestingly, ADAR1 is known to be highly active during development and in 
neurons (Wahlstedt et al., 2009) which could indicate a highly dynamic regulation of circRNA 
expression by ADAR1 in these situations. 
The high conservation of circRNA expression was especially intriguing. Approximately 80 % of 
circRNAs expressed with at least 5 reads in mouse P19 cells have a homologous circRNA in 
human or shares at least the splice sites with a circRNA expressed in human. In addition, a 
higher conservation of 7-mers in circRNA encoding regions was found. This could indicate 
additional functions of the nucleotide sequence besides coding for the open-reading frame of 
the corresponding mRNA, like binding of miRNAs, RBPs or pairing with other long RNAs. It 
could also be a feature of exons that are enclosed by long introns, which is often the case for 
circRNA producing exons. Conserved circular RNAs were flanked more often by introns with 
RCMs than non-conserved ones, which would suggest a conserved mechanism for circRNA 
production. However, Alu elements, which are primate-specific and highly abundant repeat 
elements, have been implied in gene regulation in general and are often found in genomic 
regions with a high gene density (Deininger, 2011). In human there are approximately 306 Alu 
elements per megabase and at most a subset of them will be influencing circRNA expression.  
In summary, a comprehensive circRNA catalogue for many neural tissues is provided which 
offers insights in the spatial localization of circRNAs as well as in the regulation of their 
expression during neuronal differentiation. The spatial localization however is coarse and 
limited to averages over entire brain regions or all synaptoneurosomes. Yet, starting from this 
catalogue one can select from a large set of interesting circular RNA molecules to analyze 
their potential functional roles in neuronal differentiation.  
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8.2 circSLC45A4 is required to keep neuronal cells in a progenitor 
state in cell culture systems and in the mammalian brain 
In the present work circSLC45A4 was identified as the highest expressed isoform from its 
genetic locus in developing human cortex, at gestational week 22. At gestational week 22 
neurogenesis in the cortex is almost completed, while neuronal migration and maturation are 
only beginning (Stagni et al., 2015). Additionally, we measured circSlc45a4 levels in the whole 
mouse brain and found its expression to be peaking at E16.5. A timepoint at which 
neurogenesis in the mouse brain is peaking in many mouse brain regions (Finlay and 
Darlington, 1995) and at which upper-layer neurons are formed in the cortex (Mihalas et al., 
2016). This indicated that circSLC45A4 might play a role in neurogenesis. Hence, its 
expression levels were perturbed by siRNA-mediated RNAi (Elbashir et al., 2001a) in a widely-
used human model system for neuronal differentiation (SH-SY5Y) and in the developing 
mouse cortex. In SH-SY5Y cells spontaneous neuronal differentiation was observed following 
circSLC45A4 knockdown. Induction of neuronal marker genes like TUBB3, ASCL1 and 
GABBR1 was detected by qPCR and in part by Western Blot. At the same time, knockdown of 
circSLC45A4 in SH-SY5Y cells caused a significant increase in neurite length (19.9 µm after 
circSLC45A4 KD, 12.0 µm after scramble KD). 
For both mRNA Slc45a4 and circSlc45a4 knockdown a significant depletion of cells from the 
cortical plate of mouse embryonic cortices was observed. However, only after knockdown of 
circSlc45a4 cells were also depleted from the subventricular zone, the layer that contains basal 
progenitors. Indeed, basal progenitors were found to be significantly depleted after circSlc45a4 
knockdown. Basal progenitors can be generated from apical progenitors or basal progenitors 
themselves. Basal progenitors also undergo symmetric, neurogenic divisions and thereby 
generate neurons in the developing cortex (Taverna et al., 2014). In addition to the depletion 
of the basal progenitor pool, we observed a slight but significant increase in apical progenitors, 
the number of neurons, however, was not affected. 
circSLC45A4 and mRNA SLC45A4 originate from the same genetic locus. Hence, they are 
identical in their sequence except for the head-to-tail splice junction that is specific to the 
circular RNA. Therefore, it is important to ensure that the effects described for perturbation of 
the circRNA are indeed caused by the circRNA and not through secondary effects on the 
mRNA. siRNAs and shRNAs are prone to have off-target effects, either by downregulation of 
unintended targets, e.g. the corresponding mRNA, functioning as miRNAs, depleting the 
effective concentration of AGO, or simply by overloading Dicer (shRNAs only) and thereby 
impairing its function. To minimize this risk several precautions were taken: a) several 
independent siRNAs against the same target were used and only effects observed for each of 
these siRNAs were considered, b) siSPOTR (Boudreau et al., 2013) was used to minimize the 
chance of hitting unintended targets with potential miRNA seed sequences included in the 
siRNA, c) BLAST (Altschul et al., 1990) analysis of the siRNA sequences was used to ensure 
that no other RNAs will be targeted by the siRNA. Furthermore, for each experiment conducted 
the levels of the corresponding mRNA were monitored and found stable or minimally affected. 
Additionally, in mouse cortex depletion of the mRNA caused a different phenotype than 
depletion of the circRNA. Although we cannot rule out unspecific effects, the observed 
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phenotypes are attributed to the depletion of the circRNA and likely not caused by off-target 
effects or deregulation of the mRNA. 
So how can the phenotypes observed in SH-SY5Y cells, spontaneous induction of 
neurogenesis, and mouse cortex, depletion of the basal progenitor pool, be reconciled (Figure 
38 - A)? In both cases a depletion of a neuronal progenitor pool was observed: SH-SY5Y cells 
are already mainly neuroblasts that are spontaneously differentiating towards a neuronal 
phenotype after the depletion of circSLC45A4. In mouse cortex several lines of evidence 
showed the depletion of the basal progenitor pool already in the ventricular zone. In addition 
to the depletion of the basal progenitor pool, we observed a slight but significant increase in 
apical progenitors, the number of neurons, however, was not affected. 
What causes this distortion in the apical to basal progenitor pool ratio? Here the increased 
number of Cajal-Retzius cells that was determined from the combined analysis of bulk RNA-
seq and single-cell RNA-seq data seems intriguing. Cajal-Retzius cells are the first type of 
neuron appearing in the developing neocortex. Their main function is to secrete reelin, an 
extracellular matrix glycoprotein, that helps to mediate neuronal migration and controls cell-
cell interactions in the developing brain (Gupta et al., 2002). Furthermore, it was shown that 
reelin influences the proliferation of apical progenitors by amplifying Notch signaling (Lakomá 
et al., 2011). Intriguingly, Notch2 and Rbpj were amongst the strongly and significantly 
upregulated genes after circSlc45a4 knockdown in developing mouse cortex. The amplification 
of Notch signaling through reelin is promoting the symmetric proliferative divisions of apical 
progenitors (Lakomá et al., 2011). This could explain the observed increase in the number of 
apical progenitors, while there are less basal progenitors. 
The here identified phenotype, caused by downregulation of circSLC45A4, is the first 
developmental brain phenotype described for a circRNA. However, the mechanism for this 
molecule remains elusive. Several potential modes of action have been investigated: 
interaction and regulation of miRNAs, interaction with RBPs, and translation (Figure 38 - B). 
Chimeric data obtained from mouse brain predicted an interaction of circSLC45A4 with miR-
9, miR-135 and miR-181. miR-135 was previously shown to be involved in axon outgrowth 
(van Battum et al., 2018). Knockdown of circSLC45A4 in SH-SY5Y cells caused 
downregulation of miR-135. However, the interaction of circSLC45A4 with miR-135 could not 
be validated by pulldown of circSLC45A4. Furthermore, the downregulation of miR-135 was 
not recapitulated in embryonic mouse cortex after knockdown of circSlc45a4 (data not shown). 
Hence, a function of circSLC45A4 through interaction with miR-135 was ruled out. The 
changed expression levels of miR-135 after knockdown of circSLC45A4 were most likely 
secondary effects: hippocampal neurons downregulate miR-135 early during differentiation 
(van Battum et al., 2018). 
Pulldown of circSLC45A4 was further used to identify RBPs interacting with the circular RNA 
by mass spectrometry. circSLC45A4 was strongly enriched after pulldown with the specific 
biotinylated antisense probes, but so was mRNA SLC45A4. Only 1 % of the ACTB present in 
the input was pulled down, however, given the abundance of ACTB per cell (~2500 
molecules/cell, (Kislauskis et al., 1997)) 1 % (~25 molecules) of these transcripts would still be 
6 times more than if 100 % of circSLC45A4 are pulled down (~4 copies per cell). Hence, it is 
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very likely that many of the 961 enriched proteins are not specific binders of circSLC45A4 but 
are bound by contaminating RNA molecules, even if they are strongly depleted compared to 
the input. Although some of the interactions identified by mass spectrometry could be validated 
by reverse pulldown, i.e. FXR2 and DOCK7, the interaction is not abundant and probably 
occurring too seldom to cause the observed phenotype when disrupted. However, FXR2 is a 
known regulator of BMP signaling in adult neurogenesis (Guo et al., 2011). Lowered activity 
levels of FXR2 causes an increase in Noggin expression, which in turn reduces BMP signaling 
and by that increases proliferation of neural stem/progenitor cells in the dentate gyrus. Indeed, 
an increase in Noggin expression was observed after cirSLC45A4 KD in mouse cortex. This 
could be causal for the observed increased neurogenesis or depletion of neural progenitors 
and should be further investigated. 
 
 
 
Figure 38: circSLC45A4 keeps neural cells in a progenitor state, although the mechanism remains elusive 
(A) – Consequences of depleting circSLC45A4 in SH-SY5Y cells or in embryonic mouse cortex. (B) – Potential 
mechanisms of circSLC45A4. 
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Since there have been publications on the translation of circRNAs, the coding potential of 
circSLC45A4 was investigated as well. circSLC45A4 is produced from the first annotated exon 
of SLC45A4, which includes the 5’UTR and part of the CDS. Hence, the circRNA is sharing 
the canonical start codon with the mRNA. Surprisingly, the open reading frame would extend 
beyond the head-to-tail junction for 98 nt before running into 4 consecutive STOP codons. 
Conservation analysis showed that if this part beyond the head-to-tail junction was translated, 
it would be less conserved than the CDS of the mRNA on amino acid level. Furthermore, the 
chicken and frog (Xenopus tropicalis) open-reading frames would run into a STOP codon right 
after the head-to-tail junction. This is especially intriguing as a potential circSLC45A4 peptide 
would appear together with the six-layered mammalian cortex in evolution. However, attempts 
to validate the existence of a circSLC45A4 encoded peptide were not successful. 
In summary, it was shown that circSLC45A4 depletion from either a human in vitro or a mouse 
in vivo differentiation system causes the depletion of the respective neural progenitor pools. 
This is the first developmental phenotype of a circular RNA identified. However, the mechanism 
remains elusive.  
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8.3 3D-seq: an innovative method to connect single-cell and spatial 
transcriptomics 
The developing mouse cortex processed in this study is one example for a tissue where the 
spatial organization of cells and the knowledge thereof is of great importance. However, this 
can be generalized to virtually all multicellular tissues, as almost all of them are spatially 
organized which in turn influences the functionality of the tissue itself. For example, the stem 
cells of the intestinal crypt are localized at its basal tip and as differentiation of them 
progresses, they move to the apical tip of (Clevers, 2009). Yet, the knowledge about this spatial 
organization of the intestinal crypt derives from decades of research. Furthermore, researchers 
could take advantage of the fact that the tissue organization is highly reproducible in-between 
specimens of intestinal crypts. This is usually not the case for diseased tissues, especially 
tumors, which display considerable intra- and inter-tumor heterogeneity (Burrell et al., 2013) 
that complicates the research for effective cancer therapies. Moreover, a tumor cannot be 
considered as isolated malignant tissue but is influenced by its microenvironment and vice 
versa. Efforts have been made to use high resolution imaging of pathological sections to learn 
more about a tumor’s microenvironment and combining this with independently obtained -
omics methods. Nevertheless, features unique to a certain tumor specimen would be lost 
(Heindl et al., 2015). 
Hence, there is a need for–omics methods that preserve spatial information, too. However, to 
date there is no method published that allows unbiased interrogation of any tissue with single-
cell resolution while retrieving spatial information. 3D-seq offers a solution to this problem. This 
method is combining compartmentalization of a tissue slice with a combinatorial indexing 
protocol and therefore would enable unbiased measurement of the transcriptomes of single 
cells while their approximate spatial localization is measured on the same slice. Currently, 3D-
seq allows the measurement of a few hundred genes per cell which is sufficient for cell type 
identification. Thus, for the first time 3D-seq allows the unbiased analysis of single-cell 
transcriptomes in their spatial context. 
Furthermore, the 3D-seq protocol could be used in any lab with standard molecular biology 
equipment and access to an RNA-sequencing instrument. The only non-standard item used in 
this protocol is a 3D-printed plastic grid. FISH-based methods for example require highly 
specialized microscopy equipment (cf. 3 - Introduction: - 15 -3.3 - Investigating single-cell gene 
expression with spatial resolution). Also, 3D-seq is not limited to combining the spatial 
information with transcriptomic data. Other labeling strategies could be used to index proteins 
(CITE-seq based approach, (Stoeckius et al., 2017), or iTRAQ (Ross et al., 2004)) or DNA 
(tagmentation) in each compartment and therefore create tissue maps holding proteomic or 
genomic information. 
It should be noted here, that the name “3D-seq” points to the intended future development of 
this method. Currently, the created tissue maps are two-dimensional. But the grid does not 
only provide a way to compartmentalize a single slice but could also be used as external 
coordinate system that is applied to several consecutive tissue slices. If these 
compartmentalized slices are then later on aligned in silico it would allow the three-dimensional 
reconstruction of a tissue with single-cell resolution. 
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Using the grid as external coordinate system for three-dimensional reconstruction is one 
advantage over simply cutting the tissue in small pieces. Instead of using one grid on 
consecutive tissue slices, one could also apply several grids with differing geometry to the 
same tissue slice consecutively in order to increase the resolution. 
The grid is a central part of the 3D-seq protocol. Its design and production were limited to the 
methods available (ultimaker 2+ at BIMSB, Berlin; Projet HD 3000 at Fraunhofer, Potsdam). 
However, using a microfluidic chip as grid would have had the advantage of providing smaller 
grid compartments and that the loading of these grid compartments with the reaction solution 
could have been automated. Microfluidic chips are often manufactured from 
polydimethylsiloxane (PDMS) as it is a cheap, chemical inert, non-toxic, elastic, robust and 
thermostable material that allows building structures in the micrometer range. In addition, the 
surface of PDMS can be chemically modified to change the hydrophobic material’s surface to 
become hydrophilic (Trantidou et al., 2017). 
The 3D-seq protocol itself has been extensively modified starting from the published 
combinatorial indexing protocols (Cao et al., 2017; Rosenberg et al., 2018). Optimizations 
included the reverse transcription reaction, the ligation reaction, the bead purification after 
lysis, and the recovery of cells after centrifugation. Taken together, the modifications to the 
protocol resulted in a 195 % increase in material recovery compared to the methods used in 
the published combinatorial indexing protocols (Cao et al., 2017; Rosenberg et al., 2018).  
However, the number of genes or UMIs/cell are still in the low hundreds. This number is of 
course strongly dependent on the number of reads spent per cell. In fact, the sequencing drives 
the costs of this protocol. While the library preparation for a single cell from a coronal adult 
mouse brain slices costs 2 cents/cell, sequencing the cells with 40.000 reads/cell on a Nextseq 
500 adds 25 cents per cell. Downsampling showed, that doubling the number of reads per cell 
would increase the number of UMIs/cell by 10-20 % (Nikolaos Karaiskos, personal 
communication). Hence, spending more reads to improve the number of identified UMIs/cell 
would drive up the costs considerably. And, deeper sequencing and obtaining more UMIs/cell 
does not scale linearly, unfortunately. So, while deeper sequencing might provide additional 
information initially, this would soon saturate and therefore deeper sequencing is a limited 
solution to this problem and therefore not a viable option.  
So, what is the reason for retrieving only a few hundred UMIs/cell with the current setup? 
Ideally, a UMI would be recovered for each transcript expressed within a cell. An estimated 
50.000 – 300.000 transcripts are expressed in single GM12878 cells (B-lymphocytes) (Marinov 
et al., 2014). Each step of the protocol was thoroughly evaluated and optimized where 
possible. The ligation reaction is able to ligate the necessary adapter to 75 % of molecules. 
Hence, tagmentation or reverse transcription could be responsible for retrieving only a low 
percentage of actually expressed transcripts per cell. Tagmentation will approximately mark 
50 % of the molecules in the reaction setup used for the 3D-seq protocol (Rykalina et al., 2017). 
Considering losing 25 % of transcripts due to ligation, 20 % with each bead purification (total 
of 5 in current protocol), and 50 % of transcripts due to tagmentation, this should still leave 
12.3 % of the initial number of transcripts if RT were to work with 100 % efficiency. Hence, one 
could expect to recover 6150 UMIS/cell, if there were 50.000 transcripts expressed in a single 
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cell. However, only a mean of 158 UMIs/cell was recovered which would mean, that RT 
efficiency is only 2.6 % (Figure 39). This estimation of RT efficiency does not consider 
sequencing depth, which was at ~3500 reads/cell, or PCR overamplification to produce a 
sufficient amount of material to load a Nextseq 500. But even if PCR overamplification was 10-
times, one would expect 350 UMIs/cell from 3500 reads/cell. Hence, RT efficiency could have 
been maximally 45.1 %. In conclusion, RT and tagmentation are the limiting steps for recovery 
of high numbers of UMIs/cell as they are the steps with the lowest efficiencies.  
 
 
Figure 39: Estimation of RT efficiency in the 3D-seq protocol. 
Material is lost at each enzymatic and purification step during the 3D-seq protocol to a different extent. Not 
considering the loss due to reverse transcription, a maximum of 12.3 % of the initial number of transcripts/cell would 
be left. With an initial 50.000 transcripts/cell one could expect up to 6150 UMIs/cell. However, only 158 UMIs/cell 
(mean) were recovered and would leave the RT efficiency at 2.6 %. 
 
 
However, as the enzymes mediating these reactions will become more efficient in the future, 
so will the 3D-seq protocol. Furthermore, another reason for low efficiency of the in situ RT 
could be the limited penetrance of the cells after fixation and permeabilization. However, this 
step was already optimized. 
But what can we already achieve with this kind of data? The aim of 3D-seq is the identification 
of spatial expression trends either on gene or on cell type level. 3D-seq is able to identify 
meaningful cell types even with a low number of UMIs/cell. Furthermore, spatial gene 
expression maps were created in silico based on the 3D-seq data. Zdhhc14, Myo16 and 
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Osbpl8 were found to be expressed in the expected compartments. However, one has to keep 
the low number of UMIs or genes/cell in mind as this will cause many cells to be false 
negatives. Hence, increasing the number of UMIs or genes/cell would yield more reliable and 
detailed gene expression maps. Additionally, it has to be stressed, that the shown maps are 
based on 6732 cells. However, in reality there will be approximately 50.000 - 75.000 cells 
within the grid. Estimating spatial trends from 10 % of the cells actually present in this tissue is 
limited in itself. 
Taken together, 3D-seq is still the only method that would allow unbiased analysis of single-
cell transcriptomes while preserving information on the original position of the cell within the 
tissue. The simplicity of 3D-seq is another advantage compared to other existing methods that 
try to address the same problem. 3D-seq only relies on the usage of an additional grid that can 
be tailored to the tissue’s needs, has a short turnaround time (2 days from tissue fixation to 
RNA-sequencing), does not require any prior knowledge about the tissue of interest, e.g. which 
genes to stain by smFISH methods, is easily adaptable and versatile, and will allow the three 
dimensional reconstruction of a tissue of interest in the future. 
 
8.4 Analyzing the neural transcriptional landscape in time and space 
RNA-seq is a powerful tool to discover gene expression patterns in whole tissues or in single 
cells. Here it was applied to describe the versatile expression patterns of circular RNAs in a 
number of neural tissues, leading to the discovery of thousands of circular RNAs in human and 
mouse. In addition, many hints were collected that point at the complex regulation of circRNA 
expression and function in neural systems. Hence, a specific circular RNA, circSLC45A4, was 
studied in detail. This circRNA was shown to be an important regulator that maintains neural 
cells in their progenitor state, in vitro in human neuroblastoma cells, but also in vivo in the 
developing mouse cortex. To date, this is the only circular RNA described whose depletion 
causes a phenotype in neural development. But undoubtedly there will be additional examples 
of circular RNA functions in the future. Neural development, e.g. in the developing mouse 
cortex, is spatiotemporally organized. A method to investigate transcriptomes with single-cell 
and spatial resolution, 3D-seq, was developed. It was established on adult mouse brain but 
will have applications far beyond this well studied tissue. The method is especially suited for 
rare, highly variable samples of medical relevance, e.g. tumor samples, as it allows the retrieval 
of a maximum of information without the need for prior knowledge. 
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10 Appendix 
10.1 Oligonucleotides 
Name Sequence 5’→ 3’ Purpose 
Stellaris circSLC_1 TCACAACGGTATGAGACATG 
Stellaris smFISH 
staining of 
circSLC45A4 
Stellaris circSLC_2 CAAGTGGCTATCTCACAACT 
Stellaris circSLC_3 AACACTTACATTCCTCTTTG 
Stellaris circSLC_4 CTGCTGTGTTCCTCGGGCAG 
Stellaris circSLC_5 AAGACGTCTTCTCTTTCTGC 
Stellaris circSLC_6 TCATATATCTGTAATGATAA 
Stellaris circSLC_7 TCTATCTATATAAATAATGC 
Stellaris circSLC_9 GGAGCCATTTTCATTACCAC 
Stellaris circSLC_10 AGATTCCGGGTCGGCATTCT 
Stellaris circSLC_11 CGGATAACTCTTGAACTTGC 
Stellaris circSLC_12 TTCTGCGGGTCCGGCAGGGG 
Stellaris circSLC_13 CTCGGCCTCTGCGCCTCCGG 
Stellaris circSLC_14 CCTCGCTGATGGTCTCGCAG 
Stellaris circSLC_15 ATGGGGATTCGGTCTATGGA 
Stellaris circSLC_16 CCCGTGCATCACCCACAGGC 
Stellaris circSLC_17 ACTCCCTGCCAAACATCACC 
Stellaris circSLC_18 GCGGTTTCCATGGCGTAACA 
Stellaris circSLC_19 CAACAGTATTGGTGTGACCA 
Stellaris circSLC_20 GAGTGACTGGATGATCAATC 
Stellaris circSLC_21 TGGTCCGCTGGTAATCCCCA 
Stellaris circSLC_22 GTGGGAAGGTGATACAAACA 
Stellaris circSLC_23 TGATTTTTCTTGCTACAGAG 
Stellaris circSLC_24 TATTACTGAAGAGGTGCTGA 
Stellaris circSLC_25 CAGTTAATACCAGTTTCATC 
Stellaris circSLC_26 TTAAAAATCCATAATTGCCA 
Stellaris circSLC_27 GCTGGTTTACTGTGAATTAG 
Stellaris circSLC_28 TTGGATTTTAAACATATGGC 
Stellaris circSLC_29 AGCAACACAGAACGATTTTT 
Stellaris mRNA SLC_1 GTGAAGATGAGGCCAAGGAT 
Stellaris smFISH 
staining of mRNA 
SLC45A4 
Stellaris mRNA SLC_2 ACTCGCAGACCCAATGAGAG 
Stellaris mRNA SLC_3 CAGAGGGCGAGGATGAAGGG 
Stellaris mRNA SLC_4 AACGCCAAAGAGGACGCCAA 
Stellaris mRNA SLC_5 GGCAGAGCCGTTAAGGAAAA 
Stellaris mRNA SLC_6 CGTGAGCACGATGCCAATGG 
Stellaris mRNA SLC_7 AGAAGAAGAGCACCTGGTTC 
Stellaris mRNA SLC_8 ACGGACACCGTGAAGATGAT 
Stellaris mRNA SLC_9 TCGTCGATGCTGAACAGGTG 
Stellaris mRNA SLC_10 ACTGTACCTCGTCTGGGAAG 
Stellaris mRNA SLC_11 CTTTTGCTGCGCATGATGTC 
Stellaris mRNA SLC_12 AAGATGGAGGGCTCGATGTC 
Stellaris mRNA SLC_14 TTCTGCATGTCGTACAGGTC 
Stellaris mRNA SLC_15 ACAGAGAACCAGGTGAGGAG 
Stellaris mRNA SLC_16 GAAGTCGGTGTAGAACACGG 
Stellaris mRNA SLC_17 TCGCCTTCGAAGATGACCTG 
Stellaris mRNA SLC_18 TGGCGGCATAAATGACCAGG 
Stellaris mRNA SLC_19 AGGGCTGAACAAATAGCACC 
Stellaris mRNA SLC_20 CGTAGTTGTCCAAGTACTTC 
Stellaris mRNA SLC_21 TAGATCACCCTGACGCTCAG 
Stellaris mRNA SLC_22 CGACGTAGACGTTGGGAAAC 
Stellaris mRNA SLC_23 ATGGTGCTGATGGTGACCAT 
Stellaris mRNA SLC_24 GAGATGCTCATGGAGACGAT 
Stellaris mRNA SLC_25 ACTGCTTGATGTCATGGTAC 
Stellaris mRNA SLC_26 CAAACCCTCGCTTGGAGTTC 
Stellaris mRNA SLC_27 AGGATCTGCGAGATGTACAC 
Stellaris mRNA SLC_28 TTGGGATAGATCACCAGGAA 
Stellaris mRNA SLC_29 AACGGGGAAGACAGGCCTTT 
siRNA circSLC45A4 1 GTTGCAGATTGATCATCCA-dTdT 
siRNAs against 
human circSLC45A4 
siRNA circSLC45A4 2 AATACTGTTGCAGATTGATCAT-dTdT 
siRNA circSLC45A4 3 GATTGATCATCCAGTCACTC-dTdT 
shRNA circSlc45a4 1 GATCGTTACAGATAGATCGTCTATTCAAGAGA 
TAGACGATCTATCTGTAACTTTTTGAAA 
shRNAs against 
mouse circSlc45a4 
shRNA circSlc45a4 2 GATCGTATACTGTTACAGATAGATCGTTTCAAGAGAACG 
ATCTATCTGTAACAGTATACTTTTTGAAA 
shRNA circSlc45a4 3 GATCGATAGATCGTCTAGCCGCTCTTCAAGAG 
AGAGCGGCTAGACGATCTATCTTTTTGAAA 
shRNA mRNA Slc45a4 1 GATCGGGACGACACCTTGCTTGATAACTCGAGTTATC 
AAGCAAGGTGTCGTCCTTTTTGAAA 
shRNAs against 
mouse mRNA 
Slc45a4 
shRNA mRNA Slc45a4 2 GATCGGCTGGTACATTCCACACTGGACTCGAGTCCA 
GTGTGGAATGTACCAGCTTTTTGAAA  
Scrambled siRNA CAGATTCGCGAATGTACGTTT-dTdT  
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Northern probe against 
ZNF609 
CCCTCCGGAGGCTCCACTGCTCAAGGACATCTTAGAGTC
AACGTCCCACCTCAAGATTCAAGGCTCTTCCTTGCCCCCA
GCTTTCCTATTTTCAGCTTCAGCTATGTTCTCAGACCTGCC
ACATTGGTCAGTACATGCCCAGTGGACAACATCATTGCTC
TTTTCAGACTTGACTTTCTTTAGCAGGCGACACTCATTCTC
CCCTTCCTCTGGCTCCGGTTTAGTTCCCAAAGGATTGAGC
GCTGCCCCAGGCTCAATAGCTATACTCCCAAGTGGCTCC
ACAGCTCCTGTATCCACCCCTGCACTTCCATCATACTGAC
CACCCCGTCCTCCCAAGGGAAC 
 
Northern probe against 
XPO1 
GGAAAATGTGATAAAAACAAGGTGGAAGATTCTTCCAAGG
AACCAGTGCGAAGGCAAAGAATGGCTCAAGAAGTACTGA
CACATTTAAAGGAGCATCCTGATGCTTGGACAAGAGT 
 
human circSLC45A4 FWD: GAGGGGTCCATAGACCGAAT 
REV: GGTAATCCCCATCGAGTGAC 
qPCR primer 
human mRNA SLC45A4 FWD: CTTTTCCTTAACGGCTCTGC 
REV: AGAGAAGGCGTGGATGTTGA 
human pre-mRNA 
SLC45A4 
FWD: GAGGGGTCCATAGACCGAAT 
REV: TGCCTCCAGAGGATCAGAG 
human NOTCH1 FWD: TGAATGGCGGGAAGTGTGAA 
REV: CACAGCTGCAGGCATAGTCT 
human PAX6 FWD: ACAGAGGTCAGGCTTCGCTA 
REV: GGGTTGGTGTGTGAGAGCAA 
human ASCL1 FWD: AGGAGCTTCTCGACTTCACCA 
REV: ACTAAAGATGCAGGTTGTGCG 
human TUBB3 FWD: GGCCTCTTCTCACAAGTACG 
REV: CCACTCTGACCAAAGATGAAA 
human GABBR1 
FWD: GCCAATACCCGCAGCATTTC 
REV: TAGTTGAAGTCCTCCAGGCG 
human VGLUT1 
FWD: ATCCTGCAGGGGTTGGTAGA 
REV: GGAACCACAAAAGGCTGTCG 
human ACTB 
FWD: CCAACCGCGAGAAGATGA 
REV: CCAGAGGCGTACAGGGATAG 
human GAPDH 
FWD: AAGGTGAAGGTCGGAGTCAAC 
REV: GGGGTCATTGATGGCAACAATA 
human MT-CO2 
FWD: ACGCATCCTTTACATAACAGAC 
REV: GCCAATTGATTTGATGGTAAGG 
human XIST 
FWD: GACACAAGGCCAACGACCTA 
REV: TCGCTTGGGTCCTCTATCCA 
human NEAT1 
FWD: AGTTAAGGCGCCATCCTCAC 
REV: AGCACTGCCACCTGGAAAAT 
human CCND1 
FWD: GATGCCAACCTCCTCAACGA 
REV: GGAAGCGGTCCAGGTAGTTC 
human PRKCA 
FWD: ACCATGGCTGACGTTTTCCC 
REV: CAAACTTGGCACTGGAAGCC 
human PLXNB2 
FWD: GGCGGACGTGCAGAGAATC 
REV: AGGTGGTTCAGCTCTTTCTCG 
human PLXNA2 
FWD: GACAGGCACAGCATCCATGA 
REV: GTCAAACACGAACTGGGGGT 
human PLXNA3 
FWD: AACTGCTCTACGCCAAGGAC 
REV: CAAGAGGCATCTCGGTCCAG 
human TIMM17B 
FWD: TTGTGGATGATTGCGGTGGA 
REV: CAAGGGAGCTTCAGACAGCA 
human TMEM26 
FWD: TGACCTGGCAGTACAGAACG 
REV: ACGCTGATTCCGATGTTCCA 
human NTRK2 
FWD: TTACGGTTTGTCACCCGACC 
REV: GTGCTTGGTTCAGCTCTTGC 
human ELMOD2 
FWD: AGAGCTACTCATGAAGCTTTGGA 
REV: ATGCCCATGCCTCTGAAGTC 
mouse circSlc45a4 
FWD: AGACCCAAGAGGAGACCACA 
REV: TCGAGCGGCTAGACGATCTATC 
mouse mRNA Slc45a4 
FWD: TGGGTGTTGTCTCGATGAGC 
REV: ACAGAGGCCACTATGGGGAT 
mouse Unc5b 
FWD: TGGAGGACACACCTGTAGCA 
REV: TCATGGAGGGAGAGGCGTAG 
mouse Foxp2 
FWD: GTTCATCCGTCAGTGCCCG 
REV: GTGAGGATCGAGCTTCAACAGA 
mouse Notch2 
FWD: CAGCACTGTGACAGCCCTTA 
REV: TATTCCGCTCACAGGTGCTC 
mouse Parm1 
FWD: GCCCAAGGAGAAATCACCCC 
REV: CAGCAACACTACGGCGATGA 
mouse Itga9 
FWD: CTGGAGCACTTCCACGACAA 
REV: ATCTCCGGTCAGGGTTGGTA 
mouse Cux2 
FWD: TCCAGGGTCTTCCGGACATC 
REV: CCGAGGCGACAGAACTAAGC 
mouse Scrt1 
FWD: ATTCTCTTCGGCAGACCTCG 
REV: TACATAGGCTCCGGGGATGG 
mouse Nkiras2 
FWD: CACCTCAGCGGGAGTGC 
REV: ATGTCCTCCTGGGTCTCGAT 
mouse Trank1 FWD: AGCCTTATGAAGCTGCTCGG 
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REV: TGACAACAGTAGAAATGAATGCCA 
mouse Nr0b1 
FWD: GGTCCAGGCCATCAAGAGTTT 
REV: CCGGATGTGCTCAGTAAGGAT 
mouse Eef1a 
FWD: ACAAGCGAACCATCGAAAAG 
REV: GTCTCGAATTTCCACAGGGA 
   
   
   
   
 
Name Sequence 5’→ 3’ Purpo
se 
3D-seq_RT_1 [PHO]AGGCCAGAGCATTCGCCTGCGCCTAATNNNNNNNNTTTTTTTTTTTTTTTVN 
3D-
seq 
RT 
primer 
with 
barcod
e, UMI 
and 
ligatio
n 
linker 
3D-seq_RT_2 [PHO]AGGCCAGAGCATTCGAGTATCCAGGACNNNNNNNNTTTTTTTTTTTTTTTVN 
3D-seq_RT_3 [PHO]AGGCCAGAGCATTCGGTCCTACTTGAGNNNNNNNNTTTTTTTTTTTTTTTVN 
3D-seq_RT_4 [PHO]AGGCCAGAGCATTCGATCTCTCGGTAGNNNNNNNNTTTTTTTTTTTTTTTVN 
3D-seq_RT_5 [PHO]AGGCCAGAGCATTCGGGCGGATTCTTCNNNNNNNNTTTTTTTTTTTTTTTVN 
3D-seq_RT_6 [PHO]AGGCCAGAGCATTCGGATGAGTAACTGNNNNNNNNTTTTTTTTTTTTTTTVN 
3D-seq_RT_7 [PHO]AGGCCAGAGCATTCGAATGTTACGTTGNNNNNNNNTTTTTTTTTTTTTTTVN 
3D-seq_RT_8 [PHO]AGGCCAGAGCATTCGACCTGCGTATTGNNNNNNNNTTTTTTTTTTTTTTTVN 
3D-seq_RT_9 [PHO]AGGCCAGAGCATTCGCGTGTGAATGGCNNNNNNNNTTTTTTTTTTTTTTTVN 
3D-seq_RT_10 [PHO]AGGCCAGAGCATTCGAACCACCTCCTTNNNNNNNNTTTTTTTTTTTTTTTVN 
3D-seq_RT_11 [PHO]AGGCCAGAGCATTCGCAGTCCACAGCCNNNNNNNNTTTTTTTTTTTTTTTVN 
3D-seq_RT_12 [PHO]AGGCCAGAGCATTCGTGTCGAGCTGGCNNNNNNNNTTTTTTTTTTTTTTTVN 
3D-seq_RT_13 [PHO]AGGCCAGAGCATTCGTGACTGGTATGANNNNNNNNTTTTTTTTTTTTTTTVN 
3D-seq_RT_14 [PHO]AGGCCAGAGCATTCGCGGCAAGATTCANNNNNNNNTTTTTTTTTTTTTTTVN 
3D-seq_RT_15 [PHO]AGGCCAGAGCATTCGATAGAACGATGTNNNNNNNNTTTTTTTTTTTTTTTVN 
3D-seq_RT_16 [PHO]AGGCCAGAGCATTCGCTGAGTCGCGGCNNNNNNNNTTTTTTTTTTTTTTTVN 
3D-seq_RT_17 [PHO]AGGCCAGAGCATTCGTGAGAGTTCGCTNNNNNNNNTTTTTTTTTTTTTTTVN 
3D-seq_RT_18 [PHO]AGGCCAGAGCATTCGGTGCGGAGGCATNNNNNNNNTTTTTTTTTTTTTTTVN 
3D-seq_RT_19 [PHO]AGGCCAGAGCATTCGTCTACGTGAACANNNNNNNNTTTTTTTTTTTTTTTVN 
3D-seq_RT_20 [PHO]AGGCCAGAGCATTCGCTTAGGAACGCANNNNNNNNTTTTTTTTTTTTTTTVN 
3D-seq_RT_21 [PHO]AGGCCAGAGCATTCGACGACGTCTCATNNNNNNNNTTTTTTTTTTTTTTTVN 
3D-seq_RT_22 [PHO]AGGCCAGAGCATTCGGTTATTAGCGTTNNNNNNNNTTTTTTTTTTTTTTTVN 
3D-seq_RT_23 [PHO]AGGCCAGAGCATTCGCCTTGTACTTAGNNNNNNNNTTTTTTTTTTTTTTTVN 
3D-seq_RT_24 [PHO]AGGCCAGAGCATTCGCCGTAAGATGATNNNNNNNNTTTTTTTTTTTTTTTVN 
3D-seq_RT_25 [PHO]AGGCCAGAGCATTCGTCTGGCCGCCACNNNNNNNNTTTTTTTTTTTTTTTVN 
3D-seq_RT_26 [PHO]AGGCCAGAGCATTCGATACCGGAGACTNNNNNNNNTTTTTTTTTTTTTTTVN 
3D-seq_RT_27 [PHO]AGGCCAGAGCATTCGATTATTCTAGCCNNNNNNNNTTTTTTTTTTTTTTTVN 
3D-seq_RT_28 [PHO]AGGCCAGAGCATTCGGAACACAATCATNNNNNNNNTTTTTTTTTTTTTTTVN 
3D-seq_RT_29 [PHO]AGGCCAGAGCATTCGGCGGTCTCCACTNNNNNNNNTTTTTTTTTTTTTTTVN 
3D-seq_RT_30 [PHO]AGGCCAGAGCATTCGAAGGTCGTGAGANNNNNNNNTTTTTTTTTTTTTTTVN 
3D-seq_bc2_1 CAGACGTGTGCTCTTCCGATCTATGCTACCAGACCCCCATGATCGTCCGA 
3D-
seq 
ligatio
n 
oligon
ucleoti
de, 
contai
ning 
barcod
e 2, 
the 
ligatio
n 
linker 
and 
the 
PCR 
handle 
3D-seq_bc2_2 CAGACGTGTGCTCTTCCGATCTAATCTAAGGATTCCCCATGATCGTCCGA 
3D-seq_bc2_3 CAGACGTGTGCTCTTCCGATCTAACAGTAAGCCTCCCCATGATCGTCCGA 
3D-seq_bc2_4 CAGACGTGTGCTCTTCCGATCTAGTTGCAGATGAGCCCATGATCGTCCGA 
3D-seq_bc2_5 CAGACGTGTGCTCTTCCGATCTACGAACGTCAGACCCCATGATCGTCCGA 
3D-seq_bc2_6 CAGACGTGTGCTCTTCCGATCTATCGTCCTATGGCCCCATGATCGTCCGA 
3D-seq_bc2_7 CAGACGTGTGCTCTTCCGATCTACTCAACATAATGCCCATGATCGTCCGA 
3D-seq_bc2_8 CAGACGTGTGCTCTTCCGATCTATGCGAATACCGACCCATGATCGTCCGA 
3D-seq_bc2_9 CAGACGTGTGCTCTTCCGATCTAAAGTCGGAGTCCCCCATGATCGTCCGA 
3D-seq_bc2_10 CAGACGTGTGCTCTTCCGATCTAGACATTCCGATTCCCATGATCGTCCGA 
3D-seq_bc2_11 CAGACGTGTGCTCTTCCGATCTACTTACTGAACGGCCCATGATCGTCCGA 
3D-seq_bc2_12 CAGACGTGTGCTCTTCCGATCTACCAGGCTGTTGGCCCATGATCGTCCGA 
3D-seq_bc2_13 CAGACGTGTGCTCTTCCGATCTACACTCCACCGCTCCCATGATCGTCCGA 
3D-seq_bc2_14 CAGACGTGTGCTCTTCCGATCTAACCGACGCCGTACCCATGATCGTCCGA 
3D-seq_bc2_15 CAGACGTGTGCTCTTCCGATCTATATCGGTATTAGCCCATGATCGTCCGA 
3D-seq_bc2_16 CAGACGTGTGCTCTTCCGATCTAGTCCTACTGGATCCCATGATCGTCCGA 
3D-seq_bc2_17 CAGACGTGTGCTCTTCCGATCTATCTATGTCACTTCCCATGATCGTCCGA 
3D-seq_bc2_18 CAGACGTGTGCTCTTCCGATCTATCCAGACTTCGTCCCATGATCGTCCGA 
3D-seq_bc2_19 CAGACGTGTGCTCTTCCGATCTATAGGTCACTCGGCCCATGATCGTCCGA 
3D-seq_bc2_20 CAGACGTGTGCTCTTCCGATCTATTGTAGGCAGCTCCCATGATCGTCCGA 
3D-seq_bc2_21 CAGACGTGTGCTCTTCCGATCTATGGATAGCCATCCCCATGATCGTCCGA 
3D-seq_bc2_22 CAGACGTGTGCTCTTCCGATCTAAGACCTTGCAGCCCCATGATCGTCCGA 
3D-seq_bc2_23 CAGACGTGTGCTCTTCCGATCTACAACAACGCTTACCCATGATCGTCCGA 
3D-seq_bc2_24 CAGACGTGTGCTCTTCCGATCTAGCTAGGATCTTACCCATGATCGTCCGA 
3D-seq_bc2_25 CAGACGTGTGCTCTTCCGATCTAAGTGGTGAGGCACCCATGATCGTCCGA 
3D-seq_bc2_26 CAGACGTGTGCTCTTCCGATCTAGAGCCGGTTATTCCCATGATCGTCCGA 
3D-seq_bc2_27 CAGACGTGTGCTCTTCCGATCTACACCTGCTATCTCCCATGATCGTCCGA 
3D-seq_bc2_28 CAGACGTGTGCTCTTCCGATCTAAGATGGCTAGTGCCCATGATCGTCCGA 
3D-seq_bc2_29 CAGACGTGTGCTCTTCCGATCTATCAATGCAGACGCCCATGATCGTCCGA 
3D-seq_bc2_30 CAGACGTGTGCTCTTCCGATCTACCGCAGACATGCCCCATGATCGTCCGA 
3D-seq_bc2_31 CAGACGTGTGCTCTTCCGATCTAGACGGACCCATGATCGTCCGA 
3D-seq_bc2_32 CAGACGTGTGCTCTTCCGATCTAGCGTCTACCCATGATCGTCCGA 
3D-seq_bc2_33 CAGACGTGTGCTCTTCCGATCTAGCCAGCCACCCATGATCGTCCGA 
3D-seq_bc2_34 CAGACGTGTGCTCTTCCGATCTACTGTAGAATCCCATGATCGTCCGA 
3D-seq_bc2_35 CAGACGTGTGCTCTTCCGATCTAACTACCATGCCCCATGATCGTCCGA 
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3D-seq_bc2_36 CAGACGTGTGCTCTTCCGATCTAATCCAGGACAGTCCCATGATCGTCCGA 
3D-seq_bc2_37 CAGACGTGTGCTCTTCCGATCTACCAAGATCGCAATCCCATGATCGTCCGA 
3D-seq_bc2_38 CAGACGTGTGCTCTTCCGATCTATCATGAAGGTCACCCATGATCGTCCGA 
3D-seq_bc2_39 CAGACGTGTGCTCTTCCGATCTACGATCAGACGGCTCACCCATGATCGTCCGA 
3D-seq_bc2_40 CAGACGTGTGCTCTTCCGATCTACATAGGCTGAGCCCCATGATCGTCCGA 
3D-seq_bc2_41 CAGACGTGTGCTCTTCCGATCTACTGGTTAACTAGCCCATGATCGTCCGA 
3D-seq_bc2_42 CAGACGTGTGCTCTTCCGATCTATTGGAATCTTACCCCATGATCGTCCGA 
3D-seq_bc2_43 CAGACGTGTGCTCTTCCGATCTAGGCACTAGTTCTCCCATGATCGTCCGA 
3D-seq_bc2_44 CAGACGTGTGCTCTTCCGATCTAGAGTGACTAGACCCATGATCGTCCGA 
3D-seq_bc2_45 CAGACGTGTGCTCTTCCGATCTAACGAAGGAACTCCCATGATCGTCCGA 
3D-seq_bc2_46 CAGACGTGTGCTCTTCCGATCTATATGTTCGTGCGACCCATGATCGTCCGA 
3D-seq_bc2_47 CAGACGTGTGCTCTTCCGATCTACCAATTACCTGCACCCATGATCGTCCGA 
3D-seq_bc2_48 CAGACGTGTGCTCTTCCGATCTACAACATCAAGGCGCCCATGATCGTCCGA 
3D-seq_bc2_49 CAGACGTGTGCTCTTCCGATCTAGATACATCCGGCATCCCATGATCGTCCGA 
3D-seq_bc2_50 CAGACGTGTGCTCTTCCGATCTATCCGCCACGACTATGCCCATGATCGTCCGA 
3D-seq_bc2_51 CAGACGTGTGCTCTTCCGATCTAACCAGTTGTCCTCGACCCATGATCGTCCGA 
3D-seq_bc2_52 CAGACGTGTGCTCTTCCGATCTAGTCTTGTCGTGCCGACCCATGATCGTCCGA 
3D-seq_bc2_53 CAGACGTGTGCTCTTCCGATCTATAACAGCGAATGGACACCCATGATCGTCCGA 
3D-seq_bc2_54 CAGACGTGTGCTCTTCCGATCTACTAGGCTGCCTCAATGCCCATGATCGTCCGA 
3D-seq_bc2_55 CAGACGTGTGCTCTTCCGATCTAACTCGACATCCCCATGATCGTCCGA 
3D-seq_bc2_56 CAGACGTGTGCTCTTCCGATCTAGCCGAGTAAGCCCATGATCGTCCGA 
3D-seq_bc2_57 CAGACGTGTGCTCTTCCGATCTACCAGTTGGTACCCATGATCGTCCGA 
3D-seq_bc2_58 CAGACGTGTGCTCTTCCGATCTATCTGGACCGCCCATGATCGTCCGA 
3D-seq_bc2_59 CAGACGTGTGCTCTTCCGATCTACAAGCGACCCCCATGATCGTCCGA 
3D-seq_bc2_60 CAGACGTGTGCTCTTCCGATCTACTCCGAGGACCCATGATCGTCCGA 
3D-seq_bc2_61 CAGACGTGTGCTCTTCCGATCTATTGCAGTCCCCATGATCGTCCGA 
3D-seq_bc2_62 CAGACGTGTGCTCTTCCGATCTACACTTGAGCCCATGATCGTCCGA 
3D-seq_bc2_63 CAGACGTGTGCTCTTCCGATCTACGGAATCTCCCATGATCGTCCGA 
3D-seq_bc2_64 CAGACGTGTGCTCTTCCGATCTAACAGAAGCCCATGATCGTCCGA 
3D-seq_bc2_65 CAGACGTGTGCTCTTCCGATCTATTAACGCCCCATGATCGTCCGA 
3D-seq_bc2_66 CAGACGTGTGCTCTTCCGATCTAAGCTTGCCCCATGATCGTCCGA 
3D-seq_bc2_67 CAGACGTGTGCTCTTCCGATCTAGGTCAGTCCCATGATCGTCCGA 
3D-seq_bc2_68 CAGACGTGTGCTCTTCCGATCTATAGTCCCCCATGATCGTCCGA 
3D-seq_bc2_69 CAGACGTGTGCTCTTCCGATCTAAGAACACCCATGATCGTCCGA 
3D-seq_bc2_70 CAGACGTGTGCTCTTCCGATCTAGATTGTCATCTACCCATGATCGTCCGA 
3D-seq_bc2_71 CAGACGTGTGCTCTTCCGATCTAATGCCTCCAATACCCATGATCGTCCGA 
3D-seq_bc2_72 CAGACGTGTGCTCTTCCGATCTAACCGTACATTCACCCATGATCGTCCGA 
3D-seq_bc2_73 CAGACGTGTGCTCTTCCGATCTACCGGTGACGACTGACCCATGATCGTCCGA 
3D-seq_bc2_74 CAGACGTGTGCTCTTCCGATCTATGAGTTCTTACGTGCCCATGATCGTCCGA 
3D-seq_bc2_75 CAGACGTGTGCTCTTCCGATCTACTATCTACGCCACGGACCCATGATCGTCCGA 
3D-seq_bc2_76 CAGACGTGTGCTCTTCCGATCTACTTCCGACTCCACCCATGATCGTCCGA 
3D-seq_bc2_77 CAGACGTGTGCTCTTCCGATCTAGTGAGCGTGCAGCCCATGATCGTCCGA 
3D-seq_bc2_78 CAGACGTGTGCTCTTCCGATCTATGTTCGAACTGTCCCATGATCGTCCGA 
3D-seq_bc2_79 CAGACGTGTGCTCTTCCGATCTAGGATTCTTCTAACCCATGATCGTCCGA 
3D-seq_bc2_80 CAGACGTGTGCTCTTCCGATCTAACTGCACTCAATCCCATGATCGTCCGA 
3D-seq_bc2_81 CAGACGTGTGCTCTTCCGATCTACACGATACGCAACCCATGATCGTCCGA 
3D-seq_bc2_82 CAGACGTGTGCTCTTCCGATCTAAATTCCGGAAGACCCATGATCGTCCGA 
3D-seq_bc2_83 CAGACGTGTGCTCTTCCGATCTATCACCGGTCCAACCCATGATCGTCCGA 
3D-seq_bc2_84 CAGACGTGTGCTCTTCCGATCTAAAGACATTGGTGCCCATGATCGTCCGA 
3D-seq_bc2_85 CAGACGTGTGCTCTTCCGATCTATCTGCATTAGCCCCATGATCGTCCGA 
3D-seq_bc2_86 CAGACGTGTGCTCTTCCGATCTAGACCAGTATTCCCCATGATCGTCCGA 
3D-seq_bc2_87 CAGACGTGTGCTCTTCCGATCTACGTCGCAATGACCCATGATCGTCCGA 
3D-seq_bc2_88 CAGACGTGTGCTCTTCCGATCTAGTGGACGTACCCCCATGATCGTCCGA 
3D-seq_bc2_89 CAGACGTGTGCTCTTCCGATCTAGCCATTGCTGGTCGCCCATGATCGTCCGA 
3D-seq_bc2_90 CAGACGTGTGCTCTTCCGATCTACAAGGCCTACCATCCCCATGATCGTCCGA 
3D-seq_bc2_91 CAGACGTGTGCTCTTCCGATCTATGTAGCATGCGTTACCCATGATCGTCCGA 
3D-seq_bc2_92 CAGACGTGTGCTCTTCCGATCTAATCGCAAGCGGCTGCCCATGATCGTCCGA 
3D-seq_bc2_93 CAGACGTGTGCTCTTCCGATCTATTGCTCCACCACGACCCATGATCGTCCGA 
3D-seq_bc2_94 CAGACGTGTGCTCTTCCGATCTATTATGTTCGGCCATAACCCATGATCGTCCGA 
3D-seq_bc2_95 CAGACGTGTGCTCTTCCGATCTAAATCCTACAGGCATGACCCATGATCGTCCGA 
3D-seq_bc2_96 CAGACGTGTGCTCTTCCGATCTACGCCTCGACTCCCATGATCGTCCGA 
P7_N701 CAAGCAGAAGACGGCATACGAGATTCGCCTTAGTGACTGGAGTTCAGACGTGTGCT
CTTCCGATCT 
3D-
seq 
PCR 
primer
, 
based 
on 
Illumin
a’s P7 
primer
, 
includi
ng P7 
site 
and i7 
multipl
ex 
P7_N702 CAAGCAGAAGACGGCATACGAGATCTAGTACGGTGACTGGAGTTCAGACGTGTGCT
CTTCCGATCT 
P7_N703 CAAGCAGAAGACGGCATACGAGATTTCTGCCTGTGACTGGAGTTCAGACGTGTGCT
CTTCCGATCT 
P7_N704 CAAGCAGAAGACGGCATACGAGATGCTCAGGAGTGACTGGAGTTCAGACGTGTGC
TCTTCCGATCT 
P7_N705 CAAGCAGAAGACGGCATACGAGATAGGAGTCCGTGACTGGAGTTCAGACGTGTGC
TCTTCCGATCT 
P7_N706 CAAGCAGAAGACGGCATACGAGATCATGCCTAGTGACTGGAGTTCAGACGTGTGCT
CTTCCGATCT 
P7_N707 CAAGCAGAAGACGGCATACGAGATGTAGAGAGGTGACTGGAGTTCAGACGTGTGC
TCTTCCGATCT 
P7_N710 CAAGCAGAAGACGGCATACGAGATCAGCCTCGGTGACTGGAGTTCAGACGTGTGC
TCTTCCGATCT 
P7_N711 CAAGCAGAAGACGGCATACGAGATTGCCTCTTGTGACTGGAGTTCAGACGTGTGCT
CTTCCGATCT 
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P7_N712 CAAGCAGAAGACGGCATACGAGATTCCTCTACGTGACTGGAGTTCAGACGTGTGCT
CTTCCGATCT 
barcod
es 
P7_N714 CAAGCAGAAGACGGCATACGAGATTCATGAGCGTGACTGGAGTTCAGACGTGTGCT
CTTCCGATCT 
P7_N715 CAAGCAGAAGACGGCATACGAGATCCTGAGATGTGACTGGAGTTCAGACGTGTGCT
CTTCCGATCT 
 
10.2 Definition of used sequences and identifiers 
Name Chromosome coordinates (if applicable) Database and identifier 
circSLC45A4 (human) chr8:142,264,087-142,264,728 (hg19) circbase hsa_circ_0001829 
circSlc45a4 (mouse) chr15: 73,435,871 – 73,436,506 (mm9) circbase mmu_circ_0005786 
mRNA SLC45A4 (human) chr8: 142,217,265 – 142,264,728 (hg19) RefSeq NM_001286646 
mRNA Slc45a4 (mouse) chr15: 73,407,854 – 73,455,174 (mm9)  RefSeq NM_001033219 
   
 
10.3 Used marker genes for Bseq-SC analysis 
p_val avg_logFC pct.1 pct.2 p_val_adj cluster gene marker for PMID/title/DOI 
1.8E-199 1.48 0.598 0.125 3E-195 0 Nrp1 
migrating 
excitatory 
neurons 
28507510 
1.5E-121 1.02 0.468 0.114 2.5E-117 0 Rnd2 
Regulation of cerebral cortex 
development by Rho 
GTPases: insights from in 
vivo studies 
2.13E-78 0.77 0.265 0.051 3.5E-74 0 Unc5d 
The cortical subventricular 
zone-specific molecule Svet1 
is part of the nuclear RNA 
coded by the putative netrin 
receptor gene Unc5d and is 
expressed in multipolar 
migrating cells 
1.2E-223 1.30 0.815 0.237 1.9E-219 1 Fezf2 
subcortical 
projection 
neurons 
The Fezf2–Ctip2 genetic 
pathway regulates the fate 
choice of subcortical 
projection neurons in the 
developing cerebral cortex 
1.2E-187 1.05 0.852 0.296 2E-183 1 Dab1 
Abcam neuron markers 
guide 
1.2E-126 0.84 0.526 0.13 1.9E-122 1 Ldb2 
Generating Neuronal 
Diversity in the Mammalian 
Cerebral Cortex 
1.7E-115 0.85 0.463 0.11 2.8E-111 1 Ndrg1  
2.7E-105 0.78 0.472 0.123 4.4E-101 1 Rspo3 mousebrain.org 
1.83E-86 0.66 0.476 0.145 3.01E-82 1 
Hspa12
a 
 
2.92E-82 0.72 0.439 0.131 4.81E-78 1 Sla mousebrain.org 
9.05E-82 0.70 0.57 0.212 1.49E-77 1 Nin 
 
1.99E-68 0.70 0.303 0.076 3.28E-64 1 Oma1 
 
1E-251 1.09 0.45 0.031 1.7E-247 2 Hs3st4 
Excitatory 
neurons 
mousebrain.org 
8.7E-243 1.28 0.65 0.1 1.4E-238 2 Sybu  
8.6E-230 1.34 0.681 0.119 1.4E-225 2 Tle4 
Corticothalamic projection 
neuron development beyond 
subtype 
specification: Fog2 and 
intersectional controls 
regulate intra-class neuronal 
diversity 
2E-163 0.99 0.573 0.113 3.2E-159 2 Sh3gl2  
1.3E-130 1.04 0.467 0.09 2.1E-126 2 Kitl 
Tbr1 regulates regional and 
laminar identity of 
postmitotic neurons in 
developing neocortex 
6.2E-127 0.97 0.427 0.077 1E-122 2 
Ppp1r1
b 
mousebrain.org 
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1.23E-91 0.94 0.412 0.097 2.02E-87 2 Sparcl1  
1.26E-75 0.96 0.379 0.1 2.08E-71 2 Lpl mousebrain.org 
0 1.66 0.477 0.01 0 3 Nxph1 
Cortical 
interneuro
ns 
Single-cell RNA sequencing 
identifies distinct mouse 
medial ganglionic eminence 
cell types 
0 1.53 0.451 0.01 0 3 Lhx6 mousebrain.org 
8.7E-268 1.37 0.364 0.01 1.4E-263 3 Erbb4 
Single-cell RNA sequencing 
identifies distinct mouse 
medial ganglionic eminence 
cell types 
4.2E-244 2.39 0.345 0.011 6.9E-240 3 Sst 
Single-cell RNA sequencing 
identifies distinct mouse 
medial ganglionic eminence 
cell types 
2.8E-236 1.72 0.527 0.057 4.7E-232 3 Mafb 
Single-cell RNA sequencing 
identifies distinct mouse 
medial ganglionic eminence 
cell types 
7.1E-170 1.07 0.278 0.013 1.2E-165 3 Rpp25  
2.7E-148 2.08 0.323 0.03 4.5E-144 3 Npy 
Single-cell RNA sequencing 
identifies distinct mouse 
medial ganglionic eminence 
cell types 
8E-147 1.26 0.41 0.057 1.3E-142 3 Rph3a  
9.9E-145 1.08 0.254 0.015 1.6E-140 3 Neto1  
2.8E-136 1.27 0.384 0.053 4.5E-132 3 
Cbfa2t
3 
 
1.6E-127 1.10 0.312 0.034 2.7E-123 3 Gria4 
 
6.4E-108 1.11 0.321 0.046 1.1E-103 3 Slc6a1 
 
6.9E-108 1.18 0.38 0.068 1.1E-103 3 Cux2 
 
7.38E-96 1.05 0.371 0.074 1.21E-91 3 Dlgap1 
 
0 2.39 0.846 0.061 0 4 Eomes 
Basal 
progenitor 
/ cortical 
intermediat
e 
progenitor 
Pax6, Tbr2, and Tbr1 are 
expressed sequentially by 
radial glia, intermediate 
progenitor cells, and 
postmitotic neurons in 
developing neocortex 
5.2E-273 1.56 0.601 0.062 8.5E-269 4 Mfap4 
Developmental Emergence 
of Adult Neural Stem Cells as 
Revealed by Single-Cell 
Transcriptional Profiling 
6.5E-228 1.84 0.603 0.085 1.1E-223 4 
Neurog
2 
Neurog2 Simultaneously 
Activates and Represses 
Alternative Gene Expression 
Programs in the Developing 
Neocortex 
1.8E-179 1.28 0.555 0.087 2.9E-175 4 Sstr2 
Developmental Emergence 
of Adult Neural Stem Cells as 
Revealed by Single-Cell 
Transcriptional Profiling 
5E-125 0.94 0.265 0.022 8.3E-121 4 Btbd17 
 
0 2.26 0.732 0.073 0 5 Top2a 
Neural 
Stem/Proge
nitor cells 
Distinct expression patterns 
for type II topoisomerases 
IIA and IIB in the early foetal 
human telencephalon. 
0 2.11 0.79 0.063 0 5 
281041
7H13Ri
k 
0 1.82 0.653 0.053 0 5 Mki67 
 
3.4E-307 1.83 0.697 0.083 5.5E-303 5 Rrm2 
 
2.4E-281 1.71 0.558 0.047 3.9E-277 5 Nusap1 
Developmental Emergence 
of Adult Neural Stem Cells as 
Revealed by Single-Cell 
Transcriptional Profiling 
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6.7E-251 1.55 0.498 0.041 1.1E-246 5 Ckap2l 
Radmis, a Novel Mitotic 
Spindle Protein that 
Functions in Cell Division of 
Neural Progenitors 
1.6E-248 1.76 0.538 0.052 2.6E-244 5 Prc1 
 
6.6E-224 1.63 0.469 0.041 1.1E-219 5 Cenpe 
 
5.4E-249 1.46 0.699 0.098 8.9E-245 6 Satb2 
Upper layer 
pyramidal 
neurons 
Satb2 Is a Postmitotic 
Determinant for Upper-Layer 
Neuron Specification in the 
Neocortex 
4.4E-244 1.43 0.758 0.119 7.3E-240 6 
913002
4F11Ri
k 
2E-112 0.89 0.403 0.064 3.4E-108 6 Plxna4 
Pyramidal Neurons Grow Up 
and Change Their Mind 
3.55E-89 1.10 0.374 0.073 5.83E-85 6 
Ppp1r1
4c 
 
0 2.13 0.544 0.021 0 7 Isl1 
Maturing + 
adult 
cortical 
interneuro
ns 
 
2.1E-280 2.49 0.507 0.025 3.4E-276 7 Ebf1 
 
2.7E-231 1.59 0.405 0.017 4.5E-227 7 Zfp503 
 
3.67E-90 1.00 0.294 0.033 6.05E-86 7 Dlx6 
Dlx5 and Dlx6 Regulate the 
Development of 
Parvalbumin-Expressing 
Cortical Interneurons 
8.89E-89 1.08 0.277 0.03 1.46E-84 7 
Vstm2
a 
 
1.15E-43 1.06 0.267 0.059 1.9E-39 7 Foxp2 
FoxP2 regulates neurogenesi
s during embryonic cortical d
evelopment. 
0 2.04 0.735 0.035 0 8 Aldoc 
Radial 
precursor 
cells 
Developmental Emergence 
of Adult Neural Stem Cells as 
Revealed by Single-Cell 
Transcriptional Profiling 
0 1.67 0.636 0.033 0 8 Gas1 
 
0 1.55 0.591 0.024 0 8 Mfge8 
 
9.3E-305 1.43 0.505 0.019 1.5E-300 8 Rgcc 
 
4E-286 1.88 0.773 0.083 6.6E-282 8 Ttyh1 
 
2.5E-257 1.78 0.57 0.04 4.1E-253 8 Mt2 
Developmental Emergence 
of Adult Neural Stem Cells as 
Revealed by Single-Cell 
Transcriptional Profiling 
4.5E-255 1.47 0.622 0.05 7.4E-251 8 
Ppap2
b 
 
3.1E-232 1.45 0.543 0.04 5E-228 8 Slc1a3 
Developmental Emergence 
of Adult Neural Stem Cells as 
Revealed by Single-Cell 
Transcriptional Profiling 
6.3E-227 1.70 0.704 0.086 1E-222 8 Ddah1 
 
3E-222 1.40 0.646 0.067 4.9E-218 8 Sox9 
Developmental Emergence 
of Adult Neural Stem Cells as 
Revealed by Single-Cell 
Transcriptional Profiling 
1.3E-172 1.61 0.44 0.037 2.2E-168 8 Mt3 
Developmental Emergence 
of Adult Neural Stem Cells as 
Revealed by Single-Cell 
Transcriptional Profiling 
2.33E-81 1.43 0.297 0.033 3.83E-77 9 63 
Neural 
progenitors 
63 Controls the Neural 
Progenitor Status in the 
Murine CNS 
0 2.76 0.904 0.029 0 10 Reln 
Cajal-
Retzius 
cells 
 
0 2.30 0.606 0.01 0 10 Snhg11 
 
0 2.16 0.819 0.024 0 10 
Cacna2
d2 
 
0 1.93 0.723 0.003 0 10 Lhx5 
LIM-homeobox gene Lhx5 is 
required for normal 
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development of Cajal-Retzius 
cells. 
0 1.92 0.638 0.002 0 10 Lhx1 
LIM-homeobox gene Lhx5 is 
required for normal 
development of Cajal-Retzius 
cells. 
0 1.91 0.67 0.002 0 10 
150001
6L03Ri
k 
0 1.68 0.66 0.012 0 10 Nr2f2 
 
0 1.47 0.574 0.002 0 10 
RP24-
351J24
.2 
6.4E-270 1.39 0.596 0.014 1.1E-265 10 Rcan2  
Gene expression analysis of 
the embryonic subplate 
1.4E-248 1.97 0.617 0.018 2.2E-244 10 Calb2  
 
6.4E-153 1.40 0.426 0.015 1.1E-148 10 Cdkn1a  
 
0 3.17 0.967 0.006 0 11 Alas2 
erythrocyte
s 
Hemoglobin mRNA Changes 
in the Frontal Cortex of 
Patients with 
Neurodegenerative Diseases 
0 2.71 0.767 0.012 0 11 Car2 
 
0 2.31 0.9 0.001 0 11 
Hbb-
bh1 
 
0 2.08 0.683 0 0 11 Gypa 
 
0 1.89 0.767 0.01 0 11 
Slc25a
37 
 
0 1.60 0.8 0.01 0 11 Hbb-y 
 
0 1.52 0.7 0.003 0 11 
Fam46
c 
 
0 1.39 0.5 0 0 11 Trim10 
 
1.1E-245 1.33 0.5 0.007 1.7E-241 11 Ube2l6 
 
1.3E-167 1.50 0.633 0.022 2.2E-163 11 Blvrb 
 
1.6E-158 2.11 0.85 0.05 2.6E-154 11 Fech 
 
1E-131 1.63 0.55 0.022 1.7E-127 11 Pnpo 
 
4.44E-23 1.48 0.963 0.658 7.31E-19 12 Gria2 
Excitatory 
neurons 
mousebrain.org 
2.91E-18 1.68 0.722 0.357 4.79E-14 12 Ptprs mousebrain.org 
5.77E-16 1.68 0.556 0.199 9.5E-12 12 Arpp21 
 
1.31E-11 1.50 0.63 0.349 2.16E-07 12 Cadm1 mousebrain.org 
1.99E-10 1.44 0.352 0.111 3.27E-06 12 
Ankrd1
3b 
 
8.81E-08 1.28 0.519 0.296 0.00145 12 Ank2 mousebrain.org 
0 3.63 0.951 0.002 0 13 P2ry12 
microglia 
Microglia versus myeloid cell 
nomenclature during brain 
inflammation 
0 3.45 0.951 0.001 0 13 C1qb 
Microglia versus myeloid cell 
nomenclature during brain 
inflammation 
0 3.37 0.976 0.002 0 13 Ctss 
Microglia versus myeloid cell 
nomenclature during brain 
inflammation 
0 3.36 0.951 0.002 0 13 C1qc 
Microglia versus myeloid cell 
nomenclature during brain 
inflammation 
0 3.33 0.951 0.003 0 13 Cx3cr1 
Microglia versus myeloid cell 
nomenclature during brain 
inflammation 
0 3.31 0.951 0.01 0 13 Rnase4 
Microglia versus myeloid cell 
nomenclature during brain 
inflammation 
0 3.22 0.927 0.001 0 13 C1qa 
Microglia versus myeloid cell 
nomenclature during brain 
inflammation 
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0 3.21 0.951 0.002 0 13 Laptm5 
Microglia versus myeloid cell 
nomenclature during brain 
inflammation 
0 3.19 0.951 0.001 0 13 Tyrobp 
Microglia versus myeloid cell 
nomenclature during brain 
inflammation 
0 3.19 0.951 0 0 13 Fcrls 
Microglia versus myeloid cell 
nomenclature during brain 
inflammation 
0 3.17 0.976 0.001 0 13 Csf1r 
Microglia versus myeloid cell 
nomenclature during brain 
inflammation 
0 2.97 0.927 0.002 0 13 Fcer1g 
Microglia versus myeloid cell 
nomenclature during brain 
inflammation 
0 2.94 0.927 0.007 0 13 Sepp1 
Microglia versus myeloid cell 
nomenclature during brain 
inflammation 
2.3E-147 3.44 0.927 0.047 3.8E-143 13 Hexb 
Microglia versus myeloid cell 
nomenclature during brain 
inflammation 
1.2E-131 4.10 0.951 0.057 2E-127 13 Apoe 
Microglia versus myeloid cell 
nomenclature during brain 
inflammation 
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10.4 Detailed protocol for a 3D-seq run 
All cell pelleting steps are done in Maxymum Recovery tubes. 
Store all cell counting images on USB – after RT and after Ligation. 
 
Fixation of tissue with – MeOH 
 
1. Take tissue slice containing boxes from -80°C and let come to room temperature 
a. Will take approx. 30 min 
2. Will waiting:  
a. wash grids 2x with 100 % EtOH to remove hydrophobic rests, wash with 
water and let air dry 
b. Thaw RT primers, Superscript IV buffer, DTT, dNTPs on ice 
3. Fix slices in cold MeOH (stored at -20°C), 20 min @ -20°C 
4. Dry slices at room temperature and wash 3x with cold PBS/Ribolock (1:80) 
5. Fix grid on tissue slice and take pictures with Keyence microscope 
a. Place tissue holding slide with tissue facing up in Keyence microscope, select 
4x objective, Color camera and use Multi-Dimensional Capture/ XY-Stitching -
> mark outer rims of tissue and let program do the capturing (should take ~2-
3 min) Figure 1 
b. Take out tissue slide and fix grid on tissue:  
i. place the bottom of the mounting device 
ii. put the grid in the top part of the mounting device and place it on the 
tissue 
iii. use screwdriver and 4 screws to tightly fix grid on tissue (start with 
diagonal screws) 
iv. place slice with grid back in Keyence microscope, adjust Brightness 
and Contrast until you can see the tissue through the grid (usually one 
click in Image -> Lookup Table -> Auto Shadow & Highlight) Figure 2 
v. use XY-stitching mode for taking images 
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Figure 40: Keyence setting for tissue slice capture 
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Figure 41: Taking images of tissue with grid on top. Left to right: Bottom part of mounting device with microscope 
slide that holds tissue; Grid within upper part of mounting device being screwed to the bottom part; Auto Shadow & 
Brightness adjustment 
 
RT without template switch  
Total of 1.5 µl reaction per grid well; total of 30 reactions: 
1. Put RT primer in PCR plate (same orientation as you want to have it in the grid) 
1 7 13 19 25 
2 8 14 20 26 
3 9 15 21 27 
4 10 16 22 28 
5 11 17 23 29 
6 12 18 24 30 
 
2. Mix remaining Mastermix separately, add 1.25 µl to RT primer in PCR plate 
 Per well For 30 wells = 32x 
RT primer 100 µM 0.50 ----- 
10 mM dNTPs 0.25 8.0 
5x Superscript IV Buffer 0.40 12.8 
Ribolock 0.25 8.0 
100 mM DTT 0.10 3.2 
Superscript IV 0.25 8.0 
 
3. Add 1.5 µl of Mastermix to each grid compartment, use capillary tips and LED 
magnifying glasses 
4. Close grid with cut qPCR plate foil seal 
5. Incubate: 25°C for 30 min, 37°C for 30 min; 45°C for 20 min (place on copper plate in 
96 well cycler), program is stored on silver BIOER cycler -> Christin -> 
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3D_RT_SPLIT; tighten lid of PCR cycler; use “Block control, highest possible sample 
volume”, hot lid control: 50°C 
 
 
 
6. Meanwhile:  
o prepare ligation plate (see “Ligation of barcode_2”) 
o prepare Papain for tissue digestion 15 min before RT is over 
▪ aliquot powder of one Worthington Papain Vial (Worthington 
LK003178) in 3 Eppendorf tubes // or use one aliquot 
▪ Add 500 µl EBSS 
▪ Incubate 10 min at 37°C -> cell culture incubator for O2:CO2 
equilibration, check if color changed from very pink to orange 
7. Carefully open PCR cycler (screws could stick to top part, as they are magnetic) 
8. Unscrew grid and wash slice carefully with 1xPBS/Ribolock (be fast) 
9. Dry surrounding of tissue with Q-tip, circle with hydrophobic pen 
10. Prepare single cell suspension: 
o Place microscope slide in plastic box that can be closed with a lid and place a 
water soaked Kimwipe next to is (to avoid drying out) 
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o Add 150-300 µl prepared, equilibrated Papain solution to slice and incubate 
15 min @ 37˚C, in cell culture incubator, plastic box closed 
 
o wash slice off into Eppendorf tube, if slice parts stick, scratch off with pipette 
tip 
o Completely harvest slice into Eppendorf tube, use up to 300 µl PBS/Ribolock 
(1:80) + 0.01 %BSA to aid washing off 
o Incubate another 15 min @ 37˚C on a shaker, using program F9, 12 rpm 
o Spin down cells 3000g, 15 min, 4˚C, resuspend in 320 µl 
o Take out 6 µl and mix with 6 µl Trypan blue for cell counting 
o Cell count: ________________ cells/ml (DEAD) 
Ligation of barcode_2 –10.0 µM 
1. Prepare ligation barcode plate: 
a. Anneal oCS632 and Split_bc2_1-96 
b. Dilute all barcode stocks to 50 µM 
 For 5.0 µl 20 µM barcode mix x97 
oCS632 50 µM 2.0 194.0 
Split_bc2 50 µM 2.0 --- 
CutSmart Buffer 10x 0.5 48.5 
water 0.5 48.5 
c. Heat to 95°C, 5 min, ramp down to 20°C, -0.1°C/s (Eppendorf Mastercycler 
X50s: 3D-seq -> Ligation annealing) 
 
2. Ligation reaction, add 5 µl to the annealed 5 µl in the barcode plate 
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 10 µl Rxn x97 
Cell Solution 3.0 291.0 
T4 DNA Ligation Buffer 1.0 97.0 
T4 DNA Ligase (10 U/µl 
final) 
0.25 24.25 
water 0.75 72.75 
a. Incubate 1 h at room temperature, shaking on Eppendorf MixMate 500 rpm 
 
b. Collect all cells (~1000 µl) and add BSA to 0.01 % 
c. Centrifuge at 3000g, 4°C, 15 min, take off supernatant (but leave 20-40 µl to 
not disturb the tiny cell pellet), resuspend in 960 µl of PBS/BSA + Ribolock 
d. Count cells: ______________ DEAD cells/ml, if concentration is > 5.0x104 
DEAD/ml dilute to below 5.0x104 DEAD/ml 
e. Distribute into 96-well plate, total of ______ wells (10 µl per well, DNA LoBind 
plates) 
f. Add 3 µl 4x Dropseq Lysis Buffer + DTT 
 4x Dropseq Lysis Buffer (final conc.) Mix for 1 ml  
50% Ficoll PM-400 24 % (6 % x4) 480 µl 
20% Sarkosyl 0.8 % (0.2 % x4) 40 µl 
0.5 M EDTA 80 mM (20 mM x4) 160 µl 
1 M Tris pH 7.5 120 mM 120 µl 
1 M DTT (add fresh) 200 mM (50 mM x4) 200 µl 
 
g. Incubate 30 min at room temperature, shaking on vortexer (stage 4) 
h. Fill up to 70 µl with water by adding 57 µl 
i. Add 63 µl AMPure beads (0.9x) per well mix thoroughly (5x with pipette), 
incubate at room temperature for 5 min, bind to magnet, wash with 180 µl 80 
% EtOH (take of 96-well plate from magnet, add EtOH, put on magnet, shift 
right, shift left, wait for beads to bind to magnet, take off EtOH) 
j. Repeating washing with 180 µl 80 % EtOH, let beads air dry (at appearance 
of first crack, proceed with elution) 
k. Elute in 40 µl water (add water, resuspend by pipetting, incubate 5 min at 
room temperature, put back on magnet, recover supernatant) 
l. Repeat AMPure bead clean-up, add 32 µl beads (0.8x), elute in 15 µl water 
POSSIBLE PAUSE POINT (FREEZE SAMPLES), but it is better to finish 
the SS synthesis 
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Second Strand Synthesis – without TSO 
2. Perform Second Strand Synthesis, 96 wells, add 5 µl of Mastermix to each well 
 1x X96+2 x____ 
10x Second Strand 
Buffer 
2.0 196.0  
Second Strand 
Enzyme Mix (NEB 
E6111S) 
0.8 78.4  
Ran. hexamers 0.1 9.8  
water 2.1 205.8  
Incubate 1:30 h at 16°C; Eppendorf Mastercycler 3D-seq -> Second Strand 
 
3. Purify dsDNA by adding 20 µl AMPure XP beads (1.0x): add, mix, incubate 5 min at 
room temperature; put on magnet; wash twice with 180 µl 80 % EtOH; resuspend in 
6 µl 
 
4. Take out 1 µl from 5 random wells and use for qPCR to measure cDNA amount per 
well 
a. Ok to use qPCR stripes (applied Biosystems, MicroAmp strips + optical caps)  
 
 
qPCR - 3D-seq measure cDNA amount per well
qPCR plate
1 2 3 4 5
A
B
C
D
E
F
G
H
cDNA + 7.5 ul SYBR = 11.25 ul per well
expl. wells cDNA [ul] water [ul] SYBR [ul]
sample 4 4.40 12.10 33.00
water 4 4.40 12.10 33.00
Primer - 2.5 uM mix stock = 3.75 ul per well
647/692 binds in ligation barcode + 3'end of ActB
647/694 binds in ligation barcode + 3'end of Tubb3
to make 2.5 uM mix stock from 100 uM stock:
647 20 ul
692 20 ul
water 760 ul
sample + primer 647/692
water + primer 647/692
sample + primer 647/694
water + primer 647/694
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• qPCR measurement: right machine -> New experiment from template -> Christin 
tagmentation standard.eds 
 
• use “template_quantification_before_tagmentation.xlsx” for calculation of pg/µl 
 
______ pg/µl x 6 µl (per well) x 96 wells = total mass _________ pg = _________ ng 
______ pg/µl x 6 µl (per well) = _____________ pg/well 
5 µl Amplicon Tagmentation Mix per 600 pg->______ µl ATM per well (x pg/well * 5 
µl/600 pg) 
PAUSE POINT (Freeze samples) 
 
Tagmentation 
5. Tagmentation: 5 min at 55°C, final volume 13 µl, add 7 µl to each well, mix well 
 1x X_____ 
Nextera TD Buffer (2x) 6.5  
Amplicon Tagmentation mix   
Sample 6.0 ----- 
Water    
 
6. Add 7 µl water to each well 
7. Add 5 µl NT buffer to each well, mix well by pipette using 10 pipetting steps 
8. Perform qPCR amplification for estimation (70 µl total volume, use 1 entire well for 
estimation with EvaGreen) 
 1x 
sample 25.0 
10 µM N7xx (mine) 2.0 
10 µM S5xx (kit) 2.0 
5 µM oCS683 1.0 
5 µM oCS684 1.0 
20x Evagreen 3.5 
water 2.6 
Buffer 35.0 
Terra polymerase 1.4 
 
(600 pg should leave exponential phase at 12 cycles, 50 pg at 22 cycles; 552 pg was at 14-15 
cycles in Exp_019) 
Right machine -> New experiment from template -> Christin Terra PCR 
- Determine optimal number of cycles for final PCR: change to linear view and take 
number of cycles where ΔRn is ~7500-10000 (wait for qPCR to finish!) Figure 3 
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Figure 42: Determining the cycle number for the final PCR 
 
9. Perform PCR, with Terra Polymerase for _____ cycles 
 1x X______ – Terra 
sample 25.0 ------- 
10 µM N7xx (mine) 2.0 -------- 
10 µM S5xx (kit) 2.0 ------- 
5 µM oCS683 1.0  
5 µM oCS684 1.0  
water 2.6  
Buffer 35.0  
Terra polymerase 1.4  
 
Primers used:  
- N7____, N7____, N7____, N7____, N7____, N7____, N7____ 
 
Terra Polymerase: 
98°C 2 min  
98°C 10 s 
X cycles (check qPCR) 60°C 15 s 
68°C 60 s 
68°C 5 min  
 
10. Purify with AMPure beads: combine all wells w/ same PCR cycle in 2-4x 1.5 ml tubes 
(_____µl) and add ____ µl of AMPure XP beads (0.8x) to each tube, purify as usual 
and elute in 150 µl of water (use to combine all beads in one tube) 
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11. Repeat bead clean-up by adding _____ µl AMPure beads (0.8x), as usual and elute 
in 40 µl water 
12. Tapestation profile and Qubit measurement 
a. Qubit should be between 0.5 – 2 ng/µl 
b. Tapestation profile example: 
 
 
13. For sequencing: 
a.  use 1x150 nt Mid or HighOutput on NextSeq 
b. load 2-4 pM, 5 % PhiX: in the final dilution step according to Illumina’s 
protocol use 
i. 130 µl 20 pM library (= 2 pM)  
1105 µl HT1 
65 µl 1.8 pM PhiX 
ii. 260 µl 20 pM library (= 4 pM)  
975 µl HT1 
65 µl 1.8 pM PhiX 
 
c. NO custom primers 
d. Read 1: 80 nt; Index 1: 8 nt; Index 2: 8 nt; Read 2: 67 nt 
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